LOGO

  JULY 31, 2022

 

 

  

  

2022 Annual Report

 

 

iShares U.S. ETF Trust

·   iShares Evolved U.S. Consumer Staples ETF | IECS | Cboe BZX

·   iShares Evolved U.S. Discretionary Spending ETF | IEDI | Cboe BZX

·   iShares Evolved U.S. Financials ETF | IEFN | Cboe BZX

·   iShares Evolved U.S. Healthcare Staples ETF | IEHS | Cboe BZX

·   iShares Evolved U.S. Innovative Healthcare ETF | IEIH | Cboe BZX

·   iShares Evolved U.S. Media and Entertainment ETF | IEME | Cboe BZX

·   iShares Evolved U.S. Technology ETF | IETC | Cboe BZX


The Markets in Review

Dear Shareholder,

The 12-month reporting period as of July 31, 2022 saw the emergence of significant challenges that disrupted the economic recovery and strong financial markets. The U.S. economy shrank in the first half of 2022, ending the run of robust growth that followed the reopening of global economies and the development of COVID-19 vaccines. Changes in consumer spending patterns and a tight labor market led to elevated inflation, which reached a 40-year high. Moreover, while the foremost effect of Russia’s invasion of Ukraine has been a severe humanitarian crisis, the ongoing war continued to present challenges for both investors and policymakers.

Equity prices fell as interest rates rose, particularly weighing on relatively high-valuation growth stocks and economically sensitive small-capitalization stocks. While both large- and small-capitalization U.S. stocks fell, declines for small-capitalization U.S. stocks were steeper. Both emerging market stocks and international equities from developed markets fell significantly, pressured by rising interest rates and a strengthening U.S. dollar.

The 10-year U.S. Treasury yield (which is inversely related to bond prices) rose notably during the reporting period as investors reacted to higher inflation and attempted to anticipate its impact on future interest rate changes. The corporate bond market also faced inflationary headwinds, and increasing uncertainty led to higher corporate bond spreads (the difference in yield between U.S. Treasuries and similarly-dated corporate bonds).

The U.S. Federal Reserve (the “Fed”), acknowledging that inflation is growing faster than expected, raised interest rates four times while indicating that additional rate hikes were likely. Furthermore, the Fed wound down its bond-buying programs and began to reduce its balance sheet. Continued high inflation and the Fed’s statements led many analysts to anticipate that interest rates have room to rise before peaking, although investors’ inflation expectations began to decline near the end of the period.

The horrific war in Ukraine has significantly clouded the outlook for the global economy, leading to major volatility in energy and metals markets. Sanctions on Russia, Europe’s top energy supplier, and general wartime disruption have magnified supply problems for key commodities. We believe elevated energy prices will continue to exacerbate inflationary pressure while also constraining economic growth. Combating inflation without stifling a recovery, while buffering against ongoing supply and price shocks, will be an especially challenging environment for setting effective monetary policy. Despite the likelihood of more rate increases on the horizon, we believe the Fed will ultimately err on the side of protecting employment, even at the expense of higher inflation. In the meantime, however, we believe that we are likely to see a period of slowing growth paired with relatively high inflation.

In this environment, while we favor an overweight to equities in the long-term, the market’s concerns over excessive rate hikes from central banks moderate our outlook. Furthermore, the energy shock and a deteriorating economic backdrop in China and Europe are likely to challenge corporate earnings, so we are underweight equities overall in the near-term. We take the opposite view on credit, where higher spreads provide near-term opportunities, while the likelihood of higher inflation leads us to take an underweight stance on credit in the long-term. We believe that investment-grade corporates, U.K. gilts, local-currency emerging market debt, and inflation-protected bonds (particularly in Europe) offer strong opportunities for a six- to twelve-month horizon.

Overall, our view is that investors need to think globally, extend their scope across a broad array of asset classes, and be nimble as market conditions change. We encourage you to talk with your financial advisor and visit iShares.com for further insight about investing in today’s markets.

Sincerely,

 

LOGO

Rob Kapito

President, BlackRock, Inc.

LOGO

Rob Kapito

President, BlackRock, Inc.

 

Total Returns as of July 31, 2022  
     
       6-Month       12-Month  
   

U.S. large cap equities
(S&P 500® Index)

    (7.81 )%      (4.64 )% 
   

U.S. small cap equities
(Russell 2000® Index)

    (6.42     (14.29
   

International equities
(MSCI Europe, Australasia, Far East Index)

    (11.27     (14.32
   

Emerging market equities
(MSCI Emerging Markets Index)

    (16.24     (20.09
   

3-month Treasury bills
(ICE BofA 3-Month U.S. Treasury Bill Index)

    0.21       0.22  
   

U.S. Treasury securities
(ICE BofA 10-Year U.S. Treasury Index)

    (6.38     (10.00
   

U.S. investment grade bonds
(Bloomberg U.S. Aggregate Bond Index)

    (6.14     (9.12
   

Tax-exempt municipal bonds
(Bloomberg Municipal Bond Index)

    (3.95     (6.93
   

U.S. high yield bonds
(Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index)

    (6.58     (8.03

Past performance is not an indication of future results. Index performance is shown for illustrative purposes only. You cannot invest directly in an index.

 

 

 

2  

T H I S   P A G E   I S   N O T   P A R T   O F   Y O U R   F U N D   R E P O R T


Table of Contents

 

 

     Page  

 

 

The Markets in Review

     2  

Annual Report:

  

Market Overview

     4  

Fund Summary

     5  

About Fund Performance

     19  

Disclosure of Expenses

     19  

Schedules of Investments

     20  

Financial Statements:

  

Statements of Assets and Liabilities

     44  

Statements of Operations

     46  

Statements of Changes in Net Assets

     48  

Financial Highlights

     52  

Notes to Financial Statements

     59  

Report of Independent Registered Public Accounting Firm

     67  

Important Tax Information

     68  

Board Review and Approval of Investment Advisory Contract

     69  

Supplemental Information

     71  

Trustee and Officer Information

     72  

General Information

     75  

Glossary of Terms Used in this Report

     76  

 

 

  3


Market Overview

 

iShares U.S. ETF Trust

Domestic Market Overview

U.S. stocks declined for the 12 months ended July 31, 2022 (“reporting period”), when the Russell 3000® Index, a broad measure of U.S. equity market performance, returned -7.35%. Equities advanced early in the reporting period as strong household balance sheets and robust job growth supported rising consumer spending. Increased economic activity led to strong corporate earnings as companies reaped the benefits amid a recovery from the effects of the coronavirus pandemic. However, significant challenges emerged as the reporting period continued, including high inflation, rising interest rates, slower economic growth, and the impacts of Russia’s invasion of Ukraine. These factors drove stock prices sharply lower, erasing prior gains and leading to significantly negative performance for the reporting period overall.

The U.S. economy grew briskly over the final half of 2021, powered primarily by consumer spending. Record-high personal savings rates allowed consumers to spend at an elevated level, releasing pent-up demand for goods and services. Growth subsequently stalled in the first half of 2022, and the economy contracted amid lower inventories and faltering business investment. Despite the economic downturn, indicators were mixed, showing evidence of a slowdown in some areas while others remained positive. Hiring continued to increase as businesses restored capacity, and unemployment declined substantially, falling to 3.5% in July 2022 — identical to the pre-pandemic rate in February 2020. Although high inflation negatively impacted consumer sentiment, which declined significantly, consumer spending continued to rise.

The rapid increase in consumer spending drove a significant rise in inflation. Supply chains for many goods were disrupted by the pandemic and could not quickly adapt to the rapid rebound in demand. Oil prices also rose significantly as demand increased and a lack of investment constrained the supply of oil. The strong job market led to higher wages, particularly at the lower end of the market. These factors drove prices higher in many areas of the economy.

Rising inflation led to a shift in policy from the U.S. Federal Reserve (“the Fed”). As the reporting period began, the Fed was using accommodative monetary policy to stimulate the economy. Short-term interest rates were kept at near-zero levels, and the Fed used bond-buying programs to stabilize debt markets. However, rising prices led the Fed to tighten monetary policy during the reporting period in an attempt to prevent runaway inflation. The Fed slowed and then ended its bond-buying activities, finally reversing course as it began to reduce its balance sheet in June 2022.

In March 2022, the Fed began to raise short-term interest rates, followed by three more increases for a total increase of 225 basis points, the most rapid rise in decades. Interest rates rose significantly in response, leading to higher borrowing costs for businesses. The effect of higher inflation and interest rates on equities varied significantly based on equity class. Growth stocks, which derive much of their value from expectations of future growth, declined significantly more than value stocks.

Russia’s invasion of Ukraine in late February 2022 led to substantial disruptions to the global economy and increased uncertainty in financial markets, exacerbating inflation and impacting U.S. businesses with operations in Russia. The invasion was met with widespread condemnation, and many countries imposed sanctions on the Russian state, businesses, and individuals. As Russia is a top producer of both oil and natural gas, global supply concerns led to sharp volatility in U.S. energy markets.

 

 

4  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of July 31, 2022     iShares® Evolved U.S. Consumer Staples ETF

 

Investment Objective

The iShares Evolved U.S. Consumer Staples ETF (the “Fund”) seeks to provide access to U.S. companies with consumer staples exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

        Average Annual Total Returns               Cumulative Total Returns  
               1 Year      Since
Inception
                     1 Year      Since
Inception
 

Fund NAV

    4.67      10.48       4.67      54.51

Fund Market

    4.78        10.48         4.78        54.47  

S&P Total Market IndexTM

    (7.78      11.16               (7.78      58.60  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was March 21, 2018. The first day of secondary market trading was March 23, 2018.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is not an indication of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” for more information.

Expense Example

 

    Actual     Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

           

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00            $         999.30            $         0.89               $       1,000.00            $      1,023.90            $         0.90          0.18

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Disclosure of Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  5


Fund Summary as of July 31, 2022  (continued)    iShares® Evolved U.S. Consumer Staples ETF

 

Portfolio Management Commentary

Consumer staples stocks in the U.S. advanced for the reporting period as investors, amid turbulent financial markets, sought equities generally viewed as less volatile than the broader market. Businesses within the sector offer relatively steady income and attractive dividend payouts that further enticed investors amid the increased market and economic uncertainty of early 2022. As a sector, staples outperformed all but two other U.S equity sectors (energy and utilities) for the reporting period, based on S&P Dow Jones Indices.

Large beverage companies Coca-Cola and Pepsico contributed the most to the Fund’s return. The companies benefited as sales volumes at restaurants and other public venues continued to rebound from the coronavirus pandemic. Price increases bolstered revenue gains and partly helped offset higher costs and business disruptions in Russia due to sanctions after the invasion of Ukraine. Pepsico, which has a complementary product line of snacks, benefited by combatting cost inflation for supplies with higher prices and smaller package sizes, which increased revenues.

Prepared food and snacks manufacturer, such as General Mills, also contributed to the Fund’s performance. Sales in the industry increased as companies absorbed rising input costs by increasing prices. Candy makers, including Hershey Foods, also advanced as increased production capacity failed to meet the strong demand for those products. Meanwhile, Archer Daniels Midland and other agricultural commodities processors benefited from tight global grain supplies and corresponding higher market prices, in addition to rising demand for their ingredients.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several consumer staples companies with similar businesses that have traditionally been categorized in other sectors. For example, the Fund held positions in Starbucks and Chipotle Mexican Grill, which are typically classified as companies in the consumer discretionary sector. These global quick service restaurant companies detracted from the Fund’s return as consumers’ overall discretionary spending declined during the reporting period, while food and ingredient costs rose.

Portfolio Information

 

 

INDUSTRY ALLOCATION

 

 

   
Sector    

Percent of

Total Investments

 

(a) 

Beverages

    32.6

Food

    24.6  

Agriculture

    11.8  

Cosmetics & Personal Care

    9.7  

Retail

    9.6  

Packaging & Containers

    2.7  

Household Products & Wares

    1.9  

Chemicals

    1.9  

Pharmaceuticals

    1.7  

Biotechnology

    1.0  

Other (each representing less than 1%)

    2.5  

TEN LARGEST HOLDINGS

 

 

   
Security    

Percent of

Total Investments

 

(a) 

Coca-Cola Co. (The)

    12.0

PepsiCo Inc.

    11.0  

Procter & Gamble Co. (The)

    7.5  

Philip Morris International Inc.

    4.8  

Mondelez International Inc., Class A

    4.6  

General Mills Inc.

    3.7  

Altria Group Inc.

    3.7  

Starbucks Corp.

    3.2  

Monster Beverage Corp.

    3.0  

McDonald’s Corp.

    2.8  

 

  (a) 

Excludes money market funds.

 

 

 

6  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of July 31, 2022      iShares® Evolved U.S. Discretionary Spending ETF

 

Investment Objective

The iShares Evolved U.S. Discretionary Spending ETF (the “Fund”) seeks to provide access to U.S. companies with discretionary spending exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

        Average Annual Total Returns               Cumulative Total Returns  
             1 Year      Since
Inception
                     1 Year      Since
Inception
 

Fund NAV

    (12.65 )%       12.30       (12.65 )%       65.92

Fund Market

    (12.63      12.30         (12.63      65.90  

S&P Total Market IndexTM

    (7.78      11.16               (7.78      58.60  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was March 21, 2018. The first day of secondary market trading was March 23, 2018.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is not an indication of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” for more information.

Expense Example

 

    Actual    

Hypothetical 5% Return

          
 

 

 

     

 

 

      
     

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

           

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00            $         887.60            $         0.84               $       1,000.00            $      1,023.90            $         0.90          0.18

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Disclosure of Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  7


Fund Summary as of July 31, 2022  (continued)    iShares® Evolved U.S. Discretionary Spending ETF

 

Portfolio Management Commentary

Stocks related to U.S. discretionary spending declined for the reporting period amid a variety of economic concerns, including rising inflation, Fed interest rate increases, and the war between Russia and Ukraine. As U.S. economic output contracted, consumers contemplated the possibility of a recession. Discretionary spending decreased during the reporting period, and the outlook for a near-term rebound appeared uncertain, weighing on stocks within the sector.

The commerce industry detracted the most from the Fund’s return, driven by internet commerce and direct marketers. Large e-commerce retailer Amazon declined as rising inflation led to increased labor costs and decreasing sales. Supply-chain problems further exacerbated a reduction in profit margins. Amazon’s addition of warehouse space and expansion of transportation networks during the height of the coronavirus pandemic yielded excess capacity that added to expenses when sales declined in the first half of 2022. As many investors associate e-commerce retailers with the information technology sector, that sector’s overall decline in early 2022 also weighed on companies like Amazon.

Traditional in-store retail outlets likewise detracted from the Fund’s performance. Many large chains canceled orders and marked down merchandise they had purchased during the height of the pandemic — merchandise that consumers no longer found attractive as pandemic-related restrictions disappeared and inflation increased. Sales for discount outlets Ross Stores and Burlington Stores, which cater to more cost-conscious consumers, also increasingly declined amid rising inflation, while inventory levels rose substantially. Nike a leading footwear marketer, also detracted amid a withdrawal from Russia, China’s pandemic-related lockdowns, rising freight and logistics costs, questions about the North American market outlook, and concerns about labor practices in western China.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several companies with similar businesses that traditionally have been categorized in other sectors. For example, the Fund held positions in warehouse general merchandise chains, such as Costco, which is generally classified in the consumer staples sector. Costco advanced as it profited from shoppers seeking the benefits of bulk pricing.

Portfolio Information

 

 

INDUSTRY ALLOCATION

 

 

   
Sector    

Percent of

Total Investments

 

(a) 

Retail

    54.8

Internet

    21.6  

Apparel

    6.2  

Cosmetics & Personal Care

    3.9  

Lodging

    2.4  

Food

    1.8  

Commercial Services

    1.5  

Entertainment

    1.1  

Computers

    1.1  

Distribution & Wholesale

    1.0  

Other (each representing less than 1%)

    4.6  

TEN LARGEST HOLDINGS

 

 

   
Security    

Percent of

Total Investments

 

(a) 

Amazon.com Inc.

    17.8

Home Depot Inc. (The)

    8.1  

Costco Wholesale Corp.

    7.4  

Walmart Inc.

    6.0  

Nike Inc., Class B

    3.8  

McDonald’s Corp.

    3.5  

Lowe’s Companies Inc.

    3.2  

Target Corp.

    2.8  

Procter & Gamble Co. (The)

    2.6  

TJX Companies Inc. (The)

    2.3  

 

  (a) 

Excludes money market funds.

 

 

 

8  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of July 31, 2022      iShares® Evolved U.S. Financials ETF

 

Investment Objective

The iShares Evolved U.S. Financials ETF (the “Fund”) seeks to provide access to U.S. companies with financials exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

        Average Annual Total Returns               Cumulative Total Returns  
               1 Year      Since
Inception
                     1 Year      Since
Inception
 

Fund NAV

    (3.23 )%       6.17       (3.23 )%       29.88

Fund Market

    (3.24      6.17         (3.24      29.87  

S&P Total Market IndexTM

    (7.78      11.16               (7.78      58.60  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was March 21, 2018. The first day of secondary market trading was March 23, 2018.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is not an indication of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” for more information.

Expense Example

 

    Actual     Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

(a)  

           

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00            $         892.10            $         0.84               $       1,000.00            $      1,023.90            $         0.90          0.18

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Disclosure of Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  9


Fund Summary as of July 31, 2022  (continued)    iShares® Evolved U.S. Financials ETF

 

Portfolio Management Commentary

U.S. financials stocks declined for the reporting period amid a steep decline in the broader stock market and myriad economic challenges. Rising inflation, Fed interest rate increases, and the war between Russia and Ukraine created significant economic headwinds.

A diverse group of financial services companies, including asset managers, investment banks, and credit ratings agencies detracted from the Fund’s performance. Asset management companies, such as T. Rowe Price Group, declined alongside the broader equity market. Cash inflows into equity investment funds declined considerably in the first half of 2022, and bond funds posted net outflows, reducing fees and profitability. Investment banks Morgan Stanley and Goldman Sachs detracted amid substantial decreases in revenue and in deal-making in capital markets. Investors reacted negatively to the disappointing near-term revenue outlook. In addition, stock underwriting for initial public offerings all but halted. Meanwhile, investment ratings agency Moody’s Corporation declined following a sharp decrease in corporate debt issuance amid a rising interest rate environment, which led to reduced earnings visibility.

Credit card issuers also detracted from the Fund’s return as the U.S. economy slowed. For example, Capital One Financial Corporation declined, despite benefiting both from increased consumer spending in the wake of pent-up, pandemic-induced demand and from assets yielding higher interest income. Investors grew cautious about the uncertain outlook for continued consumer spending amid mounting recession concerns, as credit card fee revenue highly correlates with customer transactions.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several financials companies with similar businesses that traditionally have been categorized in other sectors. For example, Fidelity National Information Services, which is traditionally categorized in the information technology sector, declined from relative performance as mobile and e-commerce payment gateway providers faced a challenging business outlook. On the upside, companies in the healthcare sector, such as UnitedHealth Group, a large managed healthcare company, contributed to the Fund’s relative performance. UnitedHealth benefited from lower expenses for coronavirus-related care and increased insurance enrollment.

Portfolio Information

 

 

INDUSTRY ALLOCATION

 

 

   
Sector    

Percent of

Total Investments

 

(a) 

Banks

    40.3

Insurance

    25.0  

Diversified Financial Services

    17.1  

Commercial Services

    4.2  

Health Care - Services

    4.1  

Software

    2.5  

Pharmaceuticals

    1.9  

Machinery

    1.2  

Private Equity

    1.2  

Other (each representing less than 1%)

    2.5  

TEN LARGEST HOLDINGS

 

 

   
Security    

Percent of

Total Investments

 

(a) 

Wells Fargo & Co.

    4.3

JPMorgan Chase & Co.

    4.0  

Bank of America Corp.

    3.9  

Berkshire Hathaway Inc., Class B

    3.3  

Goldman Sachs Group Inc. (The)

    3.0  

Morgan Stanley

    2.9  

Charles Schwab Corp. (The)

    2.8  

UnitedHealth Group Inc.

    2.8  

Citigroup Inc.

    2.3  

Truist Financial Corp.

    2.1  

 

  (a) 

Excludes money market funds.

 

 

 

10  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of July 31, 2022      iShares® Evolved U.S. Healthcare Staples ETF

 

Investment Objective

The iShares Evolved U.S. Healthcare Staples ETF (the “Fund”) seeks to provide access to U.S. companies with healthcare staples exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

        Average Annual Total Returns               Cumulative Total Returns  
               1 Year      Since
Inception
                     1 Year      Since
Inception
 

Fund NAV

    (5.09 )%       13.29       (5.09 )%       72.41

Fund Market

    (5.24      13.26         (5.24      72.17  

S&P Total Market IndexTM

    (7.78      11.16               (7.78      58.60  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was March 21, 2018. The first day of secondary market trading was March 23, 2018.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is not an indication of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” for more information.

Expense Example

 

    Actual     Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

           

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00            $         978.00            $         0.88               $        1,000.00            $      1,023.90            $         0.90          0.18

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Disclosure of Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  11


Fund Summary as of July 31, 2022  (continued)    iShares® Evolved U.S. Healthcare Staples ETF

 

Portfolio Management Commentary

U.S. healthcare staples stocks declined modestly for the reporting period as inflationary pressures, labor shortages, and resurging coronavirus waves outweighed favorable spending trends and pent-up demand for elective surgeries. Healthcare equipment stocks detracted the most from the Fund’s return, due to continuing supply-chain challenges and pandemic-related delays. Medtronic reported lower sales as recurring lockdowns in China constrained supply of raw materials and added to logistics delays. The shortage of nurses in the U.S. further limited the number of medical procedures conducted at hospitals. Deferred procedures due to COVID-19 also lowered sales volumes and increased near-term spending for Intuitive Surgical despite increased adoption of the firm’s robotic surgical platform. Stryker also reported a rise in sales for its surgical robots; however, the company’s revenue growth slowed overall as hospital clients increasingly shifted away from outright purchases in favor of rental or longer-term financing contracts. The resurging COVID-19 waves drove sales higher for at-home antigen tests, but test-maker Abbott Laboratories’ stock declined after a recall of baby formula products halted factory production and exacerbated a nationwide shortage.

Life sciences tools and services stocks also weighed on the Fund’s return. China’s lockdowns led to significantly lowered sales for gene-sequencing supplier Illumina. Regulatory pressure in the U.S. and Europe regarding a recent acquisition also dampened investor enthusiasm for the firm’s stock.

On the upside, managed healthcare companies contributed to the Fund’s performance as investors sought out businesses with less exposure to inflation impacts. UnitedHealth Group was the largest contributor as the managed healthcare conglomerate increased revenue through diversified business strategies, including expanding low-cost telehealth offerings and other non-hospital-based health services.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activities. During the reporting period, the evolved process identified several healthcare companies with similar businesses that have traditionally been categorized in other sectors. In the real estate investment trust (“REIT”) industry, Healthpeak Properties, which owns and develops private healthcare facilities, declined due to weakness in its continuing care residential community segment due to a one-time repayment of CARES Act relief funds.

Portfolio Information

 

 

INDUSTRY ALLOCATION

 

 

   
Sector    

Percent of

Total Investments

 

(a) 

Health Care - Products

    43.2

Health Care - Services

    31.2  

Pharmaceuticals

    20.0  

Biotechnology

    1.5  

Real Estate Investment Trusts

    1.2  

Electronics

    1.1  

Other (each representing less than 1%)

    1.8  

TEN LARGEST HOLDINGS

 

 

   
Security    

Percent of

Total Investments

 

(a) 

UnitedHealth Group Inc.

    16.7

Abbott Laboratories

    7.5  

Danaher Corp.

    5.1  

Johnson & Johnson

    4.8  

Medtronic PLC

    4.5  

Thermo Fisher Scientific Inc.

    4.2  

Elevance Health Inc.

    3.4  

CVS Health Corp.

    3.4  

AbbVie Inc.

    3.2  

Intuitive Surgical Inc.

    3.2  

 

  (a) 

Excludes money market funds.

 

 

 

12  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of July 31, 2022      iShares® Evolved U.S. Innovative Healthcare ETF

 

Investment Objective

The iShares Evolved U.S. Innovative Healthcare ETF (the “Fund”) seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

        Average Annual Total Returns               Cumulative Total Returns  
               1 Year      Since
Inception
                     1 Year      Since
Inception
 

Fund NAV

    (4.26 )%       9.64       (4.26 )%       49.44

Fund Market

    (4.22      9.63         (4.22      49.34  

S&P Total Market IndexTM

    (7.78      11.16               (7.78      58.60  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was March 21, 2018. The first day of secondary market trading was March 23, 2018.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is not an indication of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” for more information.

Expense Example

 

    Actual     Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

           

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00            $        1,015.20            $         0.90               $       1,000.00            $      1,023.90            $         0.90          0.18

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Disclosure of Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  13


Fund Summary as of July 31, 2022  (continued)    iShares® Evolved U.S. Innovative Healthcare ETF

 

Portfolio Management Commentary

U.S. innovative healthcare stocks declined modestly during the reporting period as the rising interest rate environment weighed on high-valuation stocks and cooled capital flows. Recurring COVID-19 outbreaks added to the uncertain market environment as drugmakers struggled with mismatches between vaccine supply and demand. Merger and acquisition activity within the pharmaceutical industry dropped to one of the lowest levels in the last decade amid heightened regulatory scrutiny.

Biotechnology stocks detracted the most from the Fund’s return as declining COVID-19 vaccine sales and research funding pressured the earnings of companies such as Moderna and Novavax. Moderna announced the development of a new vaccine targeting the omicron variant even as declining case rates raised doubts about the necessity of variant-specific vaccines. Competition from the introduction of new treatments for COVID-19 weighed particularly hard on less diversified companies such as Moderna, which derive nearly all their revenue from vaccines.

Other biotechnology companies reported disappointing drug sales. Biogen’s highly anticipated Alzheimer’s treatment, widely criticized for its initial high price point, encountered multiple distribution hurdles with insurance companies and prominent medical centers. Gilead Sciences’ stock also trended lower due to falling sales of its COVID-19 antiviral drug for hospitalized patients, despite increased revenue from its cancer and HIV drug divisions. In addition, clinical-stage oncology company Mirati Therapeutics reported mixed clinical trial results for its new KRAS-mutation targeting cancer drug. Competitive category pressure and management turnover further marred the stock’s performance.

On the upside, pharmaceuticals companies such as Pfizer and Eli Lilly contributed to the Fund’s return. These broadly diversified companies hold large amounts of cash on their balance sheets and generated revenue gains across multiple categories, making them less dependent on COVID-19 related drug sales alone.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several healthcare companies with similar businesses that have traditionally been categorized in other sectors. In the information technology sector, Universal Display Corporation detracted from the Fund’s return due to rising commodities prices and increased competition.

Portfolio Information

 

 

INDUSTRY ALLOCATION

 

 

   
Sector    

Percent of

Total Investments

 

(a) 

Biotechnology

    47.7

Pharmaceuticals

    46.9  

Health Care - Products

    3.2  

Health Care - Services

    2.0  

Other (each representing less than 1%)

    0.2  

TEN LARGEST HOLDINGS

 

 

   
Security    

Percent of

Total Investments

 

(a) 

Johnson & Johnson

    11.2

Eli Lilly & Co.

    8.2  

AbbVie Inc.

    6.6  

Merck & Co. Inc.

    6.3  

Bristol-Myers Squibb Co.

    5.8  

Vertex Pharmaceuticals Inc.

    5.6  

Amgen Inc.

    4.8  

Moderna Inc.

    4.7  

Gilead Sciences Inc.

    4.4  

Regeneron Pharmaceuticals Inc.

    4.3  

 

  (a) 

Excludes money market funds.

 

 

 

14  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of July 31, 2022      iShares® Evolved U.S. Media and Entertainment ETF

 

Investment Objective

The iShares Evolved U.S. Media and Entertainment ETF (the “Fund”) seeks to provide access to U.S. companies with media and entertainment exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

        Average Annual Total Returns               Cumulative Total Returns  
               1 Year      Since
Inception
                     1 Year      Since
Inception
 

Fund NAV

    (29.16 )%       2.93       (29.16 )%       13.45

Fund Market

    (29.13      2.91         (29.13      13.35  

S&P Total Market IndexTM

    (7.78      11.16               (7.78      58.60  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was March 21, 2018. The first day of secondary market trading was March 23, 2018.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is not an indication of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” for more information.

Expense Example

 

    Actual     Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period(

 

 

a)  

           

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00            $         808.40            $         0.81               $       1,000.00            $      1,023.90            $         0.90          0.18

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Disclosure of Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  15


Fund Summary as of July 31, 2022  (continued)    iShares® Evolved U.S. Media and Entertainment ETF

 

Portfolio Management Commentary

U.S. media and entertainment stocks declined sharply during the reporting period amid slowing global economic growth and a consumer shift from digital back to in-person experiences. Rising inflation increased costs, and relatively high valuations led investors to closely scrutinize corporate earnings.

Entertainment media companies detracted the most from the Fund’s return. Profits decreased as operating costs increased at Roku, a streaming and television interface company, while revenue from digital advertising declined. Increased competition also weighed on Roku as Microsoft Corporation announced plans to enter the streaming device market. Streaming service Netflix also detracted significantly, losing subscribers as customers in search of new content switched services frequently. Furthermore, Netflix incurred high costs from creating original programming to attract subscribers. The Walt Disney Company, a media conglomerate, also declined as increased competition, slowing growth, and rising costs reduced profits from its Disney Plus streaming media service. While its theme parks showed strength following the loosening of coronavirus-related restrictions, a conflict with Florida’s state government negatively impacted the company.

Broadband service companies also detracted meaningfully from the Fund’s return. New high speed internet options, such as fiberoptic services offered by wireless companies, led to increased competition for broadband service. While revenues rose at Charter Communications, a provider of cable and internet service, subscriber growth slowed markedly. Telecommunications conglomerate Comcast Communications declined due to weak growth in its streaming service, Peacock, and its broadband service, as home buying slowed, and customers switched to mobile broadband services. In the social media industry, uncertainty about billionaire Elon Musk’s plans to purchase microblogging platform Twitter led to significant price volatility for Twitter’s stock.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several consumer discretionary companies with similar businesses that have traditionally been categorized in other sectors. For example, Caesars Entertainment, a hotel and casino company, detracted from the Fund’s return. Profits from alcohol sales and gambling declined as customers reduced spending amid rising inflation.

Portfolio Information

 

 

INDUSTRY ALLOCATION

 

 

   
Sector    

Percent of

Total Investments

 

(a) 

Media

    54.1

Internet

    14.5  

Software

    12.7  

Entertainment

    8.9  

Toys, Games & Hobbies

    3.3  

Commercial Services

    2.2  

Real Estate Investment Trusts

    1.5  

Retail

    1.0  

Other (each representing less than 1%)

    1.8  

TEN LARGEST HOLDINGS

 

 

   
Security    

Percent of

Total Investments

 

(a) 

Fox Corp., Class A

    5.1

Activision Blizzard Inc.

    5.0  

Electronic Arts Inc.

    4.6  

Comcast Corp., Class A

    4.6  

Nexstar Media Group Inc., Class A

    4.5  

Walt Disney Co. (The)

    4.4  

Paramount Global, Class B

    4.0  

Charter Communications Inc., Class A

    3.8  

Twitter Inc.

    3.7  

Warner Bros. Discovery Inc.

    3.1  

 

  (a) 

Excludes money market funds.

 

 

 

16  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of July 31, 2022      iShares® Evolved U.S. Technology ETF

 

Investment Objective

The iShares Evolved U.S. Technology ETF (the “Fund”) seeks to provide access to U.S. companies with technology exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

        Average Annual Total Returns               Cumulative Total Returns  
               1 Year      Since
Inception
                     1 Year      Since
Inception
 

Fund NAV

    (16.02 )%       16.86       (16.02 )%       97.39

Fund Market

    (16.12      16.85         (16.12      97.28  

S&P Total Market IndexTM

    (7.78      11.16               (7.78      58.60  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was March 21, 2018. The first day of secondary market trading was March 23, 2018.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is not an indication of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” for more information.

Expense Example

 

    Actual     Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

(a)  

           

Beginning

Account Value

(02/01/22)

 

 

 

      

Ending

Account Value

(07/31/22)

 

 

 

      

Expenses

Paid During

the Period(

 

 

a)  

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00            $         843.30            $         0.82               $       1,000.00            $      1,023.90            $         0.90          0.18

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Disclosure of Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  17


Fund Summary as of July 31, 2022  (continued)    iShares® Evolved U.S. Technology ETF

 

Portfolio Management Commentary

U.S. technology stocks declined significantly during the reporting period. As in-person work and commerce resumed, demand weakened for certain software and online services that facilitated business during pandemic-related restrictions. Amid rising inflation, higher interest rates negatively impacted the highest valuation growth-oriented technology stocks by lowering the current value of future earnings, decreasing demand and cash flows, and raising financing costs.

The specialized software industry detracted the most from the Fund’s performance as the need for digital solutions for online learning and working diminished. Adobe Incorporated led the decline as growth in sales of its creative software platform declined. The company suspended business in Russia due to that country’s invasion of Ukraine, negatively impacting revenues. Despite strong earnings, cloud-based customer relationship management specialist Salesforce declined as investors generally turned away from high-growth stocks. Docusign Incorporated also detracted as growth in demand for digital signatures slowed sharply with many businesses returning to in-person work.

Technology service providers also detracted substantially from the Fund’s return. Online payment company PayPal declined, reflecting ongoing disruptions to supply chains and a decrease in online shopping. Earnings slowed as the company faced difficulty in growing its active user base. The high interest rate environment weighed on Block, a financial technology company, reducing demand for loans among its small business customers. A sharp decline in the price of Bitcoin also negatively impacted Block’s balance sheet.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several technology companies with similar businesses that have traditionally been categorized in other sectors. For example, the Fund held positions in Meta and Alphabet Inc., Facebook and Google’s parent companies, respectively, both traditionally classified as communication services companies. Meta’s revenues declined as growth in demand for digital advertisements contracted amid the global economic slowdown and ongoing supply chain disruptions. Although revenue from Google search advertising fared relatively well, Alphabet declined amid disappointing sales in its YouTube and Google Cloud businesses. Currency effects due to the strong U.S. dollar also weighed on Alphabet as the majority of its sales originate outside the U.S.

Portfolio Information

 

 

INDUSTRY ALLOCATION

 

 

   
Sector    

Percent of

Total Investments

 

(a) 

Software

    31.3

Internet

    22.5  

Computers

    18.2  

Semiconductors

    12.5  

Diversified Financial Services

    5.7  

Commercial Services

    3.8  

Telecommunications

    2.1  

Other (each representing less than 1%)

    3.9  

TEN LARGEST HOLDINGS

 

 

   
Security    

Percent of

Total Investments

 

(a) 

Microsoft Corp.

    15.9

Apple Inc.

    13.2  

Amazon.com Inc.

    5.8  

Alphabet Inc., Class A

    5.1  

Alphabet Inc., Class C

    5.0  

Nvidia Corp.

    4.0  

Meta Platforms Inc, Class A

    3.0  

Visa Inc., Class A

    2.6  

Mastercard Inc., Class A

    2.1  

Adobe Inc.

    1.7  

 

  (a) 

Excludes money market funds.

 

 

 

18  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


About Fund Performance

 

Past performance is not an indication of future results. Financial markets have experienced extreme volatility and trading in many instruments has been disrupted. These circumstances may continue for an extended period of time and may continue to affect adversely the value and liquidity of each Fund’s investments. As a result, current performance may be lower or higher than the performance data quoted. Performance data current to the most recent month-end is available at iShares.com. Performance results assume reinvestment of all dividends and capital gain distributions and do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. The investment return and principal value of shares will vary with changes in market conditions. Shares may be worth more or less than their original cost when they are redeemed or sold in the market. Performance for certain funds may reflect a waiver of a portion of investment advisory fees. Without such a waiver, performance would have been lower.

Net asset value or “NAV” is the value of one share of a fund as calculated in accordance with the standard formula for valuing mutual fund shares. Beginning August 10, 2020, the price used to calculate market return (“Market Price”) is the closing price. Prior to August 10, 2020, Market Price was determined using the midpoint between the highest bid and the lowest ask on the primary stock exchange on which shares of a fund are listed for trading, as of the time that such fund’s NAV is calculated. Since shares of a fund may not trade in the secondary market until after the fund’s inception, for the period from inception to the first day of secondary market trading in shares of the fund, the NAV of the fund is used as a proxy for the Market Price to calculate market returns. Market and NAV returns assume that dividends and capital gain distributions have been reinvested at Market Price and NAV, respectively.

An index is a statistical composite that tracks a specified financial market or sector. Unlike a fund, an index does not actually hold a portfolio of securities and therefore does not incur the expenses incurred by a fund. These expenses negatively impact fund performance. Also, market returns do not include brokerage commissions that may be payable on secondary market transactions. If brokerage commissions were included, market returns would be lower.

Disclosure of Expenses

Shareholders of each Fund may incur the following charges: (1) transactional expenses, including brokerage commissions on purchases and sales of fund shares and (2) ongoing expenses, including management fees and other fund expenses. The expense examples shown (which are based on a hypothetical investment of $1,000 invested at the beginning of the period and held through the end of the period) are intended to assist shareholders both in calculating expenses based on an investment in each Fund and in comparing these expenses with similar costs of investing in other funds.

The expense examples provide information about actual account values and actual expenses. Annualized expense ratios reflect contractual and voluntary fee waivers, if any. In order to estimate the expenses a shareholder paid during the period covered by this report, shareholders can divide their account value by $1,000 and then multiply the result by the number under the heading entitled “Expenses Paid During the Period.”

The expense examples also provide information about hypothetical account values and hypothetical expenses based on a Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses. In order to assist shareholders in comparing the ongoing expenses of investing in a Funds and other funds, compare the 5% hypothetical examples with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

The expenses shown in the expense examples are intended to highlight shareholders’ ongoing costs only and do not reflect any transactional expenses, such as brokerage commissions and other fees paid on purchases and sales of fund shares. Therefore, the hypothetical examples are useful in comparing ongoing expenses only and will not help shareholders determine the relative total expenses of owning different funds. If these transactional expenses were included, shareholder expenses would have been higher.

 

 

A B O U T   F U N D   P E R F O R M A N C E / S H A R E H O L D E R   E X P E N S E S

  19


Schedule of Investments  

July 31, 2022

  

iShares® Evolved U.S. Consumer Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   

Agriculture — 11.7%

   

Altria Group Inc.

    14,153     $ 620,750  

Archer-Daniels-Midland Co.

    4,818       398,786  

Bunge Ltd.

    912       84,205  

Darling Ingredients Inc.(a)

    870       60,274  

Fresh Del Monte Produce Inc.

    169       5,021  

Philip Morris International Inc.

    8,303       806,636  

Universal Corp./VA

    124       6,933  

Vector Group Ltd.

    377       4,200  
   

 

 

 
          1,986,805  
Beverages — 32.3%            

Boston Beer Co. Inc. (The), Class A, NVS(a)

    70       26,630  

Brown-Forman Corp., Class A, NVS

    372       26,933  

Brown-Forman Corp., Class B

    2,797       207,593  

Celsius Holdings Inc.(a)

    447       39,765  

Coca-Cola Co. (The)

    31,375       2,013,334  

Coca-Cola Consolidated Inc.

    51       26,163  

Constellation Brands Inc., Class A

    982       241,876  

Keurig Dr Pepper Inc.

    10,314       399,564  

MGP Ingredients Inc.

    110       11,570  

Molson Coors Beverage Co., Class B

    1,500       89,625  

Monster Beverage Corp.(a)

    5,133       511,349  

National Beverage Corp.

    300       16,254  

PepsiCo Inc.

    10,612       1,856,676  

Primo Water Corp.

    1,508       19,936  
   

 

 

 
      5,487,268  
Biotechnology — 1.0%            

Corteva Inc.

    2,899       166,838  
   

 

 

 

Chemicals — 1.9%

   

Balchem Corp.

    162       21,993  

Ecolab Inc.

    142       23,454  

FMC Corp.

    63       7,000  

International Flavors & Fragrances Inc.

    1,842       228,500  

Mosaic Co. (The)

    361       19,010  

Sensient Technologies Corp.

    240       20,635  
   

 

 

 
      320,592  
Commercial Services — 0.0%            

Medifast Inc.

    59       9,923  

WW International Inc.(a)

    180       1,195  
   

 

 

 
      11,118  
Computers — 0.1%            

ExlService Holdings Inc.(a)

    99       16,669  
   

 

 

 

Cosmetics & Personal Care — 9.6%

   

Colgate-Palmolive Co.

    4,372       344,251  

Coty Inc., Class A(a)

    1,840       13,469  

Edgewell Personal Care Co.

    150       5,967  

Procter & Gamble Co. (The)

    9,107       1,265,054  
   

 

 

 
      1,628,741  
Diversified Financial Services — 0.0%            

Jefferies Financial Group Inc.

    2       65  
   

 

 

 

Electrical Components & Equipment — 0.1%

   

Energizer Holdings Inc.

    380       11,221  
   

 

 

 

Food — 24.3%

   

B&G Foods Inc.

    770       19,027  

Beyond Meat Inc.(a)

    389       12,444  
Security   Shares     Value  

Food (continued)

   

Calavo Growers Inc.

    110     $ 4,433  

Cal-Maine Foods Inc.

    200       10,222  

Campbell Soup Co.

    2,223       109,705  

Conagra Brands Inc.

    5,429       185,726  

Flowers Foods Inc.

    1,190       33,808  

General Mills Inc.

    8,314       621,804  

Hain Celestial Group Inc. (The)(a)

    1,040       23,660  

Hershey Co. (The)

    1,753       399,614  

Hormel Foods Corp.

    2,439       120,340  

Hostess Brands Inc.(a)

    650       14,703  

Ingredion Inc.

    504       45,854  

J&J Snack Foods Corp.

    130       17,616  

JM Smucker Co. (The)

    1,248       165,135  

John B Sanfilippo & Son Inc.

    90       6,741  

Kellogg Co.

    3,153       233,070  

Kraft Heinz Co. (The)

    6,041       222,490  

Kroger Co. (The)

    1,836       85,264  

Lamb Weston Holdings Inc.

    1,198       95,433  

Lancaster Colony Corp.

    170       22,505  

McCormick & Co. Inc./MD, NVS

    2,141       187,016  

Mondelez International Inc., Class A

    11,941       764,702  

Performance Food Group Co.(a)

    711       35,344  

Pilgrim’s Pride Corp.(a)

    300       9,411  

Post Holdings Inc.(a)

    687       59,728  

Seaboard Corp.

    1       4,061  

Simply Good Foods Co. (The)(a)

    718       23,421  

Sprouts Farmers Market Inc.(a)

    450       12,438  

Sysco Corp.

    3,186       270,491  

Tootsie Roll Industries Inc.

    158       5,549  

TreeHouse Foods Inc.(a)

    640       27,789  

Tyson Foods Inc., Class A

    2,728       240,091  

U.S. Foods Holding Corp.(a)

    1,052       33,138  

United Natural Foods Inc.(a)

    220       9,352  
   

 

 

 
          4,132,125  
Health Care - Products — 0.1%            

Neogen Corp.(a)

    540       12,490  
   

 

 

 

Holding Companies - Diversified — 0.0%

   

Cannae Holdings Inc.(a)

    298       6,291  
   

 

 

 

Household Products & Wares — 1.9%

   

ACCO Brands Corp.

    2       14  

Church & Dwight Co. Inc.

    1,148       100,990  

Clorox Co. (The)

    563       79,856  

Helen of Troy Ltd.(a)

    50       6,689  

Kimberly-Clark Corp.

    1,048       138,116  

WD-40 Co.

    23       4,080  
   

 

 

 
      329,745  
Housewares — 0.1%            

Newell Brands Inc.

    264       5,335  

Scotts Miracle-Gro Co. (The)

    140       12,453  
   

 

 

 
      17,788  
Insurance — 0.1%            

Reinsurance Group of America Inc.

    158       18,293  
   

 

 

 

Machinery — 0.3%

   

AGCO Corp.

    230       25,052  

Middleby Corp. (The)(a)

    170       24,597  
   

 

 

 
      49,649  

 

 

20  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Consumer Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Manufacturing — 0.1%

   

John Bean Technologies Corp.

    120     $ 13,477  
   

 

 

 

Oil & Gas — 0.8%

   

ConocoPhillips

    1,378       134,259  
   

 

 

 

Packaging & Containers — 2.7%

   

Amcor PLC

    1,537       19,904  

AptarGroup Inc.

    39       4,203  

Ball Corp.

    2,379       174,666  

Berry Global Group Inc.(a)

    619       35,685  

Crown Holdings Inc.

    911       92,630  

Graphic Packaging Holding Co.

    1,924       42,809  

O-I Glass Inc.(a)

    780       11,474  

Packaging Corp. of America

    106       14,905  

Sealed Air Corp.

    243       14,852  

Silgan Holdings Inc.

    370       16,465  

Sonoco Products Co.

    420       26,666  
   

 

 

 
      454,259  
Pharmaceuticals — 1.7%            

BellRing Brands Inc.(a)

    1,148       27,713  

Elanco Animal Health Inc.(a)

    1,468       29,742  

Herbalife Nutrition Ltd.(a)

    459       11,204  

Perrigo Co. PLC

    131       5,485  

Prestige Consumer Healthcare Inc.(a)

    220       13,268  

Zoetis Inc.

    1,072       195,693  
   

 

 

 
              283,105  
Real Estate — 0.0%            

Douglas Elliman Inc.

    188       1,128  
   

 

 

 

Real Estate Investment Trusts — 0.6%

   

Americold Realty Trust Inc.

    841       27,543  

Equinix Inc.

    100       70,374  
   

 

 

 
      97,917  
Retail — 9.5%            

BJ’s Restaurants Inc.(a)

    61       1,432  

BJ’s Wholesale Club Holdings Inc.(a)

    264       17,873  

Casey’s General Stores Inc.

    110       22,292  

Cheesecake Factory Inc. (The)

    140       4,092  
Security   Shares     Value  
Retail (continued)            

Chipotle Mexican Grill Inc.(a)

    150     $ 234,633  

Cracker Barrel Old Country Store Inc.

    50       4,754  

Darden Restaurants Inc.

    177       22,035  

Domino’s Pizza Inc.

    82       32,153  

Freshpet Inc.(a)

    262       14,001  

Jack in the Box Inc.

    90       6,223  

McDonald’s Corp.

    1,763       464,321  

Shake Shack Inc., Class A(a)

    101       5,197  

Starbucks Corp.

    6,383       541,151  

Texas Roadhouse Inc.

    84       7,326  

Wendy’s Co. (The)

    710       14,931  

Wingstop Inc.

    90       11,356  

Yum China Holdings Inc.

    1,341       65,320  

Yum! Brands Inc.

    1,164       142,637  
   

 

 

 
      1,611,727  
Toys, Games & Hobbies — 0.1%            

Mattel Inc.(a)

    677       15,706  
   

 

 

 

Total Long-Term Investments — 99.0%
(Cost: $15,239,840)

 

    16,807,276  
   

 

 

 

Short-Term Securities

   
Money Market Funds — 0.8%            

BlackRock Cash Funds: Treasury, SL Agency Shares, 1.81%(b)(c)

    140,000       140,000  
   

 

 

 

Total Short-Term Securities — 0.8%
(Cost: $140,000)

 

    140,000  
   

 

 

 

Total Investments in Securities — 99.8%
(Cost: $15,379,840)

 

    16,947,276  

Other Assets Less Liabilities — 0.2%

 

    25,684  
   

 

 

 

Net Assets — 100.0%

 

  $   16,972,960  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

Affiliate of the Fund.

(c) 

Annualized 7-day yield as of period end.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer  

Value at

07/31/21

   

Purchases

at Cost

   

Proceeds

from Sale

   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

07/31/22

   

Shares

Held at

07/31/22

    Income    

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares(a)

  $ 15,208     $     $ (15,165 )(b)     $ (39    $ (4   $           $ 888 (c)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    140,000             0 (b)                   140,000       140,000       326        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
         $ (39    $ (4   $ 140,000       $  1,214     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a)

As of period end, the entity is no longer held.

 
  (b) 

Represents net amount purchased (sold).

 
  (c) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  21


Schedule of Investments  (continued)

July 31, 2022

   iShares® Evolved U.S. Consumer Staples ETF

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                               

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 16,807,276        $        $        $ 16,807,276  

Money Market Funds

     140,000                            140,000  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 16,947,276        $        $        $ 16,947,276  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

22  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  

July 31, 2022

  

iShares® Evolved U.S. Discretionary Spending ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   

Advertising — 0.1%

   

Interpublic Group of Companies Inc. (The)

    431     $ 12,874  
   

 

 

 

Airlines — 0.2%

   

Alaska Air Group Inc.(a)

    208       9,221  

JetBlue Airways Corp.(a)

    552       4,648  

Southwest Airlines Co.(a)

    260       9,911  
   

 

 

 
      23,780  
Apparel — 6.2%            

Capri Holdings Ltd.(a)

    526       25,606  

Carter’s Inc.

    280       22,814  

Columbia Sportswear Co.

    144       10,658  

Crocs Inc.(a)

    272       19,486  

Deckers Outdoor Corp.(a)

    129       40,404  

Hanesbrands Inc.

    1,472       16,457  

Kontoor Brands Inc.

    173       6,315  

Levi Strauss & Co., Class A

    263       4,976  

Nike Inc., Class B

    5,199       597,469  

Oxford Industries Inc.

    96       9,158  

PVH Corp.

    340       21,053  

Ralph Lauren Corp.

    241       23,770  

Skechers U.S.A. Inc., Class A(a)

    672       25,509  

Steven Madden Ltd.

    446       14,138  

Tapestry Inc.

    1,480       49,772  

Under Armour Inc., Class A(a)

    808       7,482  

Under Armour Inc., Class C, NVS(a)

    824       6,806  

Urban Outfitters Inc.(a)

    400       8,192  

VF Corp.

    1,149       51,337  

Wolverine World Wide Inc.

    248       5,573  
   

 

 

 
      966,975  
Beverages — 0.2%            

Constellation Brands Inc., Class A

    156       38,424  
   

 

 

 

Building Materials — 0.1%

   

American Woodmark Corp.(a)

    32       1,607  

Masco Corp.

    327       18,109  
   

 

 

 
      19,716  
Chemicals — 0.1%            

Valvoline Inc.

    336       10,826  
   

 

 

 

Commercial Services — 1.4%

   

Avis Budget Group Inc.(a)

    81       14,744  

Block Inc.(a)(b)

    501       38,106  

Bright Horizons Family Solutions Inc.(a)(b)

    40       3,747  

Cintas Corp.

    144       61,271  

Euronet Worldwide Inc.(a)

    80       7,862  

Grand Canyon Education Inc.(a)

    72       6,917  

H&R Block Inc.

    448       17,902  

ManpowerGroup Inc.

    120       9,409  

Monro Inc.

    136       6,820  

PayPal Holdings Inc.(a)

    252       21,806  

PROG Holdings Inc.(a)

    268       4,937  

Rent-A-Center Inc./TX

    231       5,435  

Rollins Inc.

    360       13,885  

Terminix Global Holdings Inc.(a)

    272       12,158  

WW International Inc.(a)(b)

    72       478  
   

 

 

 
      225,477  
Computers — 1.1%            

Apple Inc.

    1,025             166,573  
   

 

 

 
Security   Shares     Value  

Cosmetics & Personal Care — 3.9%

   

Colgate-Palmolive Co.

    84     $ 6,614  

Coty Inc., Class A(a)

    319       2,335  

Estee Lauder Companies Inc. (The), Class A

    715       195,266  

Inter Parfums Inc.

    62       5,175  

Procter & Gamble Co. (The)

    2,861       397,422  
   

 

 

 
            606,812  
Distribution & Wholesale — 1.0%            

Fastenal Co.

    747       38,366  

G-III Apparel Group Ltd.(a)

    232       5,125  

Leslie’s Inc.(a)(b)

    329       4,987  

LKQ Corp.

    218       11,955  

Pool Corp.

    76       27,185  

SiteOne Landscape Supply Inc.(a)

    72       10,032  

WW Grainger Inc.

    96       52,179  
   

 

 

 
      149,829  
Diversified Financial Services — 0.8%            

LendingTree Inc.(a)

    8       364  

Mastercard Inc., Class A

    163       57,668  

Visa Inc., Class A(b)

    300       63,633  
   

 

 

 
      121,665  
Entertainment — 1.1%            

AMC Entertainment Holdings Inc., Class A(a)

    1,489       21,680  

Caesars Entertainment Inc.(a)

    524       23,942  

Churchill Downs Inc.

    79       16,574  

Cinemark Holdings Inc.(a)

    256       4,692  

DraftKings Inc., Class A (a)

    476       6,535  

Live Nation Entertainment Inc.(a)

    360       33,836  

Madison Square Garden Sports Corp.(a)

    40       6,151  

Marriott Vacations Worldwide Corp.

    71       9,721  

Penn National Gaming Inc.(a)

    267       9,225  

Red Rock Resorts Inc., Class A

    232       9,125  

Scientific Games Corp., Class A(a)

    88       4,483  

Six Flags Entertainment Corp.(a)

    136       3,083  

Vail Resorts Inc.

    104       24,662  
   

 

 

 
      173,709  
Food — 1.8%            

Beyond Meat Inc.(a)(b)

    67       2,143  

Flowers Foods Inc.

    360       10,228  

Grocery Outlet Holding Corp.(a)

    450       19,224  

Kroger Co. (The)

    3,537       164,258  

Performance Food Group Co.(a)

    308       15,311  

Sprouts Farmers Market Inc.(a)

    504       13,931  

Sysco Corp.

    559       47,459  

U.S. Foods Holding Corp.(a)

    432       13,608  
   

 

 

 
      286,162  
Food Service — 0.1%            

Aramark

    640       21,376  
   

 

 

 

Holding Companies - Diversified — 0.0%

   

Cannae Holdings Inc.(a)

    120       2,533  
   

 

 

 

Home Builders — 0.1%

   

Taylor Morrison Home Corp.(a)

    160       4,592  

Toll Brothers Inc.

    208       10,229  
   

 

 

 
      14,821  
Home Furnishings — 0.1%            

Sleep Number Corp.(a)

    94       4,236  

Tempur Sealy International Inc.

    544       14,949  
   

 

 

 
      19,185  

 

 

S C H E D U L E    O F   I N V E S T M E N T S

  23


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Discretionary Spending ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Household Products & Wares — 0.2%

   

Helen of Troy Ltd.(a)

    41     $ 5,486  

Kimberly-Clark Corp.

    208       27,412  
   

 

 

 
      32,898  
Housewares — 0.1%            

Newell Brands Inc.

    758       15,319  

Scotts Miracle-Gro Co. (The)

    64       5,693  

Tupperware Brands Corp.(a)

    88       656  
   

 

 

 
      21,668  
Internet — 21.4%            

Airbnb Inc., Class A(a)

    855       94,888  

Amazon.com Inc.(a)

    20,480       2,763,776  

Booking Holdings Inc.(a)

    85       164,534  

Cars.com Inc.(a)

    120       1,411  

Chewy Inc., Class A(a)

    181       7,025  

DoorDash Inc., Class A(a)

    618       43,105  

eBay Inc.

    985       47,900  

Etsy Inc.(a)

    232       24,063  

Expedia Group Inc.(a)

    297       31,497  

Groupon Inc.(a)

    48       509  

Just Eat Takeaway.com NV SP ADR(a)(b)

    590       2,136  

Lyft Inc., Class A(a)

    394       5,461  

Match Group Inc.(a)

    76       5,571  

MercadoLibre Inc.(a)(b)

    97       78,930  

Overstock.com Inc.(a)

    100       2,900  

Pinterest Inc., Class A(a)

    1,181       23,006  

Stitch Fix Inc., Class A(a)(b)

    110       657  

Uber Technologies Inc.(a)

    1,829       42,890  

Wayfair Inc., Class A(a)(b)

    329       17,736  
   

 

 

 
          3,357,995  
Leisure Time — 0.6%            

Carnival Corp.(a)

    2,092       18,954  

Norwegian Cruise Line Holdings Ltd.(a)

    730       8,869  

Peloton Interactive Inc., Class A(a)

    581       5,514  

Planet Fitness Inc., Class A(a)

    416       32,785  

Polaris Inc.

    56       6,568  

Royal Caribbean Cruises Ltd.(a)

    313       12,116  

YETI Holdings Inc.(a)

    196       9,951  
   

 

 

 
      94,757  
Lodging — 2.4%            

Boyd Gaming Corp.

    166       9,215  

Choice Hotels International Inc.

    128       15,471  

Hilton Grand Vacations Inc.(a)

    168       6,849  

Hilton Worldwide Holdings Inc.

    886       113,470  

Hyatt Hotels Corp., Class A(a)

    128       10,592  

Las Vegas Sands Corp.(a)

    1,047       39,462  

Marriott International Inc./MD, Class A

    572       90,845  

MGM Resorts International

    885       28,966  

Travel + Leisure Co.

    328       14,140  

Wyndham Hotels & Resorts Inc.

    383       26,584  

Wynn Resorts Ltd.(a)

    200       12,696  
   

 

 

 
      368,290  
Oil & Gas — 0.8%            

ConocoPhillips

    1,260       122,762  
   

 

 

 

Pharmaceuticals — 0.0%

   

Herbalife Nutrition Ltd.(a)

    190       4,638  
   

 

 

 

Real Estate — 0.0%

   

RE/MAX Holdings Inc., Class A

    84       2,129  
   

 

 

 
Security   Shares     Value  

Real Estate Investment Trusts — 0.2%

   

Apple Hospitality REIT Inc.

    336     $ 5,604  

Host Hotels & Resorts Inc.

    1,064       18,950  

Macerich Co. (The)

    203       2,154  

Park Hotels & Resorts Inc.

    240       3,742  

Ruth’s Hospitality Group Inc.

    144       2,527  

Ryman Hospitality Properties Inc.(a)

    64       5,667  
   

 

 

 
      38,644  
Retail — 54.4%            

Abercrombie & Fitch Co., Class A(a)

    415       7,391  

Academy Sports & Outdoors Inc.

    349       15,017  

Advance Auto Parts Inc.

    288       55,763  

American Eagle Outfitters Inc.

    936       11,269  

AutoNation Inc.(a)

    168       19,948  

AutoZone Inc.(a)

    88       188,090  

Bath & Body Works Inc.

    1,255       44,603  

Bed Bath & Beyond Inc.(a)(b)

    771       3,878  

Best Buy Co. Inc.

    849       65,364  

Big Lots Inc.

    248       5,007  

BJ’s Restaurants Inc.(a)

    72       1,690  

BJ’s Wholesale Club Holdings Inc.(a)

    561       37,980  

Bloomin’ Brands Inc.

    384       7,830  

Boot Barn Holdings Inc.(a)

    173       10,778  

Brinker International Inc.(a)

    211       5,855  

Buckle Inc. (The)

    152       4,590  

Burlington Stores Inc.(a)

    363       51,230  

CarMax Inc.(a)(b)

    483       48,078  

Carvana Co., Class A(a)

    210       6,121  

Casey’s General Stores Inc.

    168       34,045  

Cheesecake Factory Inc. (The)

    168       4,911  

Chipotle Mexican Grill Inc.(a)

    92       143,908  

Costco Wholesale Corp.

    2,112           1,143,226  

Cracker Barrel Old Country Store Inc.

    112       10,648  

Darden Restaurants Inc.

    536       66,727  

Dave & Buster’s Entertainment Inc.(a)

    169       6,314  

Dick’s Sporting Goods Inc.

    345       32,289  

Dollar General Corp.

    1,248       310,041  

Dollar Tree Inc.(a)

    1,217       201,243  

Domino’s Pizza Inc.

    166       65,090  

FirstCash Holdings Inc.

    152       11,135  

Five Below Inc.(a)

    312       39,646  

Floor & Decor Holdings Inc., Class A(a)

    437       35,209  

Foot Locker Inc.

    512       14,525  

Freshpet Inc.(a)

    79       4,222  

GameStop Corp., Class A(a)(b)

    976       33,194  

Gap Inc. (The)

    1,672       16,085  

Genuine Parts Co.

    248       37,912  

Home Depot Inc. (The)

    4,191       1,261,240  

Jack in the Box Inc.

    90       6,223  

Kohl’s Corp.

    913       26,605  

La-Z-Boy Inc.

    144       4,013  

Lithia Motors Inc.

    56       14,856  

Lowe’s Companies Inc.

    2,600       497,978  

Lululemon Athletica Inc.(a)

    668       207,421  

Macy’s Inc.

    1,212       21,392  

McDonald’s Corp.

    2,076       546,756  

MSC Industrial Direct Co. Inc., Class A

    80       6,613  

Murphy USA Inc.

    96       27,299  

National Vision Holdings Inc.(a)

    200       5,828  

Nordstrom Inc.

    625       14,694  

Ollie’s Bargain Outlet Holdings Inc.(a)

    326       19,218  

 

 

24  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Discretionary Spending ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Retail (continued)

   

O’Reilly Automotive Inc.(a)

    319     $ 224,445  

Papa John’s International Inc.

    94       9,014  

PriceSmart Inc.

    112       7,435  

Qurate Retail Inc. Series A

    423       1,155  

RH(a)

    90       25,149  

Ross Stores Inc.

    1,884       153,094  

Sally Beauty Holdings Inc.(a)

    648       8,281  

Shake Shack Inc., Class A(a)

    96       4,940  

Signet Jewelers Ltd.

    323       19,690  

Starbucks Corp.

    2,947       249,847  

Target Corp.

    2,676       437,205  

Texas Roadhouse Inc.

    288       25,119  

TJX Companies Inc. (The)

    5,850       357,786  

Tractor Supply Co.

    551       105,505  

Ulta Beauty, Inc.(a)

    307       119,395  

Victoria’s Secret & Co.(a)

    419       15,486  

Walgreens Boots Alliance Inc.

    1,957       77,536  

Walmart Inc.

    7,028       928,047  

Wendy’s Co. (The)

    680       14,300  

Williams-Sonoma Inc.

    364       52,569  

Wingstop Inc.

    96       12,113  

Yum China Holdings Inc.

    1,372       66,830  

Yum! Brands Inc.

    1,183       144,965  
   

 

 

 
          8,520,894  
Software — 0.2%            

Intuit Inc.

    40       18,247  

Take-Two Interactive Software Inc.(a)

    38       5,044  
   

 

 

 
      23,291  
Textiles — 0.0%            

UniFirst Corp./MA

    32       6,269  
   

 

 

 
Security   Shares     Value  

 

 

Toys, Games & Hobbies — 0.2%

   

Hasbro Inc.

    192     $ 15,114  

Mattel Inc.(a)

    606       14,059  
   

 

 

 
      29,173  
Transportation — 0.5%            

FedEx Corp.

    336       78,318  
   

 

 

 

Total Long-Term Investments — 99.3%
(Cost: $16,394,049)

 

    15,562,463  
   

 

 

 

Short-Term Securities

   

Money Market Funds — 2.3%

   

BlackRock Cash Funds: Institutional, SL Agency Shares, 1.93%(c)(d)(e)

    298,332       298,302  

BlackRock Cash Funds: Treasury, SL Agency Shares, 1.81%(c)(d)

    60,000       60,000  
   

 

 

 

Total Short-Term Securities — 2.3%
(Cost: $358,255)

 

    358,302  
   

 

 

 

Total Investments in Securities — 101.6%
(Cost: $16,752,304)

 

    15,920,765  

Liabilities in Excess of Other Assets — (1.6)%

      (243,835
   

 

 

 

Net Assets — 100.0%

    $   15,676,930  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer   Value at
07/31/21
    Purchases
at Cost
    Proceeds
from Sale
    Net Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
07/31/22
    Shares
Held at
07/31/22
    Income    

Capital

Gain

Distributions

from

Underlying
Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 168,573     $ 129,943 (a)    $      $ (258   $ 44     $ 298,302       298,332     $ 2,580 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    205,000             (145,000 )(a)                  60,000       60,000       236        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
         $ (258   $ 44     $ 358,302       $ 2,816     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b)

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

 

 

S C H E D U L E    O F   I N V E S T M E N T S

  25


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Discretionary Spending ETF

 

Fair Value Hierarchy as of Period End (continued)

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                               

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 15,562,463        $        $        $ 15,562,463  

Money Market Funds

     358,302                            358,302  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 15,920,765        $        $        $ 15,920,765  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

26  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  

July 31, 2022

  

iShares® Evolved U.S. Financials ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   

Banks — 39.9%

   

Ameris Bancorp.

    64     $ 3,027  

Associated Banc-Corp.

    521       10,472  

Atlantic Union Bankshares Corp.

    210       7,264  

BancFirst Corp.

    70       7,517  

Bank of America Corp.

    10,235       346,045  

Bank of Hawaii Corp.

    142       11,376  

Bank of New York Mellon Corp. (The)

    1,789       77,750  

Bank OZK

    340       13,634  

BankUnited Inc.

    187       7,265  

Banner Corp.

    52       3,223  

BOK Financial Corp.

    79       6,954  

Cathay General Bancorp

    270       11,259  

Citigroup Inc.

    3,929           203,915  

Citizens Financial Group Inc.

    1,335       50,690  

City Holding Co.

    40       3,472  

Columbia Banking System Inc.

    153       4,616  

Comerica Inc.

    396       30,797  

Commerce Bancshares Inc.

    318       22,098  

Community Bank System Inc.

    114       7,676  

ConnectOne Bancorp. Inc.

    114       3,014  

Cullen/Frost Bankers Inc.

    178       23,211  

CVB Financial Corp.

    243       6,481  

Eagle Bancorp. Inc.

    67       3,285  

East West Bancorp. Inc.

    396       28,425  

Eastern Bankshares Inc.

    423       8,629  

Enterprise Financial Services Corp.

    88       4,139  

Fifth Third Bancorp.

    1,921       65,545  

First BanCorp./Puerto Rico

    372       5,613  

First Bancorp./Southern Pines NC

    71       2,689  

First Busey Corp.

    168       4,141  

First Citizens BancShares Inc./NC, Class A

    31       23,457  

First Commonwealth Financial Corp.

    268       3,972  

First Financial Bancorp

    210       4,691  

First Financial Bankshares Inc.

    426       18,821  

First Hawaiian Inc.

    391       9,967  

First Horizon Corp.

    1,609       35,977  

First Interstate BancSystem Inc., Class A

    231       9,420  

Flagstar Bancorp. Inc.

    62       2,554  

FNB Corp.

    1,043       12,474  

Fulton Financial Corp.

    574       9,580  

Glacier Bancorp. Inc.

    258       12,923  

Goldman Sachs Group Inc. (The)

    784       261,378  

Hancock Whitney Corp.

    253       12,349  

Hanmi Financial Corp.

    78       1,971  

Heartland Financial USA Inc.

    107       4,804  

Heritage Financial Corp./WA

    75       1,952  

Hilltop Holdings Inc.

    240       6,924  

Home BancShares Inc./AR

    478       11,281  

Hope Bancorp Inc.

    282       4,241  

Huntington Bancshares Inc./OH

    3,984       52,947  

Independent Bank Corp.

    89       7,458  

Independent Bank Group Inc.

    54       3,819  

International Bancshares Corp.

    202       8,860  

JPMorgan Chase & Co.

    3,027       349,195  

KeyCorp.

    2,758       50,471  

Lakeland Bancorp. Inc.

    198       3,152  

Lakeland Financial Corp.

    67       5,213  

Live Oak Bancshares Inc.

    83       3,124  
Security   Shares     Value  

Banks (continued)

   

M&T Bank Corp.

    339     $ 60,156  

Morgan Stanley

    3,064       258,295  

National Bank Holdings Corp., Class A

    71       2,955  

NBT Bancorp. Inc.

    113       4,581  

Northern Trust Corp.

    526       52,484  

OFG Bancorp

    94       2,582  

Old National Bancorp./IN

    589       10,255  

PacWest Bancorp

    343       9,614  

Park National Corp.

    33       4,275  

Pathward Financial Inc.

    57       1,922  

Pinnacle Financial Partners Inc.

    221       17,481  

Popular Inc.

    234       18,175  

Prosperity Bancshares Inc.

    259       19,189  

Regions Financial Corp.

    2,663       56,402  

Renasant Corp.

    114       3,808  

S&T Bancorp. Inc.

    84       2,599  

Sandy Spring Bancorp. Inc.

    118       4,873  

Seacoast Banking Corp. of Florida

    99       3,542  

ServisFirst Bancshares Inc.

    142       12,134  

Silvergate Capital Corp., Class A(a)

    104       9,702  

Simmons First National Corp., Class A

    177       4,204  

Southside Bancshares Inc.

    85       3,395  

SouthState Corp.

    199       16,869  

State Street Corp.

    895       63,581  

SVB Financial Group(a)

    159       64,164  

Synovus Financial Corp.

    445       17,969  

Texas Capital Bancshares Inc.(a)

    82       4,807  

Tompkins Financial Corp.

    58       4,475  

Triumph Bancorp. Inc.(a)

    35       2,543  

Truist Financial Corp.

    3,562       179,774  

Trustmark Corp.

    72       2,338  

U.S. Bancorp

    3,607       170,250  

UMB Financial Corp.

    142       12,851  

Umpqua Holdings Corp.

    598       10,531  

United Bankshares Inc./WV

    363       14,063  

United Community Banks Inc./GA

    128       4,356  

Valley National Bancorp

    892       10,428  

Veritex Holdings Inc.

    64       1,980  

Walker & Dunlop Inc.

    54       6,083  

Webster Financial Corp.

    592       27,498  

Wells Fargo & Co.

    8,574       376,141  

WesBanco Inc.

    155       5,289  

Westamerica Bancorp

    61       3,661  

Western Alliance Bancorp

    203       15,505  

Wintrust Financial Corp.

    174       14,971  

Zions Bancorp. NA

    490       26,730  
   

 

 

 
        3,536,677  
Commercial Services — 4.2%            

Automatic Data Processing Inc.

    268       64,620  

Equifax Inc.

    118       24,651  

Euronet Worldwide Inc.(a)

    37       3,636  

EVERTEC Inc.

    100       3,899  

FleetCor Technologies Inc.(a)

    58       12,765  

FTI Consulting Inc.(a)

    31       5,070  

Global Payments Inc.

    235       28,745  

Grand Canyon Education Inc.(a)

    35       3,363  

Green Dot Corp., Class A(a)

    57       1,602  

HealthEquity Inc.(a)

    55       3,199  

Insperity Inc.

    43       4,719  

MarketAxess Holdings Inc.

    43       11,644  

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  27


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Financials ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Commercial Services (continued)

   

Moody’s Corp.

    196     $ 60,809  

Morningstar Inc.

    25       6,384  

S&P Global Inc.

    210       79,155  

Service Corp. International

    167       12,435  

Verisk Analytics Inc.

    191       36,338  

WEX Inc.(a)

    37       6,150  
   

 

 

 
            369,184  
Computers — 0.1%            

Genpact Ltd.

    100       4,808  
   

 

 

 

Diversified Financial Services — 16.9%

   

Affiliated Managers Group Inc.

    91       11,501  

Ally Financial Inc.

    686       22,686  

American Express Co.

    1,139       175,429  

Ameriprise Financial Inc.

    281       75,847  

Apollo Global Management Inc.

    998       56,986  

Ares Management Corp., Class A

    207       14,832  

Artisan Partners Asset Management Inc., Class A

    106       4,215  

BGC Partners Inc., Class A

    325       1,186  

Bread Financial Holdings Inc.

    30       1,188  

Capital One Financial Corp.

    1,006       110,489  

Cboe Global Markets Inc.

    151       18,630  

Charles Schwab Corp. (The)

    3,572       246,647  

CME Group Inc.

    336       67,025  

Cohen & Steers Inc.

    54       3,979  

Credit Acceptance Corp.(a)

    24       13,822  

Discover Financial Services

    559       56,459  

Evercore Inc., Class A

    58       5,798  

Federated Hermes Inc.

    198       6,754  

Franklin Resources Inc.

    558       15,317  

Hamilton Lane Inc., Class A

    36       2,720  

Houlihan Lokey Inc.

    60       5,074  

Interactive Brokers Group Inc., Class A

    107       6,280  

Intercontinental Exchange Inc.

    658       67,109  

Invesco Ltd.

    504       8,941  

Janus Henderson Group PLC

    418       10,772  

Jefferies Financial Group Inc.

    367       11,953  

KKR & Co. Inc.

    1,058       58,677  

LendingClub Corp.(a)

    248       3,435  

LendingTree Inc.(a)

    7       319  

LPL Financial Holdings Inc.

    156       32,747  

Mastercard Inc., Class A

    92       32,549  

Moelis & Co., Class A

    61       2,841  

Mr Cooper Group Inc.(a)

    133       5,992  

Nasdaq Inc.

    157       28,401  

Navient Corp.

    407       6,703  

OneMain Holdings Inc.

    174       6,473  

PennyMac Financial Services Inc.

    100       5,479  

Piper Sandler Cos.

    37       4,669  

Radian Group Inc.

    481       10,760  

Raymond James Financial Inc.

    466       45,887  

SEI Investments Co.

    229       12,677  

SLM Corp.

    931       14,524  

SoFi Technologies Inc.(a)

    383       2,417  

Stifel Financial Corp.

    276       16,508  

Synchrony Financial

    1,061       35,522  

T Rowe Price Group Inc.

    407       50,252  

Tradeweb Markets Inc., Class A

    82       5,783  

Upstart Holdings Inc.(a)

    91       2,214  

Virtu Financial Inc., Class A

    151       3,523  
Security   Shares     Value  

Diversified Financial Services (continued)

   

Virtus Investment Partners Inc.

    17     $ 3,507  

Visa Inc., Class A

    378       80,178  

Western Union Co. (The)

    432       7,353  
   

 

 

 
      1,501,029  
Electric — 0.1%            

Hawaiian Electric Industries Inc.

    209       8,841  
   

 

 

 

Engineering & Construction — 0.0%

   

frontdoor Inc.(a)

    83       2,222  
   

 

 

 

Forest Products & Paper — 0.2%

   

International Paper Co.

    329       14,071  

Sylvamo Corp.

    29       1,138  
   

 

 

 
      15,209  
Health Care - Services — 4.1%            

Centene Corp.(a)

    163       15,154  

Elevance Health Inc.

    180       85,878  

Humana Inc.

    7       3,374  

Molina Healthcare Inc.(a)

    42       13,764  

UnitedHealth Group Inc.

    445       241,342  
   

 

 

 
          359,512  
Home Builders — 0.2%            

MDC Holdings Inc.

    76       2,755  

NVR Inc.(a)

    4       17,572  
   

 

 

 
      20,327  
Household Products & Wares — 0.0%            

Spectrum Brands Holdings Inc.

    12       835  
   

 

 

 

Insurance — 24.7%

   

Aflac Inc.

    1,692       96,952  

Alleghany Corp.(a)

    40       33,499  

Allstate Corp. (The)

    714       83,517  

American Financial Group Inc./OH

    209       27,939  

American International Group Inc.

    2,236       115,758  

Aon PLC, Class A

    259       75,379  

Arch Capital Group Ltd.

    845       37,518  

Argo Group International Holdings Ltd.

    84       2,754  

Arthur J Gallagher & Co.

    413       73,923  

Assurant Inc.

    89       15,644  

Assured Guaranty Ltd.

    127       7,416  

Axis Capital Holdings Ltd.

    202       10,199  

Berkshire Hathaway Inc., Class B(a)

    965       290,079  

Brighthouse Financial Inc.(a)

    232       10,073  

Brown & Brown Inc.

    497       32,355  

Cincinnati Financial Corp.

    415       40,396  

CNA Financial Corp.

    100       4,242  

CNO Financial Group Inc.

    313       5,869  

Employers Holdings Inc.

    56       2,224  

Enstar Group Ltd.(a)

    29       5,740  

Equitable Holdings Inc.

    904       25,701  

Erie Indemnity Co., Class A, NVS

    41       8,338  

Essent Group Ltd.

    275       11,484  

Everest Re Group Ltd.

    107       27,964  

Fidelity National Financial Inc.

    624       24,935  

First American Financial Corp.

    286       16,588  

Genworth Financial Inc., Class A(a)

    1,014       4,310  

Globe Life Inc.

    280       28,204  

Hanover Insurance Group Inc. (The)

    121       16,513  

Hartford Financial Services Group Inc. (The)

    955       61,569  

Horace Mann Educators Corp.

    85       2,911  

 

 

28  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Financials ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Insurance (continued)

   

James River Group Holdings Ltd.

    48     $ 1,140  

Kemper Corp.

    181       8,471  

Kinsale Capital Group Inc.

    59       14,349  

Lincoln National Corp.

    510       26,183  

Loews Corp.

    319       18,582  

Markel Corp.(a)

    29       37,617  

Marsh & McLennan Companies Inc.

    947       155,270  

Mercury General Corp.

    90       3,774  

MetLife Inc.

    1,090       68,943  

MGIC Investment Corp.

    979       13,843  

NMI Holdings Inc., Class A(a)

    209       3,958  

Old Republic International Corp.

    569       13,241  

Palomar Holdings Inc.(a)

    59       3,680  

Primerica Inc.

    84       10,810  

Principal Financial Group Inc.

    755       50,540  

ProAssurance Corp.

    105       2,324  

Progressive Corp. (The)

    1,529       175,927  

Prudential Financial Inc.

    1,066       106,589  

RenaissanceRe Holdings Ltd.

    113       14,612  

RLI Corp.

    136       14,957  

Safety Insurance Group Inc.

    33       2,856  

Selective Insurance Group Inc.

    168       13,080  

Travelers Companies Inc. (The)

    655       103,949  

Trupanion Inc.(a)

    37       2,332  

Universal Insurance Holdings Inc.

    64       810  

Unum Group

    592       19,056  

Voya Financial Inc.

    319       19,191  

W R Berkley Corp.

    591       36,955  

White Mountains Insurance Group Ltd.

    10       12,394  

Willis Towers Watson PLC

    182       37,663  
   

 

 

 
        2,193,089  
Leisure Time — 0.0%            

Harley-Davidson Inc.

    119       4,499  
   

 

 

 

Machinery — 1.2%

   

Caterpillar Inc.

    518       102,694  

Vertiv Holdings Co.

    294       3,357  
   

 

 

 
      106,051  
Media — 0.2%            

FactSet Research Systems Inc.

    24       10,312  

New York Times Co. (The), Class A

    218       6,965  
   

 

 

 
      17,277  
Packaging & Containers — 0.1%            

Berry Global Group Inc.(a)

    99       5,707  
   

 

 

 

Pharmaceuticals — 1.9%

   

Cigna Corp.

    275       75,724  

CVS Health Corp.

    844       80,754  

Viatris Inc.

    1,467       14,215  
   

 

 

 
      170,693  
Private Equity — 1.2%            

Blackstone Inc., NVS

    920       93,904  

Carlyle Group Inc. (The)

    306       11,907  
   

 

 

 
      105,811  
Security   Shares     Value  

 

 

Real Estate Investment Trusts — 0.5%

   

AGNC Investment Corp.

    319     $ 4,023  

Annaly Capital Management Inc.

    1,396       9,605  

New Residential Investment Corp.

    402       4,386  

Two Harbors Investment Corp.

    188       1,011  

Weyerhaeuser Co.

    738       26,804  
   

 

 

 
      45,829  
Retail — 0.3%            

FirstCash Holdings Inc.

    46       3,370  

McDonald’s Corp.

    101       26,600  
   

 

 

 
      29,970  
Savings & Loans — 0.6%            

Axos Financial Inc.(a)

    95       3,967  

Berkshire Hills Bancorp. Inc.

    75       2,113  

Brookline Bancorp. Inc.

    175       2,420  

Capitol Federal Financial Inc.

    292       2,800  

New York Community Bancorp. Inc.

    1,405       14,921  

Northwest Bancshares Inc.

    224       3,221  

OceanFirst Financial Corp.

    145       2,981  

Pacific Premier Bancorp. Inc.

    95       3,196  

Provident Financial Services Inc.

    140       3,411  

Washington Federal Inc.

    262       8,942  

WSFS Financial Corp.

    189       9,019  
   

 

 

 
      56,991  
Software — 2.5%            

Avalara Inc.(a)

    29       2,535  

Black Knight Inc.(a)

    72       4,729  

Broadridge Financial Solutions Inc.

    136       21,835  

Fidelity National Information Services Inc.

    744       76,007  

Fiserv Inc.(a)

    415       43,857  

Loyalty Ventures Inc.(a)

    18       53  

MSCI Inc.

    66       31,769  

Paychex Inc.

    233       29,889  

SS&C Technologies Holdings Inc.

    137       8,106  
   

 

 

 
      218,780  
   

 

 

 

Total Long-Term Investments — 98.9%
(Cost: $8,173,688)

      8,773,341  
   

 

 

 

Short-Term Securities

   
Money Market Funds — 0.9%            

BlackRock Cash Funds: Treasury, SL Agency Shares, 1.81%(b)(c)

    80,000       80,000  
   

 

 

 

Total Short-Term Securities — 0.9%
(Cost: $80,000)

      80,000  
   

 

 

 

Total Investments in Securities — 99.8%
(Cost: $8,253,688)

      8,853,341  

Other Assets Less Liabilities — 0.2%

      20,902  
   

 

 

 

Net Assets — 100.0%

    $  8,874,243  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

Affiliate of the Fund.

(c) 

Annualized 7-day yield as of period end.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  29


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Financials ETF

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer  

Value at

07/31/21

   

Purchases

at Cost

    Proceeds
from Sale
   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

07/31/22

   

Shares

Held at

07/31/22

    Income    

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares(a)

  $ 4,412     $     $ (4,355 )(b)     $ (57   $     $           $ 136 (c)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    60,000       20,000 (b)                        80,000       80,000       255        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
         $ (57   $     $  80,000       $ 391     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

As of period end, the entity is no longer held.

 
  (b) 

Represents net amount purchased (sold).

 
  (c) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                       

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 8,773,341        $        $        $ 8,773,341  

Money Market Funds

     80,000                            80,000  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 8,853,341        $        $        $ 8,853,341  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

30  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  

July 31, 2022

  

iShares® Evolved U.S. Healthcare Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   

Biotechnology — 1.4%

   

Amgen Inc.

    365     $ 90,327  

Bio-Rad Laboratories Inc., Class A(a)

    190       107,019  

Guardant Health Inc.(a)

    892       44,752  

Illumina Inc.(a)

    1,215       263,266  

Myriad Genetics Inc.(a)

    874       23,056  

NeoGenomics Inc.(a)

    1,404       14,208  

Veracyte Inc.(a)

    665       17,516  
   

 

 

 
      560,144  
Commercial Services — 0.4%            

AMN Healthcare Services Inc.(a)

    476       53,521  

Bright Horizons Family Solutions Inc.(a)

    304       28,476  

Grand Canyon Education Inc.(a)

    287       27,572  

Progyny Inc.(a)

    498       15,204  

R1 RCM Inc.(a)

    928       23,200  

Strategic Education Inc.

    95       6,824  
   

 

 

 
      154,797  
Computers — 0.1%            

Maximus Inc.

    403       26,941  
   

 

 

 

Cosmetics & Personal Care — 0.1%

   

Procter & Gamble Co. (The)

    228       31,671  
   

 

 

 

Electrical Components & Equipment — 0.1%

   

Novanta Inc.(a)

    341       52,582  
   

 

 

 

Electronics — 1.0%

   

Agilent Technologies Inc.

    2,112       283,219  

Fortive Corp.

    1,758       113,303  

OSI Systems Inc.(a)

    81       7,831  
   

 

 

 
      404,353  
Environmental Control — 0.0%            

Stericycle Inc.(a)

    265       12,421  
   

 

 

 

Food Service — 0.0%

   

Healthcare Services Group Inc.

    683       9,794  
   

 

 

 

Health Care - Products — 42.1%

   

10X Genomics Inc., Class A(a)

    248       9,957  

Abbott Laboratories

    25,993           2,829,078  

Abiomed Inc.(a)

    589       172,583  

Adaptive Biotechnologies Corp.(a)

    552       5,056  

Align Technology Inc.(a)

    402       112,950  

AngioDynamics Inc.(a)

    456       10,347  

AtriCure Inc.(a)

    456       22,531  

Avanos Medical Inc.(a)

    380       10,781  

Avantor Inc.(a)

    1,395       40,483  

Axogen Inc.(a)

    209       1,948  

Baxter International Inc.

    3,572       209,534  

Bio-Techne Corp.

    321       123,675  

Boston Scientific Corp.(a)

    19,857       815,130  

Bruker Corp.

    722       49,493  

Cardiovascular Systems Inc.(a)

    399       6,149  

CareDx Inc.(a)

    515       12,252  

Cooper Companies Inc. (The)

    627       205,029  

Cutera Inc.(a)

    133       6,174  

Danaher Corp.

    6,635       1,933,903  

DENTSPLY SIRONA Inc.

    1,595       57,675  

Edwards Lifesciences Corp.(a)

    8,721       876,809  

Envista Holdings Corp.(a)

    1,080       43,902  
Security   Shares     Value  

Health Care - Products (continued)

   

Exact Sciences Corp.(a)

    1,885     $ 85,013  

Glaukos Corp.(a)

    266       14,324  

Globus Medical Inc., Class A(a)

    1,121       65,791  

Haemonetics Corp.(a)

    456       31,687  

Henry Schein Inc.(a)

    1,364       107,524  

Hologic Inc.(a)

    2,828       201,863  

ICU Medical Inc.(a)

    190       33,662  

IDEXX Laboratories Inc.(a)

    757       302,179  

Inari Medical Inc.(a)

    344       26,688  

Inspire Medical Systems Inc.(a)

    344       71,893  

Insulet Corp.(a)

    912       225,994  

Integer Holdings Corp.(a)

    285       19,919  

Integra LifeSciences Holdings Corp.(a)

    798       43,922  

Intuitive Surgical Inc.(a)

    5,219       1,201,257  

iRhythm Technologies Inc.(a)

    358       55,358  

LeMaitre Vascular Inc.

    209       10,523  

LivaNova PLC(a)

    566       36,037  

Masimo Corp.(a)

    703       101,640  

Medtronic PLC

    18,528       1,714,211  

Merit Medical Systems Inc.(a)

    646       37,132  

NanoString Technologies Inc.(a)

    434       5,555  

Natera Inc.(a)

    987       46,389  

Neogen Corp.(a)

    342       7,910  

Nevro Corp.(a)

    304       13,178  

Novocure Ltd.(a)

    649       44,126  

NuVasive Inc.(a)

    684       35,924  

Omnicell Inc.(a)

    379       41,735  

OraSure Technologies Inc.(a)

    663       2,029  

Orthofix Medical Inc.(a)

    227       5,823  

Pacific Biosciences of California Inc.(a)

    1,350       5,899  

Patterson Companies Inc.

    762       23,668  

Penumbra Inc.(a)

    535       74,568  

PerkinElmer Inc.

    895       137,087  

Quanterix Corp.(a)

    300       4,797  

QuidelOrtho Corp.(a)

    578       58,979  

ResMed Inc.

    1,880       452,178  

Shockwave Medical Inc.(a)

    424       89,434  

Silk Road Medical Inc.(a)

    341       15,519  

STAAR Surgical Co.(a)

    512       41,318  

STERIS PLC

    549       123,882  

Stryker Corp.

    4,654       999,446  

Tandem Diabetes Care Inc.(a)

    648       42,904  

Teleflex Inc.

    593       142,593  

Thermo Fisher Scientific Inc.

    2,633       1,575,614  

Waters Corp.(a)

    343       124,862  

Zimmer Biomet Holdings Inc.

    2,265       250,033  

Zimvie Inc.(a)

    226       4,389  
   

 

 

 
          16,311,895  
Health Care - Services — 30.4%            

Acadia Healthcare Co. Inc.(a)

    946       78,433  

Addus HomeCare Corp.(a)

    154       14,293  

agilon health Inc.(a)

    2,006       50,210  

Amedisys Inc.(a)

    477       57,168  

Centene Corp.(a)

    6,857       637,495  

Charles River Laboratories International Inc.(a)

    171       42,842  

Chemed Corp.

    134       64,466  

Community Health Systems Inc.(a)

    1,541       4,592  

DaVita Inc.(a)

    991       83,403  

Elevance Health Inc.

    2,691       1,283,876  

Encompass Health Corp.

    1,555       78,714  

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  31


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Healthcare Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Health Care - Services (continued)

   

Enhabit Inc.

    777     $ 13,605  

Ensign Group Inc. (The)

    325       25,899  

Fulgent Genetics Inc.(a)

    264       15,774  

HCA Healthcare Inc.

    3,269       694,401  

Humana Inc.

    1,522       733,604  

ICON PLC(a)

    110       26,538  

Invitae Corp.(a)

    1,975       3,753  

IQVIA Holdings Inc.(a)

    1,255       301,539  

Laboratory Corp. of America Holdings

    1,142       299,421  

LHC Group Inc.(a)

    400       65,224  

Medpace Holdings Inc.(a)

    135       22,887  

ModivCare Inc.(a)

    134       13,373  

Molina Healthcare Inc.(a)

    562       184,179  

Oak Street Health Inc.(a)

    1,541       44,612  

OPKO Health Inc.(a)

    3,823       9,022  

Pediatrix Medical Group Inc.(a)

    1,275       28,891  

Quest Diagnostics Inc.

    1,618       220,970  

Select Medical Holdings Corp.

    1,672       49,525  

Surgery Partners Inc.(a)

    475       18,706  

Syneos Health Inc.(a)

    228       18,044  

Teladoc Health Inc.(a)

    1,507       55,533  

Tenet Healthcare Corp.(a)

    1,387       91,708  

U.S. Physical Therapy Inc.

    228       29,590  

UnitedHealth Group Inc.

    11,613       6,298,194  

Universal Health Services Inc., Class B

    949       106,734  
   

 

 

 
        11,767,218  
Household Products & Wares — 0.2%            

Church & Dwight Co. Inc.

    1,081       95,096  
   

 

 

 

Machinery — 0.1%

   

Enovis Corp.(a)

    208       12,421  

Esab Corp.

    208       8,574  
   

 

 

 
      20,995  
Pharmaceuticals — 19.5%            

AbbVie Inc.

    8,434       1,210,363  

AdaptHealth Corp.(a)

    753       16,649  

AmerisourceBergen Corp.

    1,296       189,125  

Bausch Health Companies Inc.(a)

    1,062       4,906  

Becton Dickinson and Co.

    3,753       916,895  

Cardinal Health Inc.

    3,002       178,799  

Cigna Corp.

    2,763       760,820  

Covetrus Inc.(a)

    650       13,501  

CVS Health Corp.

    13,323       1,274,745  

Dexcom Inc.(a)

    4,936       405,147  

Eli Lilly & Co.

    231       76,158  

Embecta Corp.(a)

    750       22,072  

Johnson & Johnson

    10,319       1,800,872  

McKesson Corp.

    1,346       459,767  

Merck & Co. Inc.

    721       64,414  

Option Care Health Inc.(a)

    1,008       33,869  
Security   Shares     Value  

 

 

Pharmaceuticals (continued)

   

Owens & Minor Inc.

    648     $ 22,946  

Perrigo Co. PLC

    282       11,807  

Premier Inc., Class A

    1,404       53,998  

Zoetis Inc.

    149       27,200  
   

 

 

 
      7,544,053  
Real Estate Investment Trusts — 1.2%            

Healthpeak Properties Inc.

    1,461       40,367  

Medical Properties Trust Inc.

    4,389       75,666  

National Health Investors Inc.

    250       16,210  

Omega Healthcare Investors Inc.

    986       30,566  

Physicians Realty Trust

    1,558       27,686  

Sabra Health Care REIT Inc.

    1,520       23,393  

Ventas Inc.

    2,419       130,094  

Welltower Inc.

    1,338       115,523  
   

 

 

 
      459,505  
Retail — 0.4%            

National Vision Holdings Inc.(a)

    362       10,549  

Walgreens Boots Alliance Inc.

    4,068       161,174  
   

 

 

 
      171,723  
Software — 0.4%            

Allscripts Healthcare Solutions Inc.(a)

    1,258       19,902  

Apollo Medical Holdings Inc.(a)

    445       23,598  

Change Healthcare Inc.(a)

    1,877       45,555  

Evolent Health Inc., Class A(a)

    984       33,446  

Outset Medical Inc.(a)

    498       7,694  

Phreesia Inc.(a)

    270       6,342  

Tabula Rasa HealthCare Inc.(a)

    190       846  
   

 

 

 
      137,383  
   

 

 

 

Total Long-Term Investments — 97.4%
(Cost: $33,673,872)

      37,760,571  
   

 

 

 

Short-Term Securities

   

Money Market Funds — 2.5%

   

BlackRock Cash Funds: Treasury, SL Agency Shares, 1.81%(b)(c)

    986,000       986,000  
   

 

 

 

Total Short-Term Securities — 2.5%
(Cost: $986,000)

      986,000  
   

 

 

 

Total Investments in Securities — 99.9%
(Cost: $34,659,872)

      38,746,571  

Other Assets Less Liabilities — 0.1%

      28,892  
   

 

 

 

Net Assets — 100.0%

    $   38,775,463  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

Affiliate of the Fund.

(c) 

Annualized 7-day yield as of period end.

 

 

32  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Healthcare Staples ETF

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer  

Value at

07/31/21

   

Purchases

at Cost

   

Proceeds

from Sale

   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

07/31/22

    Shares
Held at
07/31/22
    Income    

Capital

Gain
Distributions
from
Underlying
Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares(a)

  $ 175,635     $     $ (175,405 )(b)     $ (228    $ (2   $           $ 271 (c)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    1,006,000             (20,000 )(b)                  986,000       986,000       1,483        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
         $ (228    $ (2   $ 986,000       $ 1,754     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

As of period end, the entity is no longer held.

 
  (b) 

Represents net amount purchased (sold).

 
  (c) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                               

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 37,760,571        $        $        $ 37,760,571  

Money Market Funds

     986,000                            986,000  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 38,746,571        $        $        $ 38,746,571  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  33


Schedule of Investments  

July 31, 2022

  

iShares® Evolved U.S. Innovative Healthcare ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   

Biotechnology — 43.8%

   

2seventy bio Inc.(a)

    732     $ 10,533  

Abeona Therapeutics Inc.

    29       115  

ACADIA Pharmaceuticals Inc.(a)

    3,036       44,599  

Achillion Pharmaceuticals, Inc.(b)(c)

    624       287  

Acorda Therapeutics Inc.(a)

    189       82  

Aduro Biotech Inc., NVS(b)

    156       396  

Adverum Biotechnologies Inc.(a)

    1,671       2,440  

Agenus Inc.(a)

    1,914       4,938  

Alaunos Therapeutics Inc.(a)

    3,344       3,912  

Albireo Pharma Inc.(a)

    457       9,501  

Allakos Inc.(a)

    747       2,413  

Allogene Therapeutics Inc.(a)

    1,916       24,870  

Alnylam Pharmaceuticals Inc.(a)

    3,814       541,741  

Amgen Inc.

    6,518           1,613,009  

Amicus Therapeutics Inc.(a)

    7,101       70,726  

AnaptysBio Inc.(a)

    374       7,832  

Anavex Life Sciences Corp.(a)

    1,980       20,315  

ANI Pharmaceuticals Inc.(a)

    154       5,274  

Apellis Pharmaceuticals Inc.(a)

    2,216       124,716  

Applied Therapeutics Inc.(a)

    391       422  

Aprea Therapeutics Inc.(a)

    464       445  

Arcturus Therapeutics Holdings Inc.(a)

    478       8,389  

Arcus Biosciences Inc.(a)

    1,567       41,667  

Ardelyx Inc.(a)

    1,891       1,320  

Arrowhead Pharmaceuticals Inc.(a)

    2,975       126,527  

Assembly Biosciences Inc.(a)

    484       1,002  

Atara Biotherapeutics Inc.(a)

    2,136       6,472  

Athersys Inc.(a)

    5,414       1,349  

Avrobio Inc.(a)

    661       602  

Axsome Therapeutics Inc.(a)

    860       33,187  

Beam Therapeutics Inc.(a)

    1,481       93,273  

BioCryst Pharmaceuticals Inc.(a)

    5,142       56,665  

Biogen Inc.(a)

    3,920       843,035  

Biohaven Pharmaceutical Holding Co. Ltd.(a)

    1,579       230,566  

BioMarin Pharmaceutical Inc.(a)

    5,385       463,379  

Bio-Rad Laboratories Inc., Class A(a)

    44       24,783  

Bluebird Bio Inc.(a)

    2,195       8,890  

Blueprint Medicines Corp.(a)

    1,561       79,705  

Bridgebio Pharma Inc.(a)

    2,448       21,200  

C4 Therapeutics Inc.(a)

    728       7,018  

Calithera Biosciences Inc., NVS(a)

    120       382  

Cara Therapeutics Inc.(a)

    792       6,922  

Cassava Sciences Inc.(a)

    1,163       18,992  

Celldex Therapeutics Inc.(a)

    1,307       40,151  

Cerevel Therapeutics Holdings Inc.(a)

    1,314       34,545  

Certara Inc.(a)

    568       13,058  

ChemoCentryx Inc.(a)

    1,621       38,288  

Chinook Therapeutics Inc.(a)

    201       3,721  

Contra Flexion Therape(b)

    936       580  

Cortexyme Inc.(a)

    391       762  

Crinetics Pharmaceuticals Inc.(a)

    754       14,484  

Cue Biopharma Inc.(a)

    904       2,459  

Cymabay Therapeutics Inc.(a)

    1,759       5,506  

Cytokinetics Inc.(a)

    2,135       90,375  

CytomX Therapeutics Inc.(a)

    858       1,227  

Deciphera Pharmaceuticals Inc.(a)

    1,233       15,647  

Denali Therapeutics Inc.(a)

    2,251       76,579  

Dynavax Technologies Corp.(a)

    2,701       38,840  
Security   Shares     Value  

Biotechnology (continued)

   

Editas Medicine Inc.(a)

    1,446     $ 23,006  

Emergent BioSolutions Inc.(a)

    881       30,518  

Epizyme Inc.(a)

    2,089       3,092  

Esperion Therapeutics Inc.(a)

    682       3,935  

Exelixis Inc.(a)

    7,828       163,762  

Fate Therapeutics Inc.(a)

    2,288       69,853  

FibroGen Inc.(a)

    2,024       25,462  

Frequency Therapeutics Inc.(a)

    730       1,460  

Geron Corp.(a)

    2,706       5,141  

Gilead Sciences Inc.

    24,687           1,475,048  

Global Blood Therapeutics Inc.(a)

    1,651       54,021  

GlycoMimetics Inc.(a)

    1,013       693  

Gossamer Bio Inc.(a)

    1,408       15,812  

Guardant Health Inc.(a)

    877       43,999  

Halozyme Therapeutics Inc.(a)

    3,500       171,150  

Homology Medicines Inc.(a)

    941       2,023  

Horizon Therapeutics PLC(a)

    5,760       477,907  

ImmunoGen Inc.(a)

    4,178       19,804  

Incyte Corp.(a)

    5,145       399,664  

Inhibrx Inc.(a)

    634       10,994  

Innoviva Inc.(a)

    1,298       18,613  

Inovio Pharmaceuticals Inc.(a)

    5,064       10,027  

Insmed Inc.(a)

    2,967       65,630  

Instil Bio Inc.(a)

    1,401       7,902  

Intellia Therapeutics Inc.(a)

    2,076       134,442  

Intercept Pharmaceuticals Inc.(a)

    747       9,532  

Intra-Cellular Therapies Inc.(a)

    2,132       115,384  

Ionis Pharmaceuticals Inc.(a)

    3,649       137,056  

Iovance Biotherapeutics Inc.(a)

    3,665       42,697  

IVERIC bio Inc.(a)

    2,770       29,611  

Karuna Therapeutics Inc.(a)

    461       60,045  

Karyopharm Therapeutics Inc.(a)

    2,064       8,772  

Keros Therapeutics Inc.(a)

    321       10,298  

Kezar Life Sciences Inc.(a)

    1,030       10,063  

Kiniksa Pharmaceuticals Ltd., Class A(a)

    612       6,065  

Kodiak Sciences Inc.(a)

    748       7,443  

Krystal Biotech Inc.(a)

    306       22,209  

Kymera Therapeutics Inc.(a)

    799       17,602  

La Jolla Pharmaceutical Co.(a)

    506       3,142  

Lexicon Pharmaceuticals Inc.(a)

    1,166       2,775  

Ligand Pharmaceuticals Inc.(a)

    462       42,518  

MacroGenics Inc.(a)

    1,475       4,617  

Maravai LifeSciences Holdings Inc., Class A(a)

    1,431       37,335  

MEI Pharma Inc.(a)

    3,692       1,787  

Mersana Therapeutics Inc.(a)

    1,756       8,903  

Mirati Therapeutics Inc.(a)

    1,467       94,475  

Moderna Inc.(a)

    9,700       1,591,673  

Molecular Templates Inc.(a)

    993       836  

Myriad Genetics Inc.(a)

    770       20,313  

Nektar Therapeutics(a)

    5,214       20,647  

NextCure Inc.(a)

    372       1,600  

Novavax Inc.(a)

    2,082       113,490  

Nurix Therapeutics Inc.(a)

    982       15,673  

Omeros Corp.(a)

    1,034       5,149  

Pieris Pharmaceuticals Inc.(a)

    1,408       2,478  

Precigen Inc.(a)

    968       1,520  

Prothena Corp. PLC(a)

    966       30,004  

Provention Bio Inc.(a)

    1,116       4,263  

PTC Therapeutics Inc.(a)

    1,430       62,276  

Puma Biotechnology Inc.(a)

    858       2,514  

 

 

34  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Innovative Healthcare ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Biotechnology (continued)

   

Radius Health Inc.(a)

    1,100     $ 11,088  

Recursion Pharmaceuticals Inc., Class A(a)

    1,385       11,717  

Regeneron Pharmaceuticals Inc.(a)

    2,503       1,455,970  

REGENXBIO Inc.(a)

    748       23,465  

Relay Therapeutics Inc.(a)

    1,724       32,790  

Replimune Group Inc.(a)

    643       12,397  

REVOLUTION Medicines Inc.(a)

    1,668       37,680  

Rigel Pharmaceuticals Inc.(a)

    3,938       4,686  

Rocket Pharmaceuticals Inc.(a)

    573       8,308  

Royalty Pharma PLC, Class A

    6,530       283,990  

Rubius Therapeutics Inc.(a)

    901       633  

Sage Therapeutics Inc.(a)

    1,436       49,413  

Sana Biotechnology Inc.(a)

    1,861       12,431  

Sangamo Therapeutics Inc.(a)

    3,476       14,912  

Sarepta Therapeutics Inc.(a)

    2,196       204,118  

Scholar Rock Holding Corp.(a)

    724       4,967  

Seagen Inc.(a)

    3,734       672,045  

Solid Biosciences Inc.(a)

    353       238  

Sorrento Therapeutics Inc.(a)

    5,654       14,700  

SpringWorks Therapeutics Inc.(a)

    763       22,798  

Stoke Therapeutics Inc.(a)

    442       6,537  

Syndax Pharmaceuticals Inc.(a)

    1,057       21,531  

TG Therapeutics Inc.(a)

    3,787       22,684  

Theravance Biopharma Inc.(a)

    1,076       9,458  

Travere Therapeutics Inc.(a)

    1,034       24,340  

Twist Bioscience Corp.(a)

    282       12,335  

Ultragenyx Pharmaceutical Inc.(a)

    1,712       91,215  

United Therapeutics Corp.(a)

    1,034       238,926  

UroGen Pharma Ltd.(a)

    353       2,768  

Vaxart Inc.(a)

    1,751       6,444  

Vericel Corp.(a)

    527       17,149  

Vertex Pharmaceuticals Inc.(a)

    6,724       1,885,477  

Verve Therapeutics Inc.(a)

    531       13,073  

Viking Therapeutics Inc.(a)

    1,428       4,298  

Vir Biotechnology Inc.(a)

    2,427       67,495  

WaVe Life Sciences Ltd.(a)

    462       1,173  

Xencor Inc.(a)

    1,320       37,871  

Zentalis Pharmaceuticals Inc.(a)

    968       28,266  
   

 

 

 
          16,088,222  
Chemicals — 0.0%            

Codexis Inc.(a)

    991       6,798  
   

 

 

 

Electrical Components & Equipment — 0.1%

   

Universal Display Corp

    308       35,562  
   

 

 

 

Health Care - Products — 2.9%

   

10X Genomics Inc., Class A(a)

    510       20,477  

Abbott Laboratories

    464       50,502  

Adaptive Biotechnologies Corp.(a)

    1,382       12,659  

Axogen Inc.(a)

    308       2,871  

Baxter International Inc.

    2,081       122,071  

CareDx Inc.(a)

    376       8,945  

Cerus Corp.(a)

    3,318       17,917  

Cooper Companies Inc. (The)

    193       63,111  

Exact Sciences Corp.(a)

    1,501       67,695  

Glaukos Corp.(a)

    572       30,802  

Haemonetics Corp.(a)

    286       19,874  

ICU Medical Inc.(a)

    110       19,489  

IDEXX Laboratories Inc.(a)

    72       28,741  

Inspire Medical Systems Inc.(a)

    246       51,412  
Security   Shares     Value  

Health Care - Products (continued)

   

Insulet Corp.(a)

    175     $ 43,365  

Integra LifeSciences Holdings Corp.(a)

    374       20,585  

Intuitive Surgical Inc.(a)

    138       31,763  

Lantheus Holdings Inc.(a)

    1,142       87,614  

NanoString Technologies Inc.(a)

    392       5,018  

Natera Inc.(a)

    418       19,646  

Nevro Corp.(a)

    308       13,352  

Novocure Ltd.(a)

    1,344       91,379  

Penumbra Inc.(a)

    111       15,471  

Progenics Pharmaceuticals, Inc., NVS(b)

    1,001        

Repligen Corp.(a)

    640       136,550  

ResMed Inc

    350       84,182  
   

 

 

 
          1,065,491  
Health Care - Services — 1.8%            

Catalent Inc.(a)

    1,580       178,698  

Charles River Laboratories International Inc.(a)

    463       116,000  

ICON PLC(a)

    263       63,449  

IQVIA Holdings Inc.(a)

    906       217,684  

Medpace Holdings Inc.(a)

    219       37,127  

OPKO Health Inc.(a)

    5,038       11,890  

Syneos Health Inc.(a)

    616       48,750  
   

 

 

 
      673,598  
Pharmaceuticals — 43.1%            

AbbVie Inc.

    15,591       2,237,464  

Aclaris Therapeutics Inc.(a)

    748       11,527  

Aeglea BioTherapeutics Inc.(a)

    1,431       594  

Aerie Pharmaceuticals Inc.(a)

    990       6,940  

Agios Pharmaceuticals Inc.(a)

    1,780       38,395  

Akebia Therapeutics Inc.(a)

    4,510       1,763  

Alector Inc.(a)

    1,762       18,008  

Alkermes PLC(a)

    3,697       94,643  

AmerisourceBergen Corp.

    434       63,334  

Amneal Pharmaceuticals Inc.(a)

    2,949       10,439  

Amphastar Pharmaceuticals Inc.(a)

    726       27,145  

Anika Therapeutics Inc.(a)

    220       5,139  

Arvinas Inc.(a)

    1,172       62,245  

AstraZeneca PLC

    3,880       256,972  

Athenex Inc.(a)

    1,783       904  

Bausch Health Companies Inc.(a)

    4,884       22,564  

Bioxcel Therapeutics Inc.(a)

    358       5,528  

Bristol-Myers Squibb Co.

    26,729       1,972,066  

Catalyst Pharmaceuticals Inc.(a)

    1,651       16,906  

Clovis Oncology Inc.(a)

    1,276       2,131  

Coherus Biosciences Inc.(a)

    1,693       14,340  

Collegium Pharmaceutical Inc.(a)

    594       10,211  

Concert Pharmaceuticals Inc.(a)

    528       2,957  

Contra Adamas Pharmace(b)(c)

    552       33  

Contra Adamas Pharmace(b)(c)

    552       33  

Corbus Pharmaceuticals Holdings Inc.(a)

    1,232       312  

Corcept Therapeutics Inc.(a)

    2,420       69,357  

Cyclerion Therapeutics Inc.(a)

    330       317  

Dexcom Inc.(a)

    1,596       131,000  

Eagle Pharmaceuticals Inc./DE(a)

    308       12,228  

Elanco Animal Health Inc.(a)

    4,551       92,203  

Eli Lilly & Co.

    8,419       2,775,660  

Enanta Pharmaceuticals Inc.(a)

    374       20,626  

Endo International PLC(a)

    3,424       1,815  

G1 Therapeutics Inc.(a)

    484       4,032  

Harmony Biosciences Holdings Inc.(a)

    368       18,669  

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  35


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Innovative Healthcare ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Pharmaceuticals (continued)

   

Heron Therapeutics Inc.(a)

    1,804     $ 5,015  

Ironwood Pharmaceuticals Inc.(a)

    3,300       37,785  

Jazz Pharmaceuticals PLC(a)

    1,478       230,657  

Johnson & Johnson

    21,590       3,767,887  

Jounce Therapeutics Inc.(a)

    396       1,216  

Kala Pharmaceuticals Inc.(a)

    1,346       444  

Kura Oncology Inc.(a)

    1,601       24,511  

Lannett Co. Inc.(a)

    638       370  

Madrigal Pharmaceuticals Inc.(a)

    218       13,695  

MediciNova Inc.(a)

    902       2,084  

Merck & Co. Inc.

    23,775           2,124,058  

Morphic Holding Inc.(a)

    290       7,676  

Neurocrine Biosciences Inc.(a)

    2,507       235,984  

Ocugen Inc.(a)

    4,943       12,753  

Ocular Therapeutix Inc.(a)

    1,787       8,006  

Organon & Co.

    2,851       90,434  

Pacira BioSciences Inc.(a)

    836       47,284  

Paratek Pharmaceuticals Inc.(a)

    682       1,562  

Perrigo Co. PLC

    1,734       72,603  

Prestige Consumer Healthcare Inc.(a)

    352       21,229  

Protagonist Therapeutics Inc.(a)

    1,012       10,069  

Reata Pharmaceuticals Inc., Class A(a)

    683       20,954  

Relmada Therapeutics Inc.(a)

    352       9,011  

Revance Therapeutics Inc.(a)

    1,721       26,710  

Rhythm Pharmaceuticals Inc.(a)

    966       12,172  

Seres Therapeutics Inc.(a)

    1,304       5,359  

Spectrum Pharmaceuticals Inc.(a)

    2,457       1,998  

Supernus Pharmaceuticals Inc.(a)

    1,210       38,418  

Synergy Pharmaceuticals Inc.(a)(b)(c)

    1,136       7  

Syros Pharmaceuticals Inc.(a)

    1,273       999  

TherapeuticsMD Inc.(a)

    70       436  

Tricida Inc.(a)

    704       6,449  

Vanda Pharmaceuticals Inc.(a)

    1,232       13,281  

Viatris Inc.

    5,216       50,543  

Voyager Therapeutics Inc.(a)

    704       4,717  

Y-mAbs Therapeutics Inc.(a)

    638       9,946  
Security   Shares     Value  

 

 

Pharmaceuticals (continued)

   

Zoetis Inc.

    4,999     $ 912,567  
   

 

 

 
      15,837,389  
Software — 0.1%            

Contra Zogenix Inc., NVS(b)

    1,728       1,175  

Schrodinger Inc.(a)

    928       29,046  
   

 

 

 
      30,221  
Telecommunications — 0.0%            

InterDigital Inc.

    198       12,155  
   

 

 

 

Total Long-Term Investments — 91.8%
(Cost: $33,474,264)

 

    33,749,436  
   

 

 

 

Short-Term Securities

   

Money Market Funds — 7.9%

   

BlackRock Cash Funds: Institutional, SL Agency Shares, 1.93%(d)(e)(f)

    78,449       78,441  

BlackRock Cash Funds: Treasury, SL Agency Shares, 1.81%(d)(e)

    2,842,000       2,842,000  
   

 

 

 

Total Short-Term Securities — 7.9%
(Cost: $2,920,412)

 

    2,920,441  
   

 

 

 

Total Investments in Securities — 99.7%
(Cost: $36,394,676)

 

    36,669,877  

Other Assets Less Liabilities — 0.3%

 

    114,989  
   

 

 

 

Net Assets — 100.0%

 

  $   36,784,866  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(c) 

All or a portion of this security is on loan.

(d) 

Affiliate of the Fund.

(e) 

Annualized 7-day yield as of period end.

(f) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer   Value at
07/31/21
    Purchases
at Cost
    Proceeds
from Sale
    Net Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
07/31/22
    Shares
Held at
07/31/22
    Income    

Capital

Gain
Distributions
from
Underlying
Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 370,601     $     $ (291,770 )(a)      $ (325    $ (65   $ 78,441       78,449     $ 5,277 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    592,000       2,250,000 (a)                        2,842,000       2,842,000       2,125        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
          $ (325    $ (65   $ 2,920,441       $  7,402     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

 

 

36  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Innovative Healthcare ETF

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                               

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 33,746,925        $        $ 2,511        $ 33,749,436  

Money Market Funds

     2,920,441                            2,920,441  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 36,667,366        $        $ 2,511        $ 36,669,877  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  37


Schedule of Investments  

July 31, 2022

  

iShares® Evolved U.S. Media and Entertainment ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   

Advertising — 0.1%

   

Clear Channel Outdoor Holdings Inc.(a)

    3,511     $ 5,442  

Entravision Communications Corp., Class A

    1,214       6,507  

National CineMedia Inc.

    1,928       2,815  
   

 

 

 
      14,764  
Commercial Services — 2.2%            

Graham Holdings Co., Class B

    96       57,071  

John Wiley & Sons Inc., Class A

    407       21,253  

Nielsen Holdings PLC

    6,095       145,975  

Viad Corp.(a)

    128       4,323  
   

 

 

 
      228,622  
Entertainment — 8.8%            

AMC Entertainment Holdings Inc., Class A(a)

    7,910       115,170  

Caesars Entertainment Inc.(a)

    811       37,055  

Churchill Downs Inc.

    344       72,171  

Cinemark Holdings Inc.(a)

    2,488       45,605  

DraftKings Inc., Class A (a)

    4,289       58,888  

IMAX Corp.(a)

    1,536       25,820  

Lions Gate Entertainment Corp., Class A(a)

    3,224       28,242  

Lions Gate Entertainment Corp., Class B, NVS(a)

    6,077       50,500  

Live Nation Entertainment Inc.(a)

    2,169       203,864  

Madison Square Garden Entertainment Corp.(a)

    476       27,717  

Madison Square Garden Sports Corp.(a)

    384       59,051  

Penn National Gaming Inc.(a)

    485       16,757  

Reading International Inc., Class A, NVS(a)

    360       1,678  

Scientific Games Corp., Class A(a)

    1,058       53,895  

SeaWorld Entertainment Inc.(a)

    952       45,439  

Six Flags Entertainment Corp.(a)

    1,496       33,914  

Warner Music Group Corp., Class A

    1,398       41,940  
   

 

 

 
      917,706  
Home Furnishings — 0.8%            

Dolby Laboratories Inc., Class A

    1,128       87,307  
   

 

 

 

Internet — 14.3%

   

Alphabet Inc., Class A(a)

    2,220       258,230  

Alphabet Inc., Class C, NVS(a)

    2,220       258,941  

fuboTV Inc.(a)

    3,878       9,734  

IAC/InterActiveCorp.(a)

    1,135       77,747  

Match Group Inc.(a)

    717       52,563  

Netflix Inc.(a)

    1,354       304,515  

Roku Inc.(a)

    2,317       151,810  

Twitter Inc.(a)

    9,284       386,307  
   

 

 

 
          1,499,847  
Leisure Time — 0.0%            

Carnival Corp.(a)

    377       3,416  

Liberty TripAdvisor Holdings Inc., Class A(a)

    697       477  
   

 

 

 
      3,893  
Lodging — 0.2%            

Las Vegas Sands Corp.(a)

    508       19,147  

Marcus Corp. (The)(a)

    240       3,943  
   

 

 

 
      23,090  
Media — 53.3%            

Altice USA Inc., Class A(a)

    5,286       55,556  

AMC Networks Inc., Class A(a)

    1,508       46,024  

Audacy Inc(a)

    5,296       3,374  

Cable One Inc.

    130       178,968  

Charter Communications Inc., Class A(a)

    910       393,211  

Comcast Corp., Class A

    12,775       479,318  
Security   Shares     Value  

Media (continued)

   

DISH Network Corp., Class A(a)

    5,556     $ 96,508  

Endeavor Group Holdings Inc.(a)

    3,144       71,652  

EW Scripps Co. (The), Class A, NVS(a)

    3,298       47,029  

Fox Corp., Class A, NVS

    15,854       524,926  

Fox Corp., Class B

    8,928       275,875  

Gannett Co. Inc.(a)

    1,735       5,222  

Gray Television Inc.

    4,590       85,236  

Hemisphere Media Group Inc.(a)

    824       6,411  

iHeartMedia Inc., Class A(a)

    1,804       13,494  

Liberty Broadband Corp., Class A, NVS(a)

    613       66,161  

Liberty Broadband Corp., Class C (a)

    2,943       320,581  

Liberty Global PLC, Class A(a)

    2,488       54,139  

Liberty Global PLC, Class C, NVS(a)

    7,184       164,442  

Liberty Latin America Ltd., Class A(a)

    310       2,285  

Liberty Latin America Ltd., Class C, NVS(a)

    1,824       13,388  

Liberty Media Corp.-Liberty SiriusXM, Class A, NVS(a)

    576       22,954  

Liberty Media Corp.-Liberty SiriusXM, Class C, NVS(a)

    661       26,321  

New York Times Co. (The), Class A

    946       30,225  

News Corp., Class A, NVS

    11,679       200,178  

News Corp., Class B

    3,456       59,720  

Nexstar Media Group Inc., Class A

    2,437       459,058  

Paramount Global, Class A, NVS

    263       7,112  

Paramount Global, Class B, NVS

    17,322       409,665  

Saga Communications Inc., Class A

    216       5,057  

Scholastic Corp., NVS

    432       20,334  

Sinclair Broadcast Group Inc., Class A

    2,903       63,401  

Sirius XM Holdings Inc.

    30,177       201,582  

TEGNA Inc.

    11,366       238,004  

Walt Disney Co. (The)(a)

    4,303       456,548  

Warner Bros. Discovery Inc.(a)

    21,508       322,620  

World Wrestling Entertainment Inc., Class A

    2,178       150,957  
   

 

 

 
          5,577,536  
Real Estate Investment Trusts — 1.4%            

Lamar Advertising Co., Class A

    920       92,975  

Ryman Hospitality Properties Inc.(a)

    642       56,843  
   

 

 

 
      149,818  
Retail — 1.0%            

GameStop Corp., Class A(a)

    2,300       78,223  

Qurate Retail Inc. Series A

    9,451       25,801  
   

 

 

 
      104,024  
Software — 12.6%            

Activision Blizzard Inc.

    6,433       514,318  

Daily Journal Corp.(a)

    16       4,325  

Electronic Arts Inc.

    3,655       479,645  

Playtika Holding Corp.(a)

    558       6,847  

Take-Two Interactive Software Inc.(a)

    2,189       290,546  

Vimeo Inc.(a)

    652       3,625  

Xperi Holding Corp.

    855       14,330  
   

 

 

 
      1,313,636  
Telecommunications — 0.5%            

AT&T Inc.

    1,745       32,771  

Harmonic Inc.(a)

    928       10,134  

Shenandoah Telecommunications Co.

    602       13,425  
   

 

 

 
      56,330  
Toys, Games & Hobbies — 3.3%            

Hasbro Inc.

    3,278       258,044  

 

 

38  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Media and Entertainment ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Toys, Games & Hobbies (continued)

   

Mattel Inc.(a)

    3,657     $ 84,843  
   

 

 

 
      342,887  
   

 

 

 

Total Long-Term Investments — 98.5%
(Cost: $13,664,223)

 

    10,319,460  
   

 

 

 

Short-Term Securities

   

Money Market Funds — 1.4%

   

BlackRock Cash Funds: Treasury, SL Agency Shares, 1.81%(b)(c)

    148,000       148,000  
   

 

 

 

Total Short-Term Securities — 1.4%
(Cost: $148,000)

 

    148,000  
   

 

 

 

Total Investments in Securities — 99.9%
(Cost: $13,812,223)

 

    10,467,460  

Other Assets Less Liabilities — 0.1%

 

    5,618  
   

 

 

 

Net Assets — 100.0%

 

  $   10,473,078  
   

 

 

 

 

 

(a) 

Non-income producing security.

(b) 

Affiliate of the Fund.

(c) 

Annualized 7-day yield as of period end.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer   Value at
07/31/21
    Purchases
at Cost
    Proceeds
from Sale
    Net Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
07/31/22
    Shares
Held at
07/31/22
    Income    

Capital

Gain
Distributions
from
Underlying
Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares(a)

  $ 924,521     $     $ (923,644 )(b)     $ (866    $ (11   $           $ 7,283 (c)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    118,000       30,000 (b)                        148,000       148,000       424        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
         $ (866    $ (11   $ 148,000       $  7,707     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

As of period end, the entity is no longer held.

 
  (b) 

Represents net amount purchased (sold).

 
  (c) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                               

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 10,319,460        $        $        $ 10,319,460  

Money Market Funds

     148,000                            148,000  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 10,467,460        $        $        $ 10,467,460  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  39


Schedule of Investments  

July 31, 2022

  

iShares® Evolved U.S. Technology ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   

Advertising — 0.3%

   

Interpublic Group of Companies Inc. (The)

    2,886     $ 86,205  

Omnicom Group Inc.

    1,421       99,242  

Trade Desk Inc. (The), Class A(a)

    3,960       178,200  
   

 

 

 
      363,647  
Aerospace & Defense — 0.1%            

L3Harris Technologies Inc.

    289       69,351  
   

 

 

 

Banks — 0.3%

   

JPMorgan Chase & Co.

    2,793       322,201  
   

 

 

 

Biotechnology — 0.1%

   

Illumina Inc.(a)

    536       116,140  

Incyte Corp.(a)

    501       38,918  
   

 

 

 
      155,058  
Commercial Services — 3.7%            

2U Inc.(a)

    343       3,358  

Automatic Data Processing Inc.

    3,657       881,776  

Block Inc.(a)

    3,516       267,427  

Booz Allen Hamilton Holding Corp.

    641       61,523  

Chegg Inc.(a)

    1,320       28,116  

Clarivate PLC(a)

    3,214       46,571  

CoStar Group Inc.(a)(b)

    2,970       215,592  

Equifax Inc.

    686       143,312  

FleetCor Technologies Inc.(a)

    490       107,844  

Gartner Inc.(a)

    784       208,136  

Global Payments Inc.

    1,614       197,425  

Korn Ferry

    392       25,680  

LiveRamp Holdings Inc.(a)

    52       1,384  

MarketAxess Holdings Inc.

    147       39,805  

Moody’s Corp.

    637       197,629  

Nielsen Holdings PLC

    1,664       39,853  

Paylocity Holding Corp.(a)

    485       99,876  

PayPal Holdings Inc.(a)

    9,250       800,403  

Robert Half International Inc.

    539       42,656  

S&P Global Inc.

    1,801       678,851  

Sabre Corp.(a)(b)

    1,519       9,342  

TransUnion

    1,176       93,174  

Verisk Analytics Inc.(b)

    735       139,834  
   

 

 

 
          4,329,567  
Computers — 18.0%            

Accenture PLC, Class A

    5,236       1,603,577  

Apple Inc.

    93,057       15,122,693  

CACI International Inc., Class A(a)

    147       44,437  

Cognizant Technology Solutions Corp., Class A

    4,707       319,888  

Crowdstrike Holdings Inc., Class A(a)

    2,006       368,302  

Dell Technologies Inc., Class C

    1,960       88,318  

DXC Technology Co.(a)

    2,744       86,710  

EPAM Systems Inc.(a)

    392       136,906  

Fortinet Inc.(a)

    7,840       467,656  

Genpact Ltd.

    1,127       54,186  

Hewlett Packard Enterprise Co.

    12,350       175,864  

HP Inc.

    8,079       269,758  

International Business Machines Corp.

    10,174       1,330,657  

Kyndryl Holdings Inc.(a)

    2,031       21,265  

Lumentum Holdings Inc.(a)

    294       26,595  

NCR Corp.(a)

    784       25,441  

NetApp Inc.

    2,648       188,882  

Pure Storage Inc., Class A(a)

    1,078       30,561  
Security   Shares     Value  

Computers (continued)

   

Qualys Inc.(a)

    392     $ 47,949  

Rapid7 Inc.(a)

    641       41,005  

Seagate Technology Holdings PLC

    1,764       141,085  

Varonis Systems Inc.(a)

    1,363       34,661  

Western Digital Corp.(a)

    2,352       115,483  

Zscaler Inc.(a)

    932       144,516  
   

 

 

 
      20,886,395  
Cosmetics & Personal Care — 0.2%            

Procter & Gamble Co. (The)

    1,449       201,281  
   

 

 

 

Distribution & Wholesale — 0.1%

   

Copart Inc.(a)

    588       75,323  

KAR Auction Services Inc.(a)

    441       7,541  
   

 

 

 
      82,864  
Diversified Financial Services — 5.6%            

Cboe Global Markets Inc.

    490       60,456  

CME Group Inc.

    1,666       332,334  

Coinbase Global Inc., Class A(a)(b)

    1,433       90,222  

Discover Financial Services

    392       39,592  

Interactive Brokers Group Inc., Class A

    294       17,255  

Intercontinental Exchange Inc.

    2,842       289,855  

Invesco Ltd.

    1,080       19,159  

Mastercard Inc., Class A

    6,778       2,397,989  

Nasdaq Inc.

    539       97,505  

SEI Investments Co.

    588       32,552  

Tradeweb Markets Inc., Class A

    1,423       100,350  

Visa Inc., Class A

    14,222       3,016,628  

Western Union Co. (The)

    1,911       32,525  
   

 

 

 
          6,526,422  
Electronics — 0.5%            

Agilent Technologies Inc.

    782       104,866  

Allegion PLC

    299       31,604  

Flex Ltd.(a)(b)

    2,841       47,729  

Garmin Ltd.

    442       43,148  

II-VI Inc.(a)

    89       4,685  

Keysight Technologies Inc.(a)

    1,029       167,316  

Mettler-Toledo International Inc.(a)

    48       64,787  

National Instruments Corp.

    931       35,378  

TD SYNNEX Corp.

    196       19,682  

Trimble Inc.(a)

    1,274       88,454  
   

 

 

 
      607,649  
Energy - Alternate Sources — 0.3%            

Enphase Energy Inc.(a)

    692       196,652  

SolarEdge Technologies Inc.(a)(b)

    260       93,634  

Sunrun Inc.(a)

    1,019       33,311  
   

 

 

 
      323,597  
Health Care - Products — 0.2%            

10X Genomics Inc., Class A(a)(b)

    382       15,337  

Align Technology Inc.(a)

    304       85,415  

Avantor Inc.(a)

    3,018       87,583  
   

 

 

 
      188,335  
Health Care - Services — 0.2%            

Charles River Laboratories International Inc.(a)

    286       71,654  

IQVIA Holdings Inc.(a)

    539       129,506  

Teladoc Health Inc.(a)(b)

    801       29,517  
   

 

 

 
      230,677  
Insurance — 0.4%            

Aon PLC, Class A

    638       185,684  

 

 

40  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Technology ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Insurance (continued)

   

Marsh & McLennan Companies Inc.

    1,323     $ 216,919  

Willis Towers Watson PLC

    400       82,776  
   

 

 

 
      485,379  
Internet — 22.2%            

Airbnb Inc., Class A(a)

    2,184       242,380  

Alphabet Inc., Class A(a)

    50,000       5,816,000  

Alphabet Inc., Class C, NVS(a)

    48,740       5,685,034  

Amazon.com Inc.(a)

    49,384       6,664,371  

Booking Holdings Inc.(a)

    200       387,138  

CDW Corp./DE

    1,078       195,689  

DoorDash Inc., Class A(a)

    2,169       151,288  

eBay Inc.

    5,212       253,460  

Etsy Inc.(a)

    852       88,369  

Expedia Group Inc.(a)

    637       67,554  

F5 Inc.(a)

    637       106,608  

GoDaddy Inc., Class A(a)

    1,127       83,601  

IAC/InterActiveCorp.(a)

    528       36,168  

Lyft Inc., Class A(a)

    1,866       25,863  

Mandiant Inc.(a)

    1,519       34,603  

Match Group Inc.(a)

    1,508       110,551  

MercadoLibre Inc.(a)

    279       227,025  

Meta Platforms Inc, Class A(a)

    21,812       3,470,289  

Netflix Inc.(a)

    1,211       272,354  

NortonLifeLock Inc.

    4,849       118,946  

Okta Inc.(a)

    1,908       187,843  

Palo Alto Networks Inc.(a)

    980       489,118  

Pinterest Inc., Class A(a)

    2,714       52,869  

Q2 Holdings Inc.(a)

    488       21,423  

Robinhood Markets Inc., Class A(a)(b)

    4,021       36,390  

Roku Inc.(a)(b)

    654       42,850  

Snap Inc., Class A, NVS(a)

    8,483       83,812  

Twitter Inc.(a)

    5,636       234,514  

Uber Technologies Inc.(a)

    10,776       252,697  

Upwork Inc.(a)

    2,636       48,924  

VeriSign Inc.(a)

    878       166,082  

Zendesk Inc.(a)

    833       62,825  

Zillow Group Inc., Class C (a)

    686       23,928  
   

 

 

 
          25,740,566  
Leisure Time — 0.0%            

Peloton Interactive Inc., Class A(a)

    1,312       12,451  
   

 

 

 

Machinery — 0.1%

   

Cognex Corp.

    980       49,960  

Rockwell Automation Inc.

    196       50,035  
   

 

 

 
      99,995  
Manufacturing — 0.0%            

Axon Enterprise Inc.(a)(b)

    407       44,847  
   

 

 

 

Media — 0.1%

   

FactSet Research Systems Inc.

    245       105,272  
   

 

 

 

Office & Business Equipment — 0.1%

   

Zebra Technologies Corp., Class A(a)

    392       140,214  
   

 

 

 

Pharmaceuticals — 0.1%

   

Zoetis Inc.

    391       71,377  
   

 

 

 

Private Equity — 0.1%

   

Blackstone Inc., NVS

    913       93,190  
   

 

 

 
Security   Shares     Value  

Real Estate — 0.1%

   

CBRE Group Inc., Class A(a)

    1,024     $ 87,675  

Jones Lang LaSalle Inc.(a)

    196       37,371  
   

 

 

 
      125,046  
Real Estate Investment Trusts — 0.4%            

Digital Realty Trust Inc.

    928       122,914  

Equinix Inc.

    383       269,532  

Iron Mountain Inc.

    1,323       64,152  
   

 

 

 
      456,598  
Retail — 0.1%            

Best Buy Co. Inc.

    686       52,815  

Carvana Co., Class A(a)(b)

    332       9,678  

Home Depot Inc. (The)

    360       108,338  
   

 

 

 
      170,831  
Semiconductors — 12.4%            

Advanced Micro Devices Inc.(a)

    14,526       1,372,271  

Analog Devices Inc.

    3,079       529,465  

Applied Materials Inc.

    4,223       447,553  

Broadcom Inc.

    3,158       1,691,046  

Intel Corp.

    23,199       842,356  

KLA Corp.

    833       319,489  

Lam Research Corp.

    694       347,354  

Lattice Semiconductor Corp.(a)

    1,194       73,431  

Marvell Technology Inc.

    7,105       395,606  

Microchip Technology Inc.

    3,136       215,945  

Micron Technology Inc.

    7,505       464,259  

Monolithic Power Systems Inc.

    294       136,628  

Nvidia Corp.

    24,914       4,525,130  

NXP Semiconductors NV

    1,857       341,465  

ON Semiconductor Corp.(a)

    2,645       176,633  

Qorvo Inc.(a)

    738       76,804  

Qualcomm Inc.

    7,528       1,092,012  

Silicon Laboratories Inc.(a)(b)

    343       50,586  

Skyworks Solutions Inc.

    1,083       117,917  

Synaptics Inc.(a)(b)

    610       88,419  

Teradyne Inc.

    1,122       113,199  

Texas Instruments Inc.

    4,806       859,745  

Wolfspeed Inc.(a)

    833       69,389  
   

 

 

 
            14,346,702  
Software — 30.9%            

ACI Worldwide Inc.(a)

    980       27,959  

Activision Blizzard Inc.

    4,787       382,721  

Adobe Inc.(a)

    4,857       1,991,953  

Akamai Technologies Inc.(a)

    1,470       141,443  

Alteryx Inc., Class A(a)

    736       35,644  

Ansys Inc.(a)

    686       191,387  

Appian Corp.(a)

    580       28,147  

Aspen Technology Inc.(a)

    205       41,838  

Autodesk Inc.(a)

    2,055       444,538  

Avalara Inc.(a)(b)

    638       55,774  

Bentley Systems Inc., Class B

    1,470       58,212  

Bill.com Holdings Inc.(a)

    999       134,945  

Black Knight Inc.(a)

    686       45,057  

Blackbaud Inc.(a)

    441       27,042  

Blackline Inc.(a)

    784       49,565  

Box Inc., Class A(a)

    1,323       37,626  

Broadridge Financial Solutions Inc.

    686       110,137  

Cadence Design Systems Inc.(a)

    2,401       446,778  

Ceridian HCM Holding Inc.(a)

    1,371       75,090  

Citrix Systems Inc.

    1,372       139,135  

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  41


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Technology ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Software (continued)

   

Cloudflare Inc., Class A(a)

    1,861     $ 93,646  

CommVault Systems Inc.(a)

    441       24,736  

Concentrix Corp.

    310       41,466  

Consensus Cloud Solutions Inc.(a)

    115       6,213  

Coupa Software Inc.(a)

    784       51,289  

Datadog Inc., Class A(a)

    3,296       336,225  

DocuSign Inc.(a)

    1,913       122,394  

Dropbox Inc., Class A(a)

    2,937       66,787  

Dynatrace Inc.(a)

    2,213       83,275  

Elastic NV(a)

    637       50,890  

Electronic Arts Inc.

    1,813       237,920  

Everbridge Inc.(a)

    442       11,112  

Fair Isaac Corp.(a)

    245       113,197  

Fidelity National Information Services Inc.

    3,579       365,631  

Fiserv Inc.(a)

    4,251       449,246  

Five9 Inc.(a)

    731       79,036  

Guidewire Software Inc.(a)(b)

    637       49,508  

HubSpot Inc.(a)

    493       151,844  

Intuit Inc.

    2,331       1,063,332  

Jack Henry & Associates Inc.

    588       122,169  

Manhattan Associates Inc.(a)

    637       89,607  

Microsoft Corp.

    65,045           18,260,733  

MicroStrategy Inc., Class A(a)(b)

    148       42,337  

MongoDB Inc. (a)

    488       152,485  

MSCI Inc.

    588       283,028  

New Relic Inc.(a)

    441       26,755  

Nutanix Inc., Class A(a)

    2,203       33,331  

Oracle Corp.

    20,357       1,584,589  

Palantir Technologies Inc., Class A(a)

    20,381       210,943  

Paychex Inc.

    2,252       288,887  

Paycom Software Inc.(a)

    441       145,746  

Pegasystems Inc.

    392       15,739  

PTC Inc.(a)

    1,176       145,095  

RingCentral Inc., Class A(a)

    682       33,752  

Roper Technologies Inc.

    146       63,754  

SailPoint Technologies Holdings Inc.(a)

    1,212       77,289  

Salesforce Inc.(a)

    10,639       1,957,789  

ServiceNow Inc.(a)

    2,160       964,786  

Smartsheet Inc., Class A(a)

    1,474       44,308  

Snowflake Inc., Class A(a)

    3,713       556,616  

Splunk Inc.(a)

    1,818       188,908  

SPS Commerce Inc.(a)

    773       92,575  

SS&C Technologies Holdings Inc.

    1,274       75,383  

Synopsys Inc.(a)

    1,372       504,210  

Take-Two Interactive Software Inc.(a)

    804       106,715  

Teradata Corp.(a)

    2,303       88,182  

Twilio Inc., Class A(a)

    2,188       185,542  

Tyler Technologies Inc.(a)

    294       117,306  

UiPath Inc., Class A(a)

    2,967       54,385  
Security   Shares     Value  

 

 

Software (continued)

   

Unity Software Inc.(a)(b)

    2,373     $ 88,726  

Veeva Systems Inc., Class A(a)

    1,312       293,337  

Verint Systems Inc.(a)

    588       26,854  

VMware Inc., Class A

    2,186       254,013  

Workday Inc., Class A(a)

    2,303       357,195  

Workiva Inc.(a)

    828       54,234  

Ziff Davis Inc.(a)(b)

    343       28,088  

Zoom Video Communications Inc., Class A(a)

    2,374       246,564  

ZoomInfo Technologies Inc.(a)(b)

    2,889       109,464  
   

 

 

 
      35,834,157  
Telecommunications — 2.1%            

Arista Networks Inc.(a)

    2,352       274,314  

Ciena Corp.(a)

    1,176       60,682  

Cisco Systems Inc.

    39,182       1,777,687  

CommScope Holding Co. Inc.(a)(b)

    784       7,079  

Juniper Networks Inc.

    3,479       97,516  

Motorola Solutions Inc.

    784       187,055  
   

 

 

 
      2,404,333  
Transportation — 0.1%            

Expeditors International of Washington Inc.(b)

    637       67,681  

FedEx Corp.

    445       103,725  
   

 

 

 
      171,406  
   

 

 

 

Total Long-Term Investments — 98.8%
(Cost: $109,495,655)

 

    114,589,408  
   

 

 

 

Short-Term Securities

   

Money Market Funds — 2.1%

   

BlackRock Cash Funds: Institutional, SL Agency Shares, 1.93%(c)(d)(e)

    1,184,269       1,184,151  

BlackRock Cash Funds: Treasury, SL Agency Shares, 1.81%(c)(d)

    1,310,000       1,310,000  
   

 

 

 

Total Short-Term Securities — 2.1%
(Cost: $2,494,081)

 

    2,494,151  
   

 

 

 

Total Investments in Securities — 100.9%
(Cost: $111,989,736)

 

    117,083,559  

Liabilities in Excess of Other Assets — (0.9)%

 

    (1,094,092
   

 

 

 

Net Assets — 100.0%

    $   115,989,467  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

42  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

July 31, 2022

  

iShares® Evolved U.S. Technology ETF

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer   Value at
07/31/21
    Purchases
at Cost
    Proceeds
from Sale
    Net Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
07/31/22
    Shares
Held at
07/31/22
    Income    

Capital

Gain
Distributions
from
Underlying
Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 105,468     $ 1,079,190 (a)    $      $ (577   $ 70     $ 1,184,151       1,184,269     $ 1,518 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    890,000       420,000 (a)                         1,310,000       1,310,000       3,539        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
         $ (577   $ 70     $ 2,494,151       $ 5,057     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                                       

 

 
     Level 1      Level 2      Level 3      Total  

 

 

Investments

           

Assets

           

Common Stocks

   $ 114,589,408      $                 —      $                 —      $ 114,589,408  

Money Market Funds

     2,494,151                      2,494,151  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 117,083,559      $      $      $  117,083,559  
  

 

 

    

 

 

    

 

 

    

 

 

 

See notes to financial statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  43


Statements of Assets and Liabilities

July 31, 2022

 

   

iShares

Evolved

U.S. Consumer

Staples ETF

   

iShares

Evolved

U.S. Discretionary
Spending ETF

   

iShares

Evolved

U.S. Financials
ETF

   

iShares

Evolved

U.S. Healthcare
Staples ETF

 

 

 

ASSETS

                

Investments, at value — unaffiliated(a)(b)

    $ 16,807,276       $ 15,562,463       $ 8,773,341        $ 37,760,571  

Investments, at value — affiliated(c)

      140,000                      358,302         80,000          986,000  

Cash

                           9,544         6,795                      9,050                       1,092  

Receivables:

                

Investments sold

              39,957                   

Securities lending income — affiliated

      37         875         7           

Dividends — unaffiliated

      18,488         9,086         13,041          32,864  

Dividends — affiliated

      145         81         102          786  
   

 

 

     

 

 

     

 

 

      

 

 

 

Total assets

      16,975,490         15,977,559         8,875,541          38,781,313  
   

 

 

     

 

 

     

 

 

      

 

 

 

LIABILITIES

                

Collateral on securities loaned, at value

              298,278                   

Payables:

                

Investment advisory fees

      2,530         2,351         1,298          5,850  
   

 

 

     

 

 

     

 

 

      

 

 

 

Total liabilities

      2,530         300,629         1,298          5,850  
   

 

 

     

 

 

     

 

 

      

 

 

 

NET ASSETS

    $ 16,972,960       $ 15,676,930       $ 8,874,243        $ 38,775,463  
   

 

 

     

 

 

     

 

 

      

 

 

 

NET ASSETS CONSIST OF

                

Paid-in capital

    $ 15,417,748       $ 16,220,168       $ 8,269,925        $ 34,527,651  

Accumulated earnings (loss)

      1,555,212         (543,238       604,318          4,247,812  
   

 

 

     

 

 

     

 

 

      

 

 

 

NET ASSETS

    $ 16,972,960       $ 15,676,930       $ 8,874,243        $ 38,775,463  
   

 

 

     

 

 

     

 

 

      

 

 

 

NET ASSET VALUE

                

Shares outstanding

      500,000         400,000         300,000          950,000  
   

 

 

     

 

 

     

 

 

      

 

 

 

Net asset value

    $ 33.95       $ 39.19       $ 29.58        $ 40.82  
   

 

 

     

 

 

     

 

 

      

 

 

 

Shares authorized

      Unlimited         Unlimited         Unlimited          Unlimited  
   

 

 

     

 

 

     

 

 

      

 

 

 

Par value

      None         None         None          None  
   

 

 

     

 

 

     

 

 

      

 

 

 

(a)   Investments, at cost — unaffiliated

    $ 15,239,840       $ 16,394,049       $ 8,173,688        $ 33,673,872  

(b)   Securities loaned, at value

    $       $ 287,322       $        $  

(c)   Investments, at cost — affiliated

    $ 140,000       $ 358,255       $ 80,000        $ 986,000  

See notes to financial statements.

 

 

44  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Assets and Liabilities   (continued)

July 31, 2022

 

   

iShares

Evolved

U.S. Innovative

Healthcare

ETF

   

iShares

Evolved

U.S. Media and

Entertainment

ETF

   

iShares

Evolved

U.S. Technology

ETF

 

 

 

ASSETS

           

Investments, at value — unaffiliated(a)(b)

    $ 33,749,436       $ 10,319,460       $ 114,589,408  

Investments, at value — affiliated(c)

                           2,920,441         148,000         2,494,151  

Cash

      8,004         3,712         1,756  

Receivables:

           

Investments sold

      152,162                 22,582  

Securities lending income — affiliated

      262         371         498  

Capital shares sold

                      59,859  

Dividends — unaffiliated

      38,266         2,931         19,535  

Dividends — affiliated

      1,141         182         1,570  
   

 

 

     

 

 

     

 

 

 

Total assets

      36,869,712                10,474,656                117,189,359  
   

 

 

     

 

 

     

 

 

 

LIABILITIES

           

Collateral on securities loaned, at value

      79,179                 1,184,313  

Payables:

           

Investment advisory fees

      5,667         1,578         15,579  
   

 

 

     

 

 

     

 

 

 

Total liabilities

      84,846         1,578         1,199,892  
   

 

 

     

 

 

     

 

 

 

NET ASSETS

    $ 36,784,866       $ 10,473,078       $ 115,989,467  
   

 

 

     

 

 

     

 

 

 

NET ASSETS CONSIST OF

           

Paid-in capital

    $ 35,617,069       $ 14,079,435       $ 110,654,594  

Accumulated earnings (loss)

      1,167,797         (3,606,357       5,334,873  
   

 

 

     

 

 

     

 

 

 

NET ASSETS

    $ 36,784,866       $ 10,473,078       $ 115,989,467  
   

 

 

     

 

 

     

 

 

 

NET ASSET VALUE

           

Shares outstanding

      1,100,000         400,000         2,450,000  
   

 

 

     

 

 

     

 

 

 

Net asset value

    $ 33.44       $ 26.18       $ 47.34  
   

 

 

     

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited         Unlimited  
   

 

 

     

 

 

     

 

 

 

Par value

      None         None         None  
   

 

 

     

 

 

     

 

 

 

(a)   Investments, at cost — unaffiliated

    $ 33,474,264       $ 13,664,223       $ 109,495,655  

(b)   Securities loaned, at value

    $ 72,614       $       $ 1,164,368  

(c)   Investments, at cost — affiliated

    $ 2,920,412       $ 148,000       $ 2,494,081  

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  45


Statements of Operations 

Year Ended July 31, 2022

 

   

iShares

Evolved

U.S. Consumer

Staples ETF

   

iShares

Evolved

U.S. Discretionary

Spending ETF

   

iShares

Evolved

U.S. Financials

ETF

   

iShares

Evolved

U.S. Healthcare

Staples ETF

 

 

 

INVESTMENT INCOME

               

Dividends — unaffiliated

    $ 400,430       $ 235,688       $ 174,222       $ 382,253  

Dividends — affiliated

                   328                  251                  256                  1,496  

Securities lending income — affiliated — net

      886         2,565         135         258  

Foreign taxes withheld

      (56               (60        
   

 

 

     

 

 

     

 

 

     

 

 

 

Total investment income

      401,588         238,504         174,553         384,007  
   

 

 

     

 

 

     

 

 

     

 

 

 

EXPENSES

               

Investment advisory fees

      28,790         40,413         14,736         68,353  

Professional fees

      217                 217         217  
   

 

 

     

 

 

     

 

 

     

 

 

 

Total expenses

      29,007         40,413         14,953         68,570  
   

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      372,581         198,091         159,600         315,437  
   

 

 

     

 

 

     

 

 

     

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

               

Net realized gain (loss) from:

               

Investments — unaffiliated

      16,799         417,270         11,876         77,062  

Investments — affiliated

      (39       (258       (57       (228

In-kind redemptions — unaffiliated(a)

      1,097         2,445,584                 694,138  

Payments by affiliate

                      1,864          
   

 

 

     

 

 

     

 

 

     

 

 

 
      17,857         2,862,596         13,683         770,972  
   

 

 

     

 

 

     

 

 

     

 

 

 

Net change in unrealized appreciation (depreciation) on:

               

Investments — unaffiliated

      267,376         (6,108,585       (706,265       (3,284,653

Investments — affiliated

      (4       44                 (2
   

 

 

     

 

 

     

 

 

     

 

 

 
      267,372         (6,108,541       (706,265       (3,284,655
   

 

 

     

 

 

     

 

 

     

 

 

 

Net realized and unrealized gain (loss)

      285,229         (3,245,945       (692,582       (2,513,683
   

 

 

     

 

 

     

 

 

     

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

    $ 657,810       $ (3,047,854     $ (532,982     $ (2,198,246
   

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

See Note 2 of the Notes to Financial Statements.

See notes to financial statements.

 

 

46  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Operations   (continued)

Year Ended July 31, 2022

 

   

iShares

Evolved

U.S. Innovative

Healthcare

ETF

   

iShares

Evolved

U.S. Media and

Entertainment

ETF

   

iShares

Evolved

U.S. Technology

ETF

 

 

 

INVESTMENT INCOME

           

Dividends — unaffiliated

    $ 530,333       $ 55,133       $ 811,882  

Dividends — affiliated

      2,167         515         3,576  

Securities lending income — affiliated — net

      5,235         7,192         1,481  

Foreign taxes withheld

                      (461
   

 

 

     

 

 

     

 

 

 

Total investment income

                   537,735                  62,840                  816,478  
   

 

 

     

 

 

     

 

 

 

EXPENSES

           

Investment advisory fees

      69,136         27,558         239,736  

Professional fees

              217         217  
   

 

 

     

 

 

     

 

 

 

Total expenses

      69,136         27,775         239,953  
   

 

 

     

 

 

     

 

 

 

Net investment income

      468,599         35,065         576,525  
   

 

 

     

 

 

     

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

           

Net realized gain (loss) from:

           

Investments — unaffiliated

      1,052,572         (148,257       576,646  

Investments — affiliated

      (325       (866       (577

In-kind redemptions — unaffiliated(a)

      2,525,635         663,785         7,652,272  
   

 

 

     

 

 

     

 

 

 
      3,577,882         514,662         8,228,341  
   

 

 

     

 

 

     

 

 

 

Net change in unrealized appreciation (depreciation) on:

           

Investments — unaffiliated

      (6,572,693       (5,550,584       (31,887,903

Investments — affiliated

      (65       (11       70  
   

 

 

     

 

 

     

 

 

 
      (6,572,758       (5,550,595       (31,887,833
   

 

 

     

 

 

     

 

 

 

Net realized and unrealized loss

      (2,994,876       (5,035,933       (23,659,492
   

 

 

     

 

 

     

 

 

 

NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS

    $ (2,526,277     $ (5,000,868     $ (23,082,967
   

 

 

     

 

 

     

 

 

 

 

(a) 

See Note 2 of the Notes to Financial Statements.

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  47


Statements of Changes in Net Assets 

 

   

iShares

Evolved U.S. Consumer Staples ETF

          

iShares

Evolved U.S. Discretionary Spending
ETF

 

 

 

      

 

 

    Year Ended
07/31/22
   

Year Ended

07/31/21

           Year Ended
07/31/22
   

Year Ended
07/31/21

 

 

 

INCREASE (DECREASE) IN NET ASSETS

               

OPERATIONS

               

Net investment income

  $ 372,581        $ 391,716        $ 198,091                $ 187,745  

Net realized gain

    17,857          1,823,303          2,862,596         1,792,839  

Net change in unrealized appreciation (depreciation)

    267,372                   480,418                   (6,108,541       3,689,056  
 

 

 

      

 

 

      

 

 

     

 

 

 

Net increase (decrease) in net assets resulting from operations

    657,810          2,695,437          (3,047,854       5,669,640  
 

 

 

      

 

 

      

 

 

     

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

               

Decrease in net assets resulting from distributions to shareholders

    (360,114        (377,726        (192,387       (182,616
 

 

 

      

 

 

      

 

 

     

 

 

 

CAPITAL SHARE TRANSACTIONS

               

Net increase (decrease) in net assets derived from capital share transactions

    1,741,757          2,756,445          (3,715,086       5,164,697  
 

 

 

      

 

 

      

 

 

     

 

 

 

NET ASSETS

               

Total increase (decrease) in net assets

    2,039,453          5,074,156          (6,955,327       10,651,721  

Beginning of year

    14,933,507          9,859,351          22,632,257         11,980,536  
 

 

 

      

 

 

      

 

 

     

 

 

 

End of year

  $ 16,972,960        $ 14,933,507        $ 15,676,930       $ 22,632,257  
 

 

 

      

 

 

      

 

 

     

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

48  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Changes in Net Assets (continued)

 

         

iShares

Evolved U.S. Financials ETF

    

iShares

Evolved U.S. Healthcare Staples

ETF

 

 

 

      

 

 

          Year Ended
07/31/22
           Year Ended
07/31/21
           Year Ended
07/31/22
          Year Ended
07/31/21
 

 

 

INCREASE (DECREASE) IN NET ASSETS

                 

OPERATIONS

                 

Net investment income

    $     159,600                 $ 111,485                 $ 315,437                $ 194,707  

Net realized gain

      13,683          3,090          770,972         1,001,141  

Net change in unrealized appreciation (depreciation)

      (706,265        2,107,873          (3,284,655       5,124,434  
   

 

 

      

 

 

      

 

 

     

 

 

 

Net increase (decrease) in net assets resulting from operations

      (532,982        2,222,448          (2,198,246       6,320,282  
   

 

 

      

 

 

      

 

 

     

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

                 

Decrease in net assets resulting from distributions to shareholders

      (152,736        (109,149        (291,853       (166,995
   

 

 

      

 

 

      

 

 

     

 

 

 

CAPITAL SHARE TRANSACTIONS

                 

Net increase in net assets derived from capital share transactions

      3,331,765                   6,590,917         13,514,706  
   

 

 

      

 

 

      

 

 

     

 

 

 

NET ASSETS

                 

Total increase in net assets

      2,646,047          2,113,299          4,100,818         19,667,993  

Beginning of year

      6,228,196          4,114,897          34,674,645         15,006,652  
   

 

 

      

 

 

      

 

 

     

 

 

 

End of year

    $ 8,874,243        $ 6,228,196        $ 38,775,463       $ 34,674,645  
   

 

 

      

 

 

      

 

 

     

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  49


Statements of Changes in Net Assets (continued)

 

   

iShares

Evolved U.S. Innovative Healthcare
ETF

          

iShares

Evolved U.S. Media and

Entertainment ETF

 

 

 

      

 

 

    Year Ended
07/31/22
           Year Ended
07/31/21
           Year Ended
07/31/22
          Year Ended
07/31/21
 

 

 

INCREASE (DECREASE) IN NET ASSETS

               

OPERATIONS

               

Net investment income

  $ 468,599                 $ 435,435                 $ 35,065                $ 105,029  

Net realized gain

    3,577,882          785,765          514,662         2,196,957  

Net change in unrealized appreciation (depreciation)

    (6,572,758        5,285,722          (5,550,595       1,724,157  
 

 

 

      

 

 

      

 

 

     

 

 

 

Net increase (decrease) in net assets resulting from operations

    (2,526,277        6,506,922          (5,000,868       4,026,143  
 

 

 

      

 

 

      

 

 

     

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

               

Decrease in net assets resulting from distributions to shareholders

    (985,796        (885,686        (185,782       (103,291
 

 

 

      

 

 

      

 

 

     

 

 

 

CAPITAL SHARE TRANSACTIONS

               

Net increase (decrease) in net assets derived from capital share transactions

    897,869          12,756,828          (3,033,254       5,551,639  
 

 

 

      

 

 

      

 

 

     

 

 

 

NET ASSETS

               

Total increase (decrease) in net assets

    (2,614,204        18,378,064          (8,219,904       9,474,491  

Beginning of year

    39,399,070          21,021,006          18,692,982         9,218,491  
 

 

 

      

 

 

      

 

 

     

 

 

 

End of year

  $ 36,784,866        $ 39,399,070        $ 10,473,078       $ 18,692,982  
 

 

 

      

 

 

      

 

 

     

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

50  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Changes in Net Assets (continued)

 

    iShares
    Evolved U.S. Technology ETF    
 
   

Year Ended

07/31/22

   

Year Ended

07/31/21

 

 

 

INCREASE (DECREASE) IN NET ASSETS

   

OPERATIONS

   

Net investment income

  $ 576,525     $ 437,300  

Net realized gain

    8,228,341       10,101,984  

Net change in unrealized appreciation (depreciation)

    (31,887,833     22,445,624  
 

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

    (23,082,967     32,984,908  
 

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

   

Decrease in net assets resulting from distributions to shareholders

    (1,164,175     (431,621
 

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

   

Net increase in net assets derived from capital share transactions

    9,540,195               18,787,708  
 

 

 

   

 

 

 

NET ASSETS

   

Total increase (decrease) in net assets

    (14,706,947     51,340,995  

Beginning of year

    130,696,414       79,355,419  
 

 

 

   

 

 

 

End of year

  $ 115,989,467     $ 130,696,414  
 

 

 

   

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  51


Financial Highlights 

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Consumer Staples ETF  
                                                             
 

 

 

 

          Period From  
    Year Ended       Year Ended       Year Ended       Year Ended         03/21/18 (a) 
    07/31/22       07/31/21       07/31/20       07/31/19    

 

to 07/31/18

 

 

 

Net asset value, beginning of period

    $ 33.19       $ 28.17       $ 27.58       $ 25.03       $ 24.62  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(b)

      0.78         0.74         0.70         0.66         0.31 (c)  

Net realized and unrealized gain(d)

      0.75                  5.03                  0.51                  2.80                  0.26  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase from investment operations

             1.53         5.77         1.21         3.46         0.57  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(e)

                   

From net investment income

      (0.77       (0.75       (0.62       (0.85       (0.16

From net realized gain

                              (0.06        
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.77       (0.75       (0.62       (0.91       (0.16
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 33.95       $ 33.19       $ 28.17       $ 27.58       $ 25.03  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(f)

                   

Based on net asset value

      4.67       20.76       4.56       14.23       2.34 %(g) 
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(h)

                   

Total expenses

      0.18       0.18       0.18       0.18       0.18 %(i) 
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      2.33       2.39       2.58       2.59       3.58 %(c)(i) 
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

    $ 16,973       $ 14,934       $ 9,859       $ 4,137       $ 3,755  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(j)

      5       5       13       9       0 %(g)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Includes a special distribution from Dr Pepper Snapple Group Inc. Excluding such special distribution, the net investment income would have been $0.21 per share and 2.39% of average net assets.

(d) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(e) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(f) 

Where applicable, assumes the reinvestment of distributions.

(g) 

Not annualized.

(h) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(i) 

Annualized.

(j)

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

52  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Discretionary Spending ETF  
                                                             
 

 

 

 

          Period From  
    Year Ended       Year Ended       Year Ended       Year Ended         03/21/18 (a) 
    07/31/22       07/31/21       07/31/20       07/31/19    

 

to 07/31/18

 

 

 

Net asset value, beginning of period

    $ 45.26       $ 34.23       $ 29.47       $ 26.84       $ 24.95  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(b)

      0.38         0.35         0.35         0.39         0.12  

Net realized and unrealized gain (loss)(c)

      (6.07       11.01         4.90         2.70         1.86  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

             (5.69                11.36                  5.25                  3.09                  1.98  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(d)

                   

From net investment income

      (0.38       (0.33       (0.33       (0.41       (0.09

From net realized gain

                      (0.16       (0.05        
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.38       (0.33       (0.49       (0.46       (0.09
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 39.19       $ 45.26       $ 34.23       $ 29.47       $ 26.84  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(e)

                   

Based on net asset value

      (12.65 )%        33.32       18.11       11.73       7.96 %(f)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(g)

                   

Total expenses

      0.18       0.18       0.18       0.18       0.18 %(h)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      0.88       0.86       1.16       1.42       1.25 %(h)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

    $ 15,677       $ 22,632       $ 11,981       $ 5,895       $ 5,369  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(i)

      7       4       10       11       0 %(f)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

(i) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  53


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Financials ETF  
                                                             
 

 

 

 

          Period From  
    Year Ended       Year Ended       Year Ended       Year Ended         03/21/18 (a) 
    07/31/22       07/31/21       07/31/20       07/31/19       to 07/31/18  

 

 

Net asset value, beginning of period

    $ 31.14       $ 20.57       $ 24.86       $ 24.59       $ 24.98  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(b)

             0.62                  0.56                  0.56                  0.50                  0.15  

Net realized and unrealized gain (loss)(c)

      (1.59       10.56         (4.29       0.27         (0.43
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

      (0.97       11.12         (3.73       0.77         (0.28
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions from net investment income(d)

      (0.59       (0.55       (0.56       (0.50       (0.11
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 29.58       $ 31.14       $ 20.57       $ 24.86       $ 24.59  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(e)

                   

Based on net asset value

      (3.25 )%(f)        54.68       (15.10 )%        3.35       (1.11 )%(f)(g) 
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(h)

                   

Total expenses

      0.18       0.18       0.19       0.18       0.18 %(i)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      1.95       2.10       2.47       2.15       1.65 %(i)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

    $ 8,874       $ 6,228       $ 4,115       $ 4,971       $ 4,919  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(j)

      3       2       8       10       13 %(g)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Includes payment received from an affiliate, which impacted the Fund’s total return. Excluding the payment from an affiliate, the Fund’s total return would have been -3.23% for the year ended 2022 and -1.40% for the year ended 2018.

(g) 

Not annualized.

(h) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(i) 

Annualized.

(j) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

54  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Healthcare Staples ETF  
                                                             
 

 

 

 

          Period From  
    Year Ended       Year Ended       Year Ended       Year Ended         03/21/18 (a) 
    07/31/22       07/31/21       07/31/20       07/31/19    

 

to 07/31/18

 

 

 

Net asset value, beginning of period

    $ 43.34       $ 33.35       $ 29.46       $ 27.48       $ 24.86  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(b)

             0.35                  0.33                  0.31                  0.27                  0.08  

Net realized and unrealized gain (loss)(c)

      (2.54       9.96         4.07         2.11         2.60  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

      (2.19       10.29         4.38         2.38         2.68  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(d)

                   

From net investment income

      (0.33       (0.30       (0.25       (0.28       (0.06

From net realized gain

                      (0.24       (0.12        
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.33       (0.30       (0.49       (0.40       (0.06
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 40.82       $ 43.34       $ 33.35       $ 29.46       $ 27.48  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(e)

                   

Based on net asset value

      (5.09 )%        31.06       15.04       8.77       10.77 %(f) 
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(g)

                   

Total expenses

      0.18       0.18       0.18       0.18       0.18 %(h)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      0.83       0.86       1.02       0.95       0.87 %(h)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

    $ 38,775       $ 34,675       $ 15,007       $ 7,365       $ 5,495  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(i)

      5       2       12       12       0 %(f)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Commencement of operations.

(b)

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

(i) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  55


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Innovative Healthcare ETF  
                                                             
 

 

 

 

          Period From  
    Year Ended       Year Ended       Year Ended       Year Ended         03/21/18 (a) 
    07/31/22       07/31/21       07/31/20       07/31/19    

 

to 07/31/18

 

 

 

Net asset value, beginning of period

    $ 35.82       $ 30.03       $ 24.74       $ 26.03       $ 24.97  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(b)

      0.42         0.45         0.43         0.37         0.11  

Net realized and unrealized gain (loss)(c)

      (1.93       6.29         5.72         (1.15       1.04  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

             (1.51                6.74                  6.15                  (0.78                1.15  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(d)

                   

From net investment income

      (0.46       (0.39       (0.38       (0.36       (0.09

From net realized gain

      (0.41       (0.56       (0.48       (0.15        
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.87       (0.95       (0.86       (0.51       (0.09
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 33.44       $ 35.82       $ 30.03       $ 24.74       $ 26.03  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(e)

                   

Based on net asset value

      (4.26 )%        22.81       25.31       (3.04 )%        4.62 %(f)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(g)

                   

Total expenses

      0.18       0.18       0.18       0.18       0.18 %(h)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      1.22       1.37       1.53       1.45       1.25 %(h)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

    $ 36,785       $ 39,399       $ 21,021       $ 4,949       $ 5,206  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(i)

      7       6       24       8       3 %(f)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

(i) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

56  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Media and Entertainment ETF  
                                                             
 

 

 

 

          Period From  
    Year Ended       Year Ended       Year Ended       Year Ended         03/21/18 (a) 
    07/31/22       07/31/21       07/31/20       07/31/19    

 

to 07/31/18

 

 

 

Net asset value, beginning of period

    $ 37.39       $ 26.34       $ 28.22       $ 26.38       $ 25.05  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(b)

      0.07         0.23         0.20         0.26         0.10  

Net realized and unrealized gain (loss)(c)

      (10.90       11.05         (0.86       1.97         1.29  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

             (10.83                11.28                  (0.66                2.23                  1.39  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(d)

                   

From net investment income

      (0.35       (0.23       (0.21       (0.26       (0.06

From net realized gain

      (0.03               (1.01       (0.13        
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.38       (0.23       (1.22       (0.39       (0.06
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 26.18       $ 37.39       $ 26.34       $ 28.22       $ 26.38  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(e)

                   

Based on net asset value

      (29.16 )%        43.02       (2.33 )%        8.64       5.54 %(f)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(g)

                   

Total expenses

      0.18       0.18       0.18       0.18       0.18 %(h) 
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      0.23       0.67       0.79       0.99       1.04 %(h) 
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

    $ 10,473       $ 18,693       $ 9,218       $ 7,056       $ 5,277  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(i)

      6       4       16       10       0 %(f)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

(i) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  57


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Technology ETF  
                                                             
 

 

 

 

          Period From  
    Year Ended       Year Ended       Year Ended       Year Ended         03/21/18 (a) 
    07/31/22       07/31/21       07/31/20       07/31/19    

 

to 07/31/18

 

 

 

Net asset value, beginning of period

    $ 56.82       $ 40.70       $ 29.95       $ 26.33       $ 24.89  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(b)

      0.23         0.21         0.24         0.23         0.06  

Net realized and unrealized gain (loss)(c)

      (9.25       16.12         10.80         3.73         1.43  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

      (9.02       16.33         11.04         3.96         1.49  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(d)

                   

From net investment income

      (0.25       (0.21       (0.24       (0.27       (0.05

From net realized gain

      (0.21               (0.05       (0.07        
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

             (0.46                (0.21                (0.29                (0.34                (0.05
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 47.34       $ 56.82       $ 40.70       $ 29.95       $ 26.33  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(e)

                   

Based on net asset value

      (16.02 )%        40.24       37.15       15.27       6.00 %(f) 
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(g)

                   

Total expenses

      0.18       0.18       0.18       0.18       0.18 %(h)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      0.43       0.44       0.72       0.85       0.70 %(h)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                   

Net assets, end of period (000)

    $ 115,989       $ 130,696       $ 79,355       $ 16,470       $ 5,266  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(i)

      7       6       5       7       0 %(f)  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

(i) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

58  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements

 

1.

ORGANIZATION

iShares U.S. ETF Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust is organized as a Delaware statutory trust and is authorized to have multiple series or portfolios.

These financial statements relate only to the following funds (each, a “Fund” and collectively, the “Funds”):

 

   
iShares ETF   Diversification
Classification
 

Evolved U.S. Consumer Staples

    Non-diversified    

Evolved U.S. Discretionary Spending

    Non-diversified  

Evolved U.S. Financials

    Diversified  

Evolved U.S. Healthcare Staples

    Non-diversified  

Evolved U.S. Innovative Healthcare

    Non-diversified  

Evolved U.S. Media and Entertainment

    Non-diversified  

Evolved U.S. Technology

    Non-diversified  

 

2.

SIGNIFICANT ACCOUNTING POLICIES

The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which may require management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the financial statements, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies. Below is a summary of significant accounting policies:

Investment Transactions and Income Recognition: For financial reporting purposes, investment transactions are recorded on the dates the transactions are executed. Realized gains and losses on investment transactions are determined using the specific identification method. Dividend income and capital gain distributions, if any, are recorded on the ex-dividend date. Non-cash dividends, if any, are recorded on the ex-dividend date at fair value. Dividends from foreign securities where the ex-dividend date may have passed are subsequently recorded when the Funds are informed of the ex-dividend date. Under the applicable foreign tax laws, a withholding tax at various rates may be imposed on capital gains, dividends and interest. Upon notification from issuers or as estimated by management, a portion of the dividend income received from a real estate investment trust may be redesignated as a reduction of cost of the related investment and/or realized gain.

Foreign Taxes: The Funds may be subject to foreign taxes (a portion of which may be reclaimable) on income, stock dividends, capital gains on investments, or certain foreign currency transactions. All foreign taxes are recorded in accordance with the applicable foreign tax regulations and rates that exist in the foreign jurisdictions in which each Fund invests. These foreign taxes, if any, are paid by each Fund and are reflected in its Statements of Operations as follows: foreign taxes withheld at source are presented as a reduction of income, foreign taxes on securities lending income are presented as a reduction of securities lending income, foreign taxes on stock dividends are presented as “Other foreign taxes”, and foreign taxes on capital gains from sales of investments and foreign taxes on foreign currency transactions are included in their respective net realized gain (loss) categories. Foreign taxes payable or deferred as of July 31, 2022, if any, are disclosed in the Statements of Assets and Liabilities.

The Funds file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. The Funds may record a reclaim receivable based on collectability, which includes factors such as the jurisdiction’s applicable laws, payment history and market convention. The Statements of Operations includes tax reclaims recorded as well as professional and other fees, if any, associated with recovery of foreign withholding taxes.

In-kind Redemptions: For financial reporting purposes, in-kind redemptions are treated as sales of securities resulting in realized capital gains or losses to the Funds. Because such gains or losses are not taxable to the Funds and are not distributed to existing Fund shareholders, the gains or losses are reclassified from accumulated net realized gain (loss) to paid-in capital at the end of the Funds’ tax year. These reclassifications have no effect on net assets or net asset value (“NAV”) per share.

Distributions: Dividends and distributions paid by each Fund are recorded on the ex-dividend dates. Distributions are determined on a tax basis and may differ from net investment income and net realized capital gains for financial reporting purposes. Dividends and distributions are paid in U.S. dollars and cannot be automatically reinvested in additional shares of the Funds. The character and timing of distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP.

Indemnifications: In the normal course of business, each Fund enters into contracts that contain a variety of representations that provide general indemnification. The Funds’ maximum exposure under these arrangements is unknown because it involves future potential claims against the Funds, which cannot be predicted with any certainty.

 

3.

INVESTMENT VALUATION AND FAIR VALUE MEASUREMENTS

Investment Valuation Policies: Each Fund’s investments are valued at fair value (also referred to as “market value” within the financial statements) each day that the Fund’s listing exchange is open and, for financial reporting purposes, as of the report date. U.S. GAAP defines fair value as the price a fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. Each Fund determines the fair values of its financial instruments using various independent dealers or pricing services under policies approved by the Board of Trustees of the Trust (the “Board”). If a security’s market price is not readily

 

 

N O T E S    T O   F I N A N C I A L   S T A T E M E N T S

  59


Notes to Financial Statements   (continued)

 

available or does not otherwise accurately represent the fair value of the security, the security will be valued in accordance with a policy approved by the Board as reflecting fair value. The BlackRock Global Valuation Methodologies Committee (the “Global Valuation Committee”) is the committee formed by management to develop global pricing policies and procedures and to oversee the pricing function for all financial instruments.

Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Fund’s assets and liabilities:

 

   

Equity investments traded on a recognized securities exchange are valued at that day’s official closing price, as applicable, on the exchange where the stock is primarily traded. Equity investments traded on a recognized exchange for which there were no sales on that day are valued at the last traded price.

 

   

Investments in open-end U.S. mutual funds (including money market funds) are valued at that day’s published NAV.

If events (e.g., market volatility, company announcement or a natural disaster) occur that are expected to materially affect the value of such investment, or in the event that application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Global Valuation Committee, in accordance with a policy approved by the Board as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that may be used by the Global Valuation Committee include market approach, income approach and cost approach. Valuation techniques such as discounted cash flow, use of market comparables and matrix pricing are types of valuation approaches and are typically used in determining fair value. When determining the price for Fair Valued Investments, the Global Valuation Committee, or its delegate, seeks to determine the price that each Fund might reasonably expect to receive or pay from the current sale or purchase of that asset or liability in an arm’s-length transaction. Fair value determinations shall be based upon all available factors that the Global Valuation Committee, or its delegate, deems relevant and consistent with the principles of fair value measurement. The pricing of all Fair Valued Investments is subsequently reported to the Board or a committee thereof on a quarterly basis.

Fair Value Hierarchy: Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

 

   

Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Fund has the ability to access;

 

   

Level 2 – Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market-corroborated inputs); and

 

   

Level 3 – Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available, (including the Global Valuation Committee’s assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Global Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by privately held companies or funds that may not have a secondary market and/or may have a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities.

 

4.

SECURITIES AND OTHER INVESTMENTS

Securities Lending: Each Fund may lend its securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Fund collateral consisting of cash, an irrevocable letter of credit issued by an approved bank, or securities issued or guaranteed by the U.S. government. The initial collateral received by each Fund is required to have a value of at least 102% of the current market value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Fund and any additional required collateral is delivered to the Fund or excess collateral is returned by the Fund, on the next business day. During the term of the loan, each Fund is entitled to all distributions made on or in respect of the loaned securities but does not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.

As of period end, any securities on loan were collateralized by cash and/or U.S. Government obligations. Cash collateral invested in money market funds managed by BlackRock Fund Advisors (“BFA”), the Funds’ investment adviser, or its affiliates is disclosed in the Schedule of Investments. Any non-cash collateral received cannot be sold, re-invested or pledged by the Fund, except in the event of borrower default. The securities on loan, if any, are also disclosed in each Fund’s Schedule of Investments. The market value of any securities on loan and the value of any related cash collateral are disclosed in the Statements of Assets and Liabilities.

Securities lending transactions are entered into by the Funds under Master Securities Lending Agreements (each, an “MSLA”) which provide the right, in the event of default (including bankruptcy or insolvency) for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Funds, as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and the Funds can reinvest cash collateral

 

 

60  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements   (continued)

 

received in connection with loaned securities. Upon an event of default, the parties’ obligations to return the securities or collateral to the other party are extinguished, and the parties can resell or re-pledge the loaned securities or the collateral received in connection with the loaned securities in order to satisfy the defaulting party’s net payment obligation for all transactions under the MSLA. The defaulting party remains liable for any deficiency.

As of period end, the following table is a summary of the securities on loan by counterparty which are subject to offset under an MSLA:

 

 

 
iShares ETF and Counterparty    
Securities Loaned
at Value
 
 
    
Cash Collateral
Received
 
(a)  
   
Non-Cash Collateral
Received, at Fair Value
 
(a) 
    Net Amount  

 

 

Evolved U.S. Discretionary Spending

        

Citigroup Global Markets, Inc.

  $ 48,007      $ (48,007   $     $  

HSBC Bank PLC

    63,359        (63,359            

J.P. Morgan Securities LLC

    37,650        (37,650            

Morgan Stanley

    39,824        (39,824            

SG Americas Securities LLC

    1,448        (1,438           10 (b)  

UBS AG

    4,483        (4,483            

UBS Securities LLC

    92,551        (92,551            
 

 

 

    

 

 

   

 

 

   

 

 

 
  $ 287,322      $ (287,312   $     $ 10  
 

 

 

    

 

 

   

 

 

   

 

 

 

Evolved U.S. Innovative Healthcare

        

Credit Suisse Securities (USA) LLC

  $ 276      $ (276   $     $  

Morgan Stanley

    2        (2            

UBS Securities LLC

    72,336        (72,336            
 

 

 

    

 

 

   

 

 

   

 

 

 
  $ 72,614      $ (72,614   $     $  
 

 

 

    

 

 

   

 

 

   

 

 

 

Evolved U.S. Technology

        

Barclays Capital, Inc.

  $ 17,747      $ (17,747   $     $  

Citigroup Global Markets, Inc.

    267,817        (267,817            

HSBC Bank PLC

    91,420        (91,420            

J.P. Morgan Securities LLC

    99,499        (99,499            

Jefferies LLC

    328,314        (324,556           3,758 (b) 

Morgan Stanley

    124,695        (124,695            

RBC Capital Markets LLC

    45,866        (45,866            

Scotia Capital (USA), Inc.

    13,892        (13,892            

SG Americas Securities LLC

    45,310        (45,169           141 (b)  

Toronto-Dominion Bank

    213        (213            

UBS AG

    89,688        (89,688            

UBS Securities LLC

    24,321        (24,021           300 (b)  

Virtu Americas LLC

    15,586        (15,586            
 

 

 

    

 

 

   

 

 

   

 

 

 
  $ 1,164,368      $ (1,160,169   $     $ 4,199  
 

 

 

    

 

 

   

 

 

   

 

 

 

 

  (a) 

Collateral received in excess of the market value of securities on loan is not presented in this table. The total cash collateral received by each Fund is disclosed in the Fund’s statement of assets and liabilities.

 
  (b) 

The market value of the loaned securities is determined as of July 31, 2022. Additional collateral is delivered to the Fund on the next business day in accordance with the MSLA. The net amount would be subject to the borrower default indemnity in the event of default by a counterparty.

 

The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, each Fund benefits from a borrower default indemnity provided by BlackRock, Inc. (“BlackRock”). BlackRock’s indemnity allows for full replacement of the securities loaned to the extent the collateral received does not cover the value of the securities loaned in the event of borrower default. Each Fund could incur a loss if the value of an investment purchased with cash collateral falls below the market value of the loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received. Such losses are borne entirely by each Fund.

 

5.

INVESTMENT ADVISORY AGREEMENT AND OTHER TRANSACTIONS WITH AFFILIATES

Investment Advisory Fees: Pursuant to an Investment Advisory Agreement with the Trust, BFA manages the investment of each Fund’s assets. BFA is a California corporation indirectly owned by BlackRock. Under the Investment Advisory Agreement, BFA is responsible for substantially all expenses of the Funds, except (i) interest and taxes; (ii) brokerage commissions and other expenses connected with the execution of portfolio transactions; (iii) distribution fees; (iv) the advisory fee payable to BFA; and (v) litigation expenses and any extraordinary expenses (in each case as determined by a majority of the independent trustees).

For its investment advisory services to each Fund, BFA is entitled to an annual investment advisory fee of 0.18%, accrued daily and paid monthly by the Funds, based on the average daily net assets of each Fund.

Distributor: BlackRock Investments, LLC (“BRIL”), an affiliate of BFA, is the distributor for each Fund. Pursuant to the distribution agreement, BFA is responsible for any fees or expenses for distribution services provided to the Funds.

 

 

N O T E S    T O   F I N A N C I A L   S T A T E M E N T S

  61


Notes to Financial Statements   (continued)

 

ETF Servicing Fees: Each Fund has entered into an ETF Services Agreement with BRIL to perform certain order processing, Authorized Participant communications, and related services in connection with the issuance and redemption of Creation Units (“ETF Services”). BRIL is entitled to a transaction fee from Authorized Participants on each creation or redemption order for the ETF Services provided. The Funds do not pay BRIL for ETF Services.

Prior to April 25, 2022, ETF Services were performed by State Street Bank and Trust Company.

Securities Lending: The U.S. Securities and Exchange Commission (the “SEC”) has issued an exemptive order which permits BlackRock Institutional Trust Company, N.A. (“BTC”), an affiliate of BFA, to serve as securities lending agent for the Funds, subject to applicable conditions. As securities lending agent, BTC bears all operational costs directly related to securities lending, including any custodial costs. Each Fund is responsible for fees in connection with the investment of cash collateral received for securities on loan (the “collateral investment fees”). The cash collateral is invested in a money market fund, BlackRock Cash Funds: Institutional or BlackRock Cash Funds: Treasury, managed by BFA, or its affiliates. However, BTC has agreed to reduce the amount of securities lending income it receives in order to effectively limit the collateral investment fees each Fund bears to an annual rate of 0.04%. The SL Agency Shares of such money market fund will not be subject to a sales load, distribution fee or service fee. The money market fund in which the cash collateral has been invested may, under certain circumstances, impose a liquidity fee of up to 2% of the value redeemed or temporarily restrict redemptions for up to 10 business days during a 90 day period, in the event that the money market fund’s weekly liquid assets fall below certain thresholds.

Securities lending income is equal to the total of income earned from the reinvestment of cash collateral, net of fees and other payments to and from borrowers of securities, and less the collateral investment fees. Each Fund retains a portion of securities lending income and remits the remaining portion to BTC as compensation for its services as securities lending agent.

Pursuant to the current securities lending agreement, each Fund retains 81% of securities lending income (which excludes collateral investment fees) and the amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.

In addition, commencing the business day following the date that the aggregate securities lending income plus the collateral investment fees generated across all 1940 Act iShares exchange-traded funds (the “iShares ETF Complex”) in that calendar year exceeds a specified threshold, each Fund, pursuant to the securities lending agreement, will retain for the remainder of that calendar year 81% of securities lending income (which excludes collateral investment fees), and the amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.

Prior to January 1, 2022, each Fund retained 77% of securities lending income (which excludes collateral investment fees) and the amount retained was not less than 70% of the total of securities lending income plus the collateral investment fees. In addition, commencing the business day following the date that the aggregate securities lending income plus the collateral investment fees generated across the iShares ETF Complex in a calendar year exceeded a specified threshold, each Fund, pursuant to the securities lending agreement, retained for the remainder of that calendar year 81% of securities lending income (which excludes collateral investment fees), and the amount retained could never be less than 70% of the total of securities lending income plus the collateral investment fees.

The share of securities lending income earned by each Fund is shown as securities lending income – affiliated – net in its Statements of Operations. For the year ended July 31, 2022, the Funds paid BTC the following amounts for securities lending agent services:

 

   
iShares ETF   Fees Paid
to BTC
 

Evolved U.S. Consumer Staples

  $ 232  

Evolved U.S. Discretionary Spending

    696  

Evolved U.S. Financials

    37  

Evolved U.S. Healthcare Staples

    112  

Evolved U.S. Innovative Healthcare

    1,415  

Evolved U.S. Media and Entertainment

    1,974  

Evolved U.S. Technology

    327  

Officers and Trustees: Certain officers and/or trustees of the Trust are officers and/or trustees of BlackRock or its affiliates.

Other Transactions: Cross trading is the buying or selling of portfolio securities between funds to which BFA (or an affiliate) serves as investment adviser. At its regularly scheduled quarterly meetings, the Board reviews such transactions as of the most recent calendar quarter for compliance with the requirements and restrictions set forth by Rule 17a-7.

For the year ended July 31, 2022, transactions executed by the Funds pursuant to Rule 17a-7 under the 1940 Act were as follows:

 

       
iShares ETF   Purchases      Sales      Net Realized
Gain (Loss)
 

Evolved U.S. Consumer Staples

  $      $ 410,147      $ 23,901  

Evolved U.S. Discretionary Spending

    118,453        721,570        358,884  

Evolved U.S. Healthcare Staples

      1,163,867        184,558        (56,026

Evolved U.S. Innovative Healthcare

    163,550          2,006,117        278,338  

Evolved U.S. Media and Entertainment

    133,264                

Evolved U.S. Technology

    957,795        3,692,425        39,328  

 

 

62  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements   (continued)

 

During the year ended July 31, 2022, iShares Evolved U.S. Financials ETF received reimbursement of $1,864 from an affiliate, which is included in payment by affiliate in the statements of operations, related to an operating event.

Each Fund may invest its positive cash balances in certain money market funds managed by BFA or an affiliate. The income earned on these temporary cash investments is shown as dividends – affiliated in the Statements of Operations.

 

6.

PURCHASES AND SALES

For the year ended July 31, 2022, purchases and sales of investments, excluding short-term investments and in-kind transactions, were as follows:

 

       
iShares ETF   Purchases         Sales      

Evolved U.S. Consumer Staples

  $     786,095      $ 766,330       

Evolved U.S. Discretionary Spending

  1,648,200        1,530,961      

Evolved U.S. Financials

  525,504                 274,153      

Evolved U.S. Healthcare Staples

  2,294,737        1,802,721      

Evolved U.S. Innovative Healthcare

  2,819,018        5,688,145      

Evolved U.S. Media and Entertainment

  919,400        998,469      

Evolved U.S. Technology

  9,558,479          10,542,911      

For the year ended July 31, 2022, in-kind transactions were as follows:

 

       
iShares ETF   In-kind
Purchases
       

In-kind  

Sales  

 

Evolved U.S. Consumer Staples

  $    1,724,833      $ —     

Evolved U.S. Discretionary Spending

  4,642,967        8,362,805    

Evolved U.S. Financials

  3,067,118                 —    

Evolved U.S. Healthcare Staples

  7,986,511        1,838,595    

Evolved U.S. Innovative Healthcare

  10,347,101        9,477,944    

Evolved U.S. Media and Entertainment

         3,008,350    

Evolved U.S. Technology

  29,380,445          19,932,406    

 

7.

INCOME TAX INFORMATION

Each Fund is treated as an entity separate from the Trust’s other funds for federal income tax purposes. It is each Fund’s policy to comply with the requirements of the Internal Revenue Code of 1986, as amended, applicable to regulated investment companies, and to distribute substantially all of its taxable income to its shareholders. Therefore, no U.S. federal income tax provision is required.

Management has analyzed tax laws and regulations and their application to the Funds as of July 31, 2022, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Funds’ financial statements.

U.S. GAAP requires that certain components of net assets be adjusted to reflect permanent differences between financial and tax reporting. These reclassifications have no effect on net assets or NAV per share. As of July 31, 2022, permanent differences attributable to certain deemed distributions, distributions paid in excess of taxable income, undistributed capital gains and realized gains (losses) from in-kind redemptions were reclassified to the following accounts:

 

     
iShares ETF   Paid-in Capital      Accumulated
Earnings (Loss)
 

Evolved U.S. Consumer Staples

  $ 1,097      $ (1,097

Evolved U.S. Discretionary Spending

    2,563,413        (2,563,413

Evolved U.S. Healthcare Staples

    719,489        (719,489

Evolved U.S. Innovative Healthcare

    2,645,335        (2,645,335

Evolved U.S. Media and Entertainment

    650,862        (650,862

Evolved U.S. Technology

    7,689,498        (7,689,498

The tax character of distributions paid was as follows:

 

 

iShares ETF   Year Ended
07/31/22
     Year Ended
07/31/21
 

 

Evolved U.S. Consumer Staples

    

Ordinary income

  $ 360,114      $ 377,726  
 

 

 

    

 

 

 

Evolved U.S. Discretionary Spending

    

Ordinary income

  $ 192,387      $ 182,616  
 

 

 

    

 

 

 

 

 

N O T E S    T O   F I N A N C I A L   S T A T E M E N T S

  63


Notes to Financial Statements   (continued)

 

 

 
iShares ETF   Year Ended
07/31/22
     Year Ended
07/31/21
 

 

 

Evolved U.S. Financials

    

Ordinary income

  $ 152,736      $ 109,149  
 

 

 

    

 

 

 

Evolved U.S. Healthcare Staples

    

Ordinary income

  $ 291,853      $ 168,715  

Long-term capital gains

           2,462  
 

 

 

    

 

 

 
  $ 291,853      $ 171,177  
 

 

 

    

 

 

 

Evolved U.S. Innovative Healthcare

    

Ordinary income

  $ 760,862      $ 706,851  

Long-term capital gains

    224,934        178,835  
 

 

 

    

 

 

 
  $ 985,796      $ 885,686  
 

 

 

    

 

 

 

Evolved U.S. Media and Entertainment

    

Ordinary income

  $ 185,782      $   106,942  
 

 

 

    

 

 

 

Evolved U.S. Technology

    

Ordinary income

  $ 1,129,839      $ 464,897  

Long-term capital gains

    34,336         
 

 

 

    

 

 

 
  $   1,164,175      $ 464,897  
 

 

 

    

 

 

 

As of July 31, 2022, the tax components of accumulated net earnings (losses) were as follows:

 

             
iShares ETF    
Undistributed
Ordinary Income
 
 
   
Undistributed
Long-Term Capital Gains
 
 
   

Non-expiring
Capital Loss
Carryforwards
 
 
(a) 
   
Net Unrealized
Gains (Losses)
 
(b) 
   
Qualified
Late-Year Losses
 
(c) 
    Total  

Evolved U.S. Consumer Staples

  $ 64,228     $     $ (73,259   $ 1,564,243     $     $ 1,555,212  

Evolved U.S. Discretionary Spending

    33,052       255,249             (831,539           (543,238

Evolved U.S. Financials

    20,892             (7,332     590,758             604,318  

Evolved U.S. Healthcare Staples

    86,508       76,043             4,085,261             4,247,812  

Evolved U.S. Innovative Healthcare

    127,069       817,637             223,091             1,167,797  

Evolved U.S. Media and Entertainment

                (229,502     (3,345,047     (31,808     (3,606,357

Evolved U.S. Technology

    156,011       86,576             5,092,286             5,334,873  

 

  (a) 

Amounts available to offset future realized capital gains.

 
  (b) 

The difference between book-basis and tax-basis unrealized gains (losses) was attributable primarily to the tax deferral of losses on wash sales, the characterization of corporate actions and the realization for tax purposes of unrealized gains on investments in passive foreign investment companies.

 
  (c) 

The Funds have elected to defer certain qualified late-year losses and recognize such losses in the next taxable year.

 

For the year ended July 31, 2022, the Funds listed below utilized the following amounts of their respective capital loss carryforwards:

 

   
iShares ETF   Utilized  

Evolved U.S. Consumer Staples

  $  15,992  

Evolved U.S. Discretionary Spending

    25,528  

Evolved U.S. Financials

    14,500  

As of July 31, 2022, gross unrealized appreciation and depreciation based on cost of investments (including short positions and derivatives, if any) for U.S. federal income tax purposes were as follows:

 

         
iShares ETF   Tax Cost      Gross Unrealized
Appreciation
     Gross Unrealized
Depreciation
     Net Unrealized
Appreciation
(Depreciation)
 

Evolved U.S. Consumer Staples

  $ 15,383,033      $ 2,055,046      $ (490,803    $ 1,564,243  

Evolved U.S. Discretionary Spending

    16,752,304        1,192,579        (2,024,118      (831,539

Evolved U.S. Financials

    8,262,583        1,041,963        (451,205      590,758  

Evolved U.S. Healthcare Staples

    34,661,310        6,243,410        (2,158,149      4,085,261  

Evolved U.S. Innovative Healthcare

    36,446,786        4,322,613        (4,099,522      223,091  

Evolved U.S. Media and Entertainment

    13,812,507        496,841        (3,841,888      (3,345,047

Evolved U.S. Technology

    111,991,273        17,213,827        (12,121,541      5,092,286  

 

 

64  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements   (continued)

 

8.

PRINCIPAL RISKS

In the normal course of business, each Fund invests in securities or other instruments and may enter into certain transactions, and such activities subject the Fund to various risks, including, among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate or price fluctuations. Local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, recessions, or other events could have a significant impact on the Funds and their investments. Each Fund’s prospectus provides details of the risks to which the Fund is subject.

The Funds may be exposed to additional risks when reinvesting cash collateral in money market funds that do not seek to maintain a stable NAV per share of $1.00, which may be subject to redemption gates or liquidity fees under certain circumstances.

Market Risk: An outbreak of respiratory disease caused by a novel coronavirus has developed into a global pandemic and has resulted in closing borders, quarantines, disruptions to supply chains and customer activity, as well as general concern and uncertainty. The impact of this pandemic, and other global health crises that may arise in the future, could affect the economies of many nations, individual companies and the market in general in ways that cannot necessarily be foreseen at the present time. This pandemic may result in substantial market volatility and may adversely impact the prices and liquidity of a fund’s investments. Although vaccines have been developed and approved for use by various governments, the duration of this pandemic and its effects cannot be determined with certainty.

Valuation Risk: The market values of equities, such as common stocks and preferred securities or equity related investments, such as futures and options, may decline due to general market conditions which are not specifically related to a particular company. They may also decline due to factors which affect a particular industry or industries. A fund may invest in illiquid investments. An illiquid investment is any investment that a fund reasonably expects cannot be sold or disposed of in current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the investment. A fund may experience difficulty in selling illiquid investments in a timely manner at the price that it believes the investments are worth. Prices may fluctuate widely over short or extended periods in response to company, market or economic news. Markets also tend to move in cycles, with periods of rising and falling prices. This volatility may cause a fund’s NAV to experience significant increases or decreases over short periods of time. If there is a general decline in the securities and other markets, the NAV of a fund may lose value, regardless of the individual results of the securities and other instruments in which a fund invests.

The price each Fund could receive upon the sale of any particular portfolio investment may differ from each Fund’s valuation of the investment, particularly for securities that trade in thin or volatile markets or that are valued using a fair valuation technique or a price provided by an independent pricing service. Changes to significant unobservable inputs and assumptions (i.e., publicly traded company multiples, growth rate, time to exit) due to the lack of observable inputs.

Counterparty Credit Risk: The Funds may be exposed to counterparty credit risk, or the risk that an entity may fail to or be unable to perform on its commitments related to unsettled or open transactions, including making timely interest and/or principal payments or otherwise honoring its obligations. The Funds manage counterparty credit risk by entering into transactions only with counterparties that the Manager believes have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose the Funds to market, issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of the Funds’ exposure to market, issuer and counterparty credit risks with respect to these financial assets is approximately their value recorded in the Statements of Assets and Liabilities, less any collateral held by the Funds.

Concentration Risk: A diversified portfolio, where this is appropriate and consistent with a fund’s objectives, minimizes the risk that a price change of a particular investment will have a material impact on the NAV of a fund. The investment concentrations within each Fund’s portfolio are disclosed in its Schedule of Investments.

Certain Funds invest a significant portion of their assets in securities within a single or limited number of market sectors. When a Fund concentrates its investments in this manner, it assumes the risk that economic, regulatory, political and social conditions affecting such sectors may have a significant impact on the fund and could affect the income from, or the value or liquidity of, the fund’s portfolio.

Significant Shareholder Redemption Risk: Certain shareholders may own or manage a substantial amount of fund shares and/or hold their fund investments for a limited period of time. Large redemptions of fund shares by these shareholders may force a fund to sell portfolio securities, which may negatively impact the fund’s NAV, increase the fund’s brokerage costs, and/or accelerate the realization of taxable income/gains and cause the fund to make additional taxable distributions to shareholders.

LIBOR Transition Risk: The United Kingdom’s Financial Conduct Authority announced a phase out of the London Interbank Offered Rate (“LIBOR”). Although many LIBOR rates ceased to be published or no longer are representative of the underlying market they seek to measure after December 31, 2021, a selection of widely used USD LIBOR rates will continue to be published through June 2023 in order to assist with the transition. The Funds may be exposed to financial instruments tied to LIBOR to determine payment obligations, financing terms, hedging strategies or investment value. The transition process away from LIBOR might lead to increased volatility and illiquidity in markets for, and reduce the effectiveness of new hedges placed against instruments whose terms currently include LIBOR. The ultimate effect of the LIBOR transition process on the Funds is uncertain.

 

9.

CAPITAL SHARE TRANSACTIONS

Capital shares are issued and redeemed by each Fund only in aggregations of a specified number of shares or multiples thereof (“Creation Units”) at NAV. Except when aggregated in Creation Units, shares of each Fund are not redeemable.

 

 

N O T E S    T O   F I N A N C I A L   S T A T E M E N T S

  65


 

Notes to Financial Statements   (continued)

 

Transactions in capital shares were as follows:

 

 

 
   

Year Ended

07/31/22

   

Year Ended

07/31/21

 
 

 

 

   

 

 

 
iShares ETF   Shares         Amount     Shares         Amount  

 

 

Evolved U.S. Consumer Staples

           

Shares sold

    50,000       $     1,741,757       450,000     $     13,332,379  

Shares redeemed

                  (350,000       (10,575,934
 

 

 

     

 

 

   

 

 

     

 

 

 
    50,000     $     1,741,757       100,000     $     2,756,445  
 

 

 

     

 

 

   

 

 

   

 

 

Evolved U.S. Discretionary Spending

           

Shares sold

    100,000     $     4,731,128       250,000     $     9,369,893  

Shares redeemed

    (200,000       (8,446,214     (100,000       (4,205,196
 

 

 

     

 

 

   

 

 

     

 

 

 
    (100,000   $     (3,715,086     150,000     $     5,164,697  
 

 

 

     

 

 

   

 

 

   

 

 

Evolved U.S. Financials

           

Shares sold

    100,000     $     3,331,765           $      
 

 

 

     

 

 

   

 

 

     

 

 

 

Evolved U.S. Healthcare Staples

           

Shares sold

    200,000     $     8,526,112       400,000     $     15,662,808  

Shares redeemed

    (50,000       (1,935,195     (50,000       (2,148,102
 

 

 

     

 

 

   

 

 

     

 

 

 
    150,000     $     6,590,917           350,000     $     13,514,706  
 

 

 

     

 

 

   

 

 

   

 

 

Evolved U.S. Innovative Healthcare

           

Shares sold

    300,000     $     10,512,475       400,000     $     12,756,828  

Shares redeemed

    (300,000       (9,614,606              
 

 

 

     

 

 

   

 

 

     

 

 

 
        $     897,869       400,000     $     12,756,828  
 

 

 

     

 

 

   

 

 

   

 

 

Evolved U.S. Media and Entertainment

           

Shares sold

        $           300,000     $     10,739,995  

Shares redeemed

    (100,000       (3,033,254     (150,000       (5,188,356
 

 

 

     

 

 

   

 

 

     

 

 

 
    (100,000   $     (3,033,254     150,000     $     5,551,639  
 

 

 

     

 

 

   

 

 

   

 

 

Evolved U.S. Technology

           

Shares sold

    550,000     $     29,635,752       800,000     $     39,917,886  

Shares redeemed

    (400,000       (20,095,557     (450,000       (21,130,178
 

 

 

     

 

 

   

 

 

     

 

 

 
    150,000     $     9,540,195       350,000     $     18,787,708  
 

 

 

     

 

 

   

 

 

   

 

 

The consideration for the purchase of Creation Units of a fund in the Trust generally consists of the in-kind deposit of a designated portfolio of securities and a specified amount of cash. Certain funds in the Trust may be offered in Creation Units solely or partially for cash in U.S. dollars. Investors purchasing and redeeming Creation Units may pay a purchase transaction fee and a redemption transaction fee directly to BRIL, to offset transfer and other transaction costs associated with the issuance and redemption of Creation Units, including Creation Units for cash. Investors transacting in Creation Units for cash may also pay an additional variable charge to compensate the relevant fund for certain transaction costs (i.e., stamp taxes, taxes on currency or other financial transactions, and brokerage costs) and market impact expenses relating to investing in portfolio securities. Such variable charges, if any, are included in shares sold in the table above.

From time to time, settlement of securities related to in-kind contributions or in-kind redemptions may be delayed. In such cases, securities related to in-kind transactions are reflected as a receivable or a payable in the Statements of Assets and Liabilities.

 

10.

SUBSEQUENT EVENTS

Management’s evaluation of the impact of all subsequent events on the Funds’ financial statements was completed through the date the financial statements were available to be issued and the following items were noted:

On June 15, 2022, the Board approved the liquidation of iShares Evolved U.S. Healthcare Staples ETF, iShares Evolved U.S. Innovative Healthcare ETF, iShares Evolved U.S. Consumer Staples ETF, iShares Evolved U.S. Media and Entertainment ETF and iShares Evolved U.S. Financials ETF. After the close of business on August 22, 2022, each Fund no longer accepts creation orders. Trading in each Fund halted prior to market open on August 23, 2022. Proceeds of the liquidation were sent to shareholders on August 25, 2022.

 

 

66  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Report of Independent Registered Public Accounting Firm

 

To the Board of Trustees of

iShares U.S. ETF Trust and Shareholders of each of the seven funds listed in the table below

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of each of the funds listed in the table below (seven of the funds constituting iShares U.S. ETF Trust, hereafter collectively referred to as the “Funds”) as of July 31, 2022, the related statements of operations for the year ended July 31, 2022, the statements of changes in net assets for each of the two years in the period ended July 31, 2022, including the related notes, and the financial highlights for each of the periods indicated therein (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of July 31, 2022, the results of each of their operations for the year then ended, the changes in each of their net assets for each of the two years in the period ended July 31, 2022 and each of the financial highlights for each of the periods indicated therein, in conformity with accounting principles generally accepted in the United States of America.

 

iShares Evolved U.S. Consumer Staples ETF

iShares Evolved U.S. Discretionary Spending ETF

iShares Evolved U.S. Financials ETF

iShares Evolved U.S. Healthcare Staples ETF

iShares Evolved U.S. Innovative Healthcare ETF

iShares Evolved U.S. Media and Entertainment ETF

iShares Evolved U.S. Technology ETF

Basis for Opinions

These financial statements are the responsibility of the Funds’ management. Our responsibility is to express an opinion on the Funds’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of July 31, 2022 by correspondence with the custodian, transfer agent and brokers. We believe that our audits provide a reasonable basis for our opinions.

/s/PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

September 23, 2022

We have served as the auditor of one or more BlackRock investment companies since 2000.

 

 

R E P O R T   O F   I N D E P E N D E N T   R E G I S T E R E D   P U B L I C   A C C O U N T I N G   F I R M

  67


Important Tax Information (unaudited)

 

The following amounts, or maximum amounts allowable by law, are hereby designated as qualified dividend income for individuals for the fiscal year ended July 31, 2022:

 

   
iShares ETF   Qualified Dividend
Income
 

Evolved U.S. Consumer Staples

  $ 397,108  

Evolved U.S. Discretionary Spending

    235,004  

Evolved U.S. Financials

    170,302  

Evolved U.S. Healthcare Staples

    370,349  

Evolved U.S. Innovative Healthcare

    527,738  

Evolved U.S. Media and Entertainment

    178,757     

Evolved U.S. Technology

    816,020  

The following amounts, or maximum amounts allowable by law, are hereby designated as qualified business income for individuals for the fiscal year ended July 31, 2022:

 

   
iShares ETF   Qualified Business
Income
 

Evolved U.S. Consumer Staples

  $ 1,630  

Evolved U.S. Healthcare Staples

    2,835  

Evolved U.S. Media and Entertainment

    2,301  

Evolved U.S. Technology

    1,761     

The Funds hereby designate the following amounts, or maximum amounts allowable by law, as capital gain dividends, subject to a long-term capital gains tax rate as noted below, for the fiscal year ended July 31, 2022:

 

   
iShares ETF   20% Rate Long-Term
Capital Gain Dividends
 

Evolved U.S. Discretionary Spending

  $ 109,905  

Evolved U.S. Healthcare Staples

    831  

Evolved U.S. Innovative Healthcare

    345,560  

Evolved U.S. Technology

    53,597     

The following percentage, or maximum percentage allowable by law, of ordinary income distributions paid during the fiscal year ended July 31, 2022 qualified for the dividends-received deduction for corporate shareholders:

 

   
iShares ETF   Dividends-Received
Deduction
 

Evolved U.S. Consumer Staples

    100.00

Evolved U.S. Discretionary Spending

    100.00

Evolved U.S. Financials

    100.00

Evolved U.S. Healthcare Staples

    98.77

Evolved U.S. Innovative Healthcare

    92.60

Evolved U.S. Media and Entertainment

    100.00

Evolved U.S. Technology

    77.63

The Funds hereby designate the following amount(s), or maximum amount(s) allowable by law, as qualified short-term capital gains eligible for exemption from U.S. withholding tax for nonresident aliens and foreign corporations for the fiscal year ended July 31, 2022:

 

   
iShares ETF   Qualified Short-Term
Capital Gain
 

Evolved U.S. Innovative Healthcare

  $ 269,534  

Evolved U.S. Media and Entertainment

    15,717  

Evolved U.S. Technology

    514,598  

 

 

68  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Board Review and Approval of Investment Advisory Contract

 

iShares Evolved U.S. Consumer Staples ETF, iShares Evolved U.S. Discretionary Spending ETF, iShares Evolved U.S. Financials ETF, iShares Evolved U.S. Healthcare Staples ETF, iShares Evolved U.S. Innovative Healthcare ETF, iShares Evolved U.S. Media And Entertainment ETF, iShares Evolved U.S. Technology ETF (each the “Fund”)

Under Section 15(c) of the Investment Company Act of 1940 (the “1940 Act”), the Trust’s Board of Trustees (the “Board”), including a majority of Board Members who are not “interested persons” of the Trust (as that term is defined in the 1940 Act) (the “Independent Board Members”), is required annually to consider and approve the Investment Advisory Agreement between the Trust and BFA (the “Advisory Agreement”) on behalf of the Fund. The Board’s consideration entails a year-long process whereby the Board and its committees (composed solely of Independent Board Members) assess BlackRock’s services to the Fund, including investment management; fund accounting; administrative and shareholder services; oversight of the Fund’s service providers; risk management and oversight; legal and compliance services; and ability to meet applicable legal and regulatory requirements. The Independent Board Members requested, and BFA provided, such information as the Independent Board Members, with advice from independent counsel, deemed reasonably necessary to evaluate the Advisory Agreement. At meetings on May 3, 2022 and May 18, 2022, a committee composed of all of the Independent Board Members (the “15(c) Committee”), with independent counsel, met with management and reviewed and discussed information provided in response to initial requests of the 15(c) Committee and/or its independent counsel, and requested certain additional information, which management agreed to provide. At a meeting held on June 13-15, 2022, the Board, including the Independent Board Members, reviewed the additional information provided by management in response to these requests.

After extensive discussions and deliberations, the Board, including all of the Independent Board Members, approved the continuance of the Advisory Agreement for the Fund, based on a review of qualitative and quantitative information provided by BFA and their cumulative experience as Board Members. The Board noted its satisfaction with the extent and quality of information provided and its frequent interactions with management, as well as the detailed responses and other information provided by BFA. The Independent Board Members were advised by their independent counsel throughout the process, including about the legal standards applicable to their review. In approving the continuance of the Advisory Agreement for the Fund, the Board, including the Independent Board Members, considered various factors, including: (i) the expenses and performance of the Fund; (ii) the nature, extent and quality of the services provided by BFA; (iii) the costs of services provided to the Fund and profits realized by BFA and its affiliates; (iv) potential economies of scale and the sharing of related benefits; (v) the fees and services provided for other comparable funds/accounts managed by BFA and its affiliates; and (vi) other benefits to BFA and/or its affiliates. The material factors, none of which was controlling, and conclusions that formed the basis for the Board, including the Independent Board Members, to approve the continuance of the Advisory Agreement are discussed below.

Expenses and Performance of the Fund: The Board reviewed statistical information prepared by Broadridge Financial Solutions Inc. (“Broadridge”), an independent provider of investment company data, regarding the expense ratio components, including gross and net total expenses, fees and expenses of another fund in which the Fund invests (if applicable), and waivers/reimbursements (if applicable) of the Fund in comparison with the same information for other ETFs, objectively selected by Broadridge as comprising the Fund’s applicable expense peer group pursuant to Broadridge’s proprietary ETF methodology (the “Peer Group”). The Board was provided with a detailed description of the proprietary ETF methodology used by Broadridge to determine the Fund’s Peer Group. The Board noted that, due to the limitations in providing comparable funds in the Peer Group, the statistical information provided in Broadridge’s report may or may not provide meaningful direct comparisons to the Fund in all instances. The Board also noted that the investment advisory fee rate and overall expenses (net of waivers and reimbursements) for the Fund were lower than the median of the investment advisory fee rates and overall expenses (net of waivers and reimbursements) of the funds in its Peer Group, excluding iShares funds.

The Board noted that the Fund is an actively managed ETF that does not seek to track the performance of a specified index and that the management team for the Fund manages the Fund’s portfolio in accordance with its investment objective. The Board further noted that, during the year, the Board received periodic reports on the Fund’s short- and longer-term performance in comparison with its reference benchmark. Such periodic comparative performance information, including additional detailed information as requested by the Board, was also considered. The Board noted that the Fund generally performed in line with expectations relative to the Fund’s peer group (where applicable) and reference benchmark.

Based on this review, the other factors considered at the meeting, and their general knowledge of ETF pricing, the Board concluded that the investment advisory fee rate and expense level and the historical performance of the Fund supported the Board’s approval of the continuance of the Advisory Agreement for the coming year.

Nature, Extent and Quality of Services Provided: Based on management’s representations, including information about recent enhancements and initiatives with respect to the iShares business, including with respect to capital markets support and analysis, technology, portfolio management, product design and quality, compliance and risk management, global public policy and other services, the Board expected that there would be no diminution in the scope of services required of or provided by BFA under the Advisory Agreement for the coming year as compared with the scope of services provided by BFA during prior years. In reviewing the scope of these services, the Board considered BFA’s investment philosophy and experience, noting that BFA and its affiliates have committed significant resources over time, including during the past year, to support the iShares funds and their shareholders and have made significant investments into the iShares business. The Board also considered BFA’s compliance program and its compliance record with respect to the Fund. In that regard, the Board noted that BFA reports to the Board about portfolio management and compliance matters on a periodic basis in connection with regularly scheduled meetings of the Board, and on other occasions as necessary and appropriate, and has provided information and made relevant officers and other employees of BFA (and its affiliates) available as needed to provide further assistance with these matters. The Board also reviewed the background and experience of the persons responsible for the day-to-day management of the Fund, as well as the resources available to them in managing the Fund. In addition to the above considerations, the Board reviewed and considered detailed presentations regarding BFA’s investment performance, investment and risk management processes and strategies, provided at the May 3, 2022 meeting and throughout the year, and matters related to BFA’s portfolio compliance program.

Based on review of this information, and the performance information discussed above, the Board concluded that the nature, extent and quality of services provided to the Fund under the Advisory Agreement supported the Board’s approval of the continuance of the Advisory Agreement for the coming year.

 

 

B O A R D    R E V I E W   A N D   A P P R O V A L   O F   I N V E S T M E N T   A D V I S O R Y   C O N T R A C T

  69


Board Review and Approval of Investment Advisory Contract  (continued)

 

Costs of Services Provided to the Fund and Profits Realized by BFA and its Affiliates: The Board reviewed information about the estimated profitability to BlackRock in managing the Fund, based on the fees payable to BFA and its affiliates (including fees under the Advisory Agreement), and other sources of revenue and expense to BFA and its affiliates from the Fund’s operations for the last calendar year. The Board reviewed BlackRock’s methodology for calculating estimated profitability of the iShares funds, noting that the 15(c) Committee and the Board had focused on the methodology and profitability presentation. The Board recognized that profitability may be affected by numerous factors, including, among other things, fee waivers by BFA, the types of funds managed, expense allocations and business mix. The Board thus recognized that calculating and comparing profitability at individual fund levels is challenging. The Board discussed with management the sources of direct and ancillary revenue, including the revenues to BTC, a BlackRock affiliate, from securities lending by the Fund. The Board also discussed BFA’s estimated profit margin as reflected in the Fund’s profitability analysis and reviewed information regarding potential economies of scale (as discussed below).

Based on this review, the Board concluded that the information considered with respect to the profits realized by BFA and its affiliates under the Advisory Agreement and from other relationships between the Fund and BFA and/or its affiliates, if any, as well as the other factors considered at the meeting, supported the Board’s approval of the continuance of the Advisory Agreement for the coming year.

Economies of Scale: The Board reviewed information and considered the extent to which economies of scale might be realized as the assets of the Fund increase, noting that the issue of potential economies of scale had been focused on by the 15(c) Committee and the Board during their meetings and addressed by management. The 15(c) Committee and the Board received information regarding BlackRock’s historical estimated profitability, including BFA’s and its affiliates’ estimated costs in providing services. The estimated cost information distinguished, among other things, between fixed and variable costs, and showed how the level and nature of fixed and variable costs may impact the existence or size of scale benefits, with the Board recognizing that potential economies of scale are difficult to measure. The 15(c) Committee and the Board reviewed information provided by BFA regarding the sharing of scale benefits with the iShares funds through various means, including, as applicable, through relatively low fee rates established at inception, breakpoints, waivers, or other fee reductions, as well as through additional investment in the iShares business and the provision of improved or additional infrastructure and services to the iShares funds and their shareholders. The Board noted that the Advisory Agreement for the Fund did not provide for breakpoints in the Fund’s investment advisory fee rate as the assets of the Fund increase. However, the Board noted that it would continue to assess the appropriateness of adding breakpoints in the future.

The Board concluded that this review of potential economies of scale and the sharing of related benefits, as well as the other factors considered at the meeting, supported the Board’s approval of the continuance of the Advisory Agreement for the coming year.

Fees and Services Provided for Other Comparable Funds/Accounts Managed by BFA and its Affiliates: The Board received and considered information regarding the investment advisory/management fee rates for other funds/accounts in the U.S. for which BFA (or its affiliates) provides investment advisory/management services, including open-end funds registered under the 1940 Act (including sub-advised funds), collective trust funds, and institutional separate accounts (collectively, the “Other Accounts”). The Board acknowledged BFA’s representation that the iShares funds are fundamentally different investment vehicles from the Other Accounts.

The Board received detailed information regarding how the Other Accounts generally differ from the Fund, including in terms of the types of services and generally more extensive services provided to the Fund, as well as other significant differences. In that regard, the Board considered that the pricing of services to institutional clients is typically based on a number of factors beyond the nature and extent of the specific services to be provided and often depends on the overall relationship between the client and its affiliates and the adviser and its affiliates. In addition, the Board considered the relative complexity and inherent risks and challenges of managing and providing other services to the Fund, as a publicly traded investment vehicle, as compared to the Other Accounts, particularly those that are institutional clients, in light of differing regulatory requirements and client-imposed mandates. The Board noted that BFA and its affiliates do not manage Other Accounts with a similar investment strategy or investment mandate as the Fund. The Board also acknowledged management’s assertion that, for certain iShares funds, and for client segmentation purposes, BlackRock has launched an iShares fund that may provide a similar investment exposure at a lower investment advisory fee rate.

The Board considered the “all-inclusive” nature of the Fund’s advisory fee structure, and the Fund’s expenses borne by BFA under this arrangement and noted that the investment advisory fee rate under the Advisory Agreement for the Fund was generally higher than the investment advisory/management fee rates for certain of the Other Accounts (particularly institutional clients) and concluded that the differences appeared to be consistent with the factors discussed.

Other Benefits to BFA and/or its Affiliates: The Board reviewed other benefits or ancillary revenue received by BFA and/or its affiliates in connection with the services provided to the Fund by BFA, both direct and indirect, including, but not limited to, payment of revenue to BTC, the Fund’s securities lending agent, for loaning portfolio securities (which was included in the profit margins reviewed by the Board pursuant to BFA’s estimated profitability methodology), payment of advisory fees or other fees to BFA (or its affiliates) in connection with any investments by the Fund in other funds for which BFA (or its affiliates) provides investment advisory services or other services, and BlackRock’s profile in the investment community. The Board also noted the revenue received by BFA and/or its affiliates pursuant to an agreement that permits a service provider to use certain portions of BlackRock’s technology platform to service accounts managed by BFA and/or its affiliates, including the iShares funds. The Board noted that BFA generally does not use soft dollars or consider the value of research or other services that may be provided to BFA (including its affiliates) in selecting brokers for portfolio transactions for the Fund. The Board concluded that any such ancillary benefits would not be disadvantageous to the Fund and thus would not alter the Board’s conclusion with respect to the appropriateness of approving the continuance of the Advisory Agreement for the coming year.

Conclusion: Based on a review of the factors described above, as well as such other factors as deemed appropriate by the Board, the Board, including all of the Independent Board Members, determined that the Fund’s investment advisory fee rate under the Advisory Agreement does not constitute a fee that is so disproportionately large as to bear no reasonable relationship to the services rendered and that could not have been the product of arm’s-length bargaining, and concluded to approve the continuance of the Advisory Agreement for the coming year.

 

 

70  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Supplemental Information (unaudited)

 

Section 19(a) Notices

The amounts and sources of distributions reported are estimates and are being provided pursuant to regulatory requirements and are not being provided for tax reporting purposes. The actual amounts and sources for tax reporting purposes will depend upon each Fund’s investment experience during the year and may be subject to changes based on tax regulations. Shareholders will receive a Form 1099-DIV each calendar year that will inform them how to report these distributions for federal income tax purposes.

July 31, 2022

 

       
   

Total Cumulative Distributions

for the Fiscal Year

        

% Breakdown of the Total Cumulative

Distributions for the Fiscal Year

 
 

 

 

      

 

 

 
iShares ETF  

Net

Investment

Income

    

Net Realized

Capital Gains

    

Return of

Capital

    

Total Per

Share

           

Net

Investment

Income

    

Net Realized

Capital Gains

    

Return of

Capital

    

Total Per

Share

 

Evolved U.S. Consumer Staples

  $   0.767882        $        $       $  0.767882          100                100

Evolved U.S. Discretionary Spending

    0.377488                      0.377488          100                      100  

Evolved U.S. Financials

    0.589728                      0.589728          100                      100  

Evolved U.S. Healthcare Staples

    0.329926                      0.329926          100                      100  

Evolved U.S. Innovative Healthcare

    0.453457        0.412057               0.865514          52        48               100  

Evolved U.S. Media and Entertainment(a)

    0.326750        0.031434        0.020105        0.378289          87        8        5        100  

Evolved U.S. Technology

    0.248471        0.207145               0.455616            55        45               100  

 

  (a) 

The Fund estimates that it has distributed more than its net investment income and net realized capital gains; therefore, a portion of the distribution may be a return of capital. A return of capital may occur, for example, when some or all of the shareholder’s investment in the Fund is returned to the shareholder. A return of capital does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income”. When distributions exceed total return performance, the difference will incrementally reduce the Fund’s net asset value per share.

 

Premium/Discount Information

Information on the Fund’s net asset value, market price, premiums and discounts, and bid-ask spreads can be found at iShares.com.

 

 

S U P P L E M E N T A L   I N F O R M A T I O N

  71


Trustee and Officer Information (unaudited)

 

The Board of Trustees has responsibility for the overall management and operations of the Funds, including general supervision of the duties performed by BFA and other service providers. Each Trustee serves until he or she resigns, is removed, dies, retires or becomes incapacitated. The President, Chief Compliance Officer, Treasurer and Secretary shall each hold office until their successors are chosen and qualify, and all other officers shall hold office until he or she resigns or is removed. Trustees who are not “interested persons” (as defined in the 1940 Act) of the Trust are referred to as independent trustees (“Independent Trustees”).

The registered investment companies advised by BFA or its affiliates (the “BlackRock-advised Funds”) are organized into one complex of open-end equity, multi-asset, index and money market funds and ETFs (the “BlackRock Multi-Asset Complex”), one complex of closed-end funds and open-end non-index fixed-income funds (including ETFs) (the “BlackRock Fixed-Income Complex”) and one complex of ETFs (“Exchange-Traded Fund Complex”) (each, a “BlackRock Fund Complex”). Each Fund is included in the Exchange-Traded Fund Complex. Each Trustee also serves as a Director of iShares, Inc. and a Trustee of iShares Trust, and, as a result, oversees all of the funds within the Exchange-Traded Fund Complex, which consists of 384 funds as of July 31, 2022. With the exception of Robert S. Kapito, Salim Ramji and Charles Park, the address of each Trustee and officer is c/o BlackRock, Inc., 400 Howard Street, San Francisco, CA 94105. The address of Mr. Kapito, Mr. Ramji and Mr. Park is c/o BlackRock, Inc., Park Avenue Plaza, 55 East 52nd Street, New York, NY 10055. The Board has designated Cecilia H. Herbert as its Independent Board Chair. Additional information about the Funds’ Trustees and officers may be found in the Funds’ combined Statement of Additional Information, which is available without charge, upon request, by calling toll-free 1-800-iShares (1-800-474-2737).

 

Interested Trustees
       
 Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

   Other Directorships Held by Trustee
Robert S. Kapito(a) (65)    Trustee (since 2011).    President, BlackRock, Inc. (since 2006); Vice Chairman of BlackRock, Inc. and Head of BlackRock’s Portfolio Management Group (since its formation in 1998) and BlackRock, Inc.’s predecessor entities (since 1988); Trustee, University of Pennsylvania (since 2009); President of Board of Directors, Hope & Heroes Children’s Cancer Fund (since 2002).    Director of BlackRock, Inc. (since 2006); Director of iShares, Inc. (since 2009); Trustee of iShares Trust (since 2009).
Salim Ramji(b) (52)    Trustee (since 2019).    Senior Managing Director, BlackRock, Inc. (since 2014); Global Head of BlackRock’s ETF and Index Investments Business (since 2019); Head of BlackRock’s U.S. Wealth Advisory Business (2015-2019); Global Head of Corporate Strategy, BlackRock, Inc. (2014-2015); Senior Partner, McKinsey & Company (2010-2014).    Director of iShares, Inc. (since 2019); Trustee of iShares Trust (since 2019).

 

(a)  Robert S. Kapito is deemed to be an “interested person” (as defined in the 1940 Act) of the Trust due to his affiliations with BlackRock, Inc. and its affiliates.

 

(b)  Salim Ramji is deemed to be an “interested person” (as defined in the 1940 Act) of the Trust due to his affiliations with BlackRock, Inc. and its affiliates.

          Independent Trustees     
       
 Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

   Other Directorships Held by Trustee
John E. Kerrigan (67)    Trustee (since 2011); Independent Board Chair (since 2022).    Chief Investment Officer, Santa Clara University (since 2002).    Director of iShares, Inc. (since 2005); Trustee of iShares Trust (since 2005); Independent Board Chair of iShares, Inc. and iShares Trust.
Jane D. Carlin (66)    Trustee (since 2015); Risk Committee Chair (since 2016).    Consultant (since 2012); Member of the Audit Committee (2012-2018), Chair of the Nominating and Governance Committee (2017-2018) and Director of PHH Corporation (mortgage solutions) (2012-2018); Managing Director and Global Head of Financial Holding Company Governance & Assurance and the Global Head of Operational Risk Management of Morgan Stanley (2006-2012).    Director of iShares, Inc. (since 2015); Trustee of iShares Trust (since 2015); Member of the Audit Committee (since 2016), Chair of the Audit Committee (since 2020) and Director of The Hanover Insurance Group, Inc. (since (2016).
Richard L. Fagnani (67)    Trustee (since 2017); Audit Committee Chair (since 2019).    Partner, KPMG LLP (2002-2016).    Director of iShares, Inc. (since 2017); Trustee of iShares Trust (since 2017).

 

 

72  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Trustee and Officer Information (unaudited) (continued)

 

          Independent Trustees (continued)     
       
 Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

   Other Directorships Held by Trustee
Cecilia H. Herbert (73)    Trustee (since 2011); Independent Board Chair (since 2016).    Chair of the Finance Committee (since 2019) and Trustee and Member of the Finance, Audit and Quality Committees of Stanford Health Care (since 2016); Trustee of WNET, New York’s public media company (since 2011) and Member of the Audit Committee (since 2018) and Investment Committee (since 2011); Chair (1994-2005) and Member (since 1992) of the Investment Committee, Archdiocese of San Francisco; Trustee of Forward Funds (14 portfolios) (2009-2018); Trustee of Salient MF Trust (4 portfolios) (2015-2018); Director (1998-2013) and President (2007-2011) of the Board of Directors, Catholic Charities CYO; Trustee (2002-2011) and Chair of the Finance and Investment Committee (2006-2010) of the Thacher School; Director of the Senior Center of Jackson Hole (since 2020).    Director of iShares, Inc. (since 2005); Trustee of iShares Trust (since 2005); Independent Board Chair of iShares, Inc. and iShares Trust (since 2016); Trustee of Thrivent Church Loan and Income Fund (since 2019).
Drew E. Lawton (63)    Trustee (since 2017); 15(c) Committee Chair (since 2017).    Senior Managing Director of New York Life Insurance Company (2010-2015).    Director of iShares, Inc. (since 2017); Trustee of iShares Trust (since 2017).
John E. Martinez (61)    Trustee (since 2011); Securities Lending Committee Chair (since 2019).    Director of Real Estate Equity Exchange, Inc. (since 2005); Director of Cloudera Foundation (2017-2020); and Director of Reading Partners (2012-2016).    Director of iShares, Inc. (since 2003); Trustee of iShares Trust (since 2003).
Madhav V. Rajan (57)    Trustee (since 2011); Fixed Income Plus Committee Chair (since 2019).    Dean, and George Pratt Shultz Professor of Accounting, University of Chicago Booth School of Business (since 2017); Advisory Board Member (since 2016) and Director (since 2020) of C.M. Capital Corporation; Chair of the Board for the Center for Research in Security Prices, LLC (since 2020); Robert K. Jaedicke Professor of Accounting, Stanford University Graduate School of Business (2001-2017); Professor of Law (by courtesy), Stanford Law School (2005-2017); Senior Associate Dean for Academic Affairs and Head of MBA Program, Stanford University Graduate School of Business (2010-2016).    Director of iShares, Inc. (since 2011); Trustee of iShares Trust (since 2011).

 

Officers
     
 Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

Armando Senra (51)    President (since 2019).    Managing Director, BlackRock, Inc. (since 2007); Head of U.S., Canada and Latam iShares, BlackRock, Inc. (since 2019); Head of Latin America Region, BlackRock, Inc. (2006-2019); Managing Director, Bank of America Merrill Lynch (1994-2006).
Trent Walker (48)    Treasurer and Chief Financial Officer (since 2020).    Managing Director, BlackRock, Inc. (since September 2019); Chief Financial Officer of iShares Delaware Trust Sponsor LLC, BlackRock Funds, BlackRock Funds II, BlackRock Funds IV, BlackRock Funds V and BlackRock Funds VI (since 2021); Executive Vice President of PIMCO (2016-2019); Senior Vice President of PIMCO (2008-2015); Treasurer (2013-2019) and Assistant Treasurer (2007-2017) of PIMCO Funds, PIMCO Variable Insurance Trust, PIMCO ETF Trust, PIMCO Equity Series, PIMCO Equity Series VIT, PIMCO Managed Accounts Trust, 2 PIMCO-sponsored interval funds and 21 PIMCO-sponsored closed-end funds.
Charles Park (54)    Chief Compliance Officer (since 2011).    Chief Compliance Officer of BlackRock Advisors, LLC and the BlackRock-advised Funds in the BlackRock Multi-Asset Complex and the BlackRock Fixed-Income Complex (since 2014); Chief Compliance Officer of BFA (since 2006).
Marisa Rolland (41)    Secretary (since 2022).    Director, BlackRock, Inc. (since 2018); Vice President, BlackRock, Inc. (2010-2017).
Rachel Aguirre (40)    Executive Vice President (since 2022).    Managing Director, BlackRock, Inc. (since 2018); Director, BlackRock, Inc. (2009-2018); Head of U.S. iShares Product (since 2022); Head of EII U.S. Product Engineering (since 2021); Co-Head of EII’s Americas Portfolio Engineering (2020-2021); Head of Developed Markets Portfolio Engineering (2016-2019).
Jennifer Hsui (46)    Executive Vice President (since 2022).    Managing Director, BlackRock, Inc. (since 2009); Co-Head of Index Equity (since 2022).
James Mauro (51)    Executive Vice President (since 2022).    Managing Director, BlackRock, Inc. (since 2010); Head of Fixed Income Index Investments in the Americas and Head of San Francisco Core Portfolio Management (since 2020).

 

 

T R U S T E E   A N D   O F F I C E R   I N F O R M A T I O N

  73


Trustee and Officer Information (unaudited) (continued)

 

 

 

Effective March 18, 2022, Rachel Aguirre, Jennifer Hsui, and James Mauro have replaced Scott Radell, Alan Mason, and Marybeth Leithead as Executive Vice Presidents.

 

Effective June 15, 2022, Marisa Rolland replaced Deepa Damre Smith as Secretary.

 

 

 

74  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


General Information

 

Electronic Delivery

Shareholders can sign up for e-mail notifications announcing that the shareholder report or prospectus has been posted on the iShares website at iShares.com. Once you have enrolled, you will no longer receive prospectuses and shareholder reports in the mail.

To enroll in electronic delivery:

 

   

Go to icsdelivery.com.

   

If your brokerage firm is not listed, electronic delivery may not be available. Please contact your broker-dealer or financial advisor.

Householding

Householding is an option available to certain fund investors. Householding is a method of delivery, based on the preference of the individual investor, in which a single copy of certain shareholder documents and Rule 30e-3 notices can be delivered to investors who share the same address, even if their accounts are registered under different names. Please contact your broker-dealer if you are interested in enrolling in householding and receiving a single copy of prospectuses and other shareholder documents, or if you are currently enrolled in householding and wish to change your householding status.

Availability of Quarterly Schedule of Investments

The Funds file their complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year as an exhibit to their reports on Form N-PORT. The Funds’ Forms N-PORT are available on the SEC’s website at sec.gov. Additionally, each Fund makes its portfolio holdings for the first and third quarters of each fiscal year available at iShares.com/fundreports.

Availability of Proxy Voting Policies and Proxy Voting Records

A description of the policies and procedures that the iShares Funds use to determine how to vote proxies relating to portfolio securities and information about how the iShares Funds voted proxies relating to portfolio securities during the most recent twelve-month period ending June 30 is available without charge, upon request (1) by calling toll-free 1-800-474-2737; (2) on the iShares website at iShares.com; and (3) on the SEC website at sec.gov.

A description of the Trust’s policies and procedures with respect to the disclosure of the Fund’s portfolio securities is available in the Fund Prospectus. The Fund discloses its portfolio holdings daily and provides information regarding its top holdings in Fund fact sheets at iShares.com.

 

 

G E N E R A L   I N F O R M A T I O N

  75


Glossary of Terms Used in this Report

 

Portfolio Abbreviations
ADR    American Depositary Receipt
NVS    Non-Voting Shares
REIT    Real Estate Investment Trust

 

 

76  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


 

 

 

 

 

Want to know more?

iShares.com     |     1-800-474-2737

This report is intended for the Funds’ shareholders. It may not be distributed to prospective investors unless it is preceded or accompanied by the current prospectus.

Investing involves risk, including possible loss of principal.

The iShares Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”).

©2022 BlackRock, Inc. All rights reserved. iSHARES and BLACKROCK are registered trademarks of BlackRock, Inc. or its subsidiaries. All other marks are the property of their respective owners.

iS-AR-715-0722

 

 

 

LOGO

   LOGO